,words,labels,sentence_id,full sentence
72,Moreover,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
73,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
74,selenium,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
75,content,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
76,in,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
77,products,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
78,based,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
79,on,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
80,popular,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
81,gluten,B-AG.01.i,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
82,-,I-AG.01.i,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
83,free,I-AG.01.i,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
84,cereals,I-AG.01.i,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
85,like,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
86,corn,B-AG.01.i,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
87,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
88,rice,B-AG.01.i,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
89,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
90,and,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
91,buckwheat,B-AG.01.i,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
92,and,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
93,in,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
94,relatively,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
95,new,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
96,or,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
97,less,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
98,popular,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
99,products,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
100,based,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
101,on,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
102,oat,B-AG.01.i,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
103,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
104,amaranth,B-AG.01.i,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
105,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
106,teff,B-AG.01.i,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
107,",",O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
108,and,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
109,quinoa,B-AG.01.i,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
110,was,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
111,compared,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
112,.,O,2.0,"Moreover , selenium content in products based on popular gluten - free cereals like corn , rice , and buckwheat and in relatively new or less popular products based on oat , amaranth , teff , and quinoa was compared ."
253,Modern,O,6.0,Modern breeding programs were conceived in the 1960s .
254,breeding,O,6.0,Modern breeding programs were conceived in the 1960s .
255,programs,O,6.0,Modern breeding programs were conceived in the 1960s .
256,were,O,6.0,Modern breeding programs were conceived in the 1960s .
257,conceived,O,6.0,Modern breeding programs were conceived in the 1960s .
258,in,O,6.0,Modern breeding programs were conceived in the 1960s .
259,the,O,6.0,Modern breeding programs were conceived in the 1960s .
260,1960s,O,6.0,Modern breeding programs were conceived in the 1960s .
261,.,O,6.0,Modern breeding programs were conceived in the 1960s .
262,The,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
263,most,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
264,efficient,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
265,selection,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
266,scheme,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
267,for,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
268,local,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
269,dairy,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
270,sheep,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
271,breeds,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
272,is,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
273,based,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
274,on,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
275,pyramidal,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
276,management,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
277,of,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
278,the,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
279,population,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
280,with,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
281,the,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
282,breeders,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
283,of,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
284,nucleus,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
285,flocks,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
286,at,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
287,the,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
288,top,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
289,",",O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
290,where,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
291,pedigree,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
292,and,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
293,official,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
294,milk,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
295,recording,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
296,",",O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
297,artificial,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
298,insemination,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
299,",",O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
300,controlled,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
301,natural,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
302,mating,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
303,",",O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
304,and,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
305,breeding,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
306,value,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
307,estimation,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
308,are,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
309,carried,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
310,out,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
311,to,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
312,generate,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
313,genetic,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
314,progress,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
315,.,O,7.0,"The most efficient selection scheme for local dairy sheep breeds is based on pyramidal management of the population with the breeders of nucleus flocks at the top , where pedigree and official milk recording , artificial insemination , controlled natural mating , and breeding value estimation are carried out to generate genetic progress ."
739,Elderly,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
740,people,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
741,in,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
742,particular,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
743,might,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
744,benefit,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
745,from,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
746,the,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
747,new,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
748,product,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
749,because,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
750,it,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
751,reduces,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
752,their,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
753,calcium,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
754,loss,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
755,as,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
756,well,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
757,as,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
758,their,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
759,intake,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
760,of,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
761,protein,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
762,",",O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
763,phosphorus,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
764,",",O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
765,energy,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
766,",",O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
767,and,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
768,liquid,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
769,volume,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
770,.,O,24.0,"Elderly people in particular might benefit from the new product because it reduces their calcium loss as well as their intake of protein , phosphorus , energy , and liquid volume ."
929,Polyphenols,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
930,may,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
931,also,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
932,enhance,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
933,insulin,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
934,-,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
935,dependent,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
936,glucose,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
937,uptake,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
938,",",O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
939,activate,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
940,5,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
941,',O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
942,adenosine,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
943,monophosphate,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
944,-,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
945,activated,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
946,protein,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
947,kinase,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
948,(,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
949,AMPK,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
950,),O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
951,",",O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
952,modify,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
953,the,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
954,microbiome,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
955,and,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
956,have,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
957,anti,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
958,-,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
959,inflammatory,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
960,effects,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
961,.,O,28.0,"Polyphenols may also enhance insulin - dependent glucose uptake , activate 5 ' adenosine monophosphate - activated protein kinase ( AMPK ) , modify the microbiome and have anti - inflammatory effects ."
1275,Several,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1276,spices,B-AG.01.l.03,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1277,are,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1278,potential,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1279,sources,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1280,for,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1281,prevention,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1282,and,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1283,treatment,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1284,of,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1285,cancers,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1286,",",O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1287,such,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1288,as,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1289,Curcuma,B-AG.01.l.03,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1290,longa,I-AG.01.l.03,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1291,(,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1292,tumeric,B-AG.01.l.03,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1293,),O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1294,",",O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1295,Nigella,B-AG.01.l.03,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1296,sativa,I-AG.01.l.03,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1297,(,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1298,black,B-AG.01.l.03,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1299,cumin,I-AG.01.l.03,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1300,),O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1301,",",O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1302,Zingiber,B-AG.01.l.03,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1303,officinale,I-AG.01.l.03,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1304,(,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1305,ginger,B-AG.01.l.03,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1306,),O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1307,",",O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1308,Allium,B-AG.01.h.02.e,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1309,sativum,I-AG.01.h.02.e,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1310,(,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1311,garlic,B-AG.01.h.02.e,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1312,),O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1313,",",O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1314,Crocus,B-AG.01.l.03,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1315,sativus,I-AG.01.l.03,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1316,(,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1317,saffron,B-AG.01.l.03,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1318,),O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1319,",",O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1320,Piper,B-AG.01.l.03,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1321,nigrum,I-AG.01.l.03,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1322,(,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1323,black,B-AG.01.l.03,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1324,pepper,I-AG.01.l.03,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1325,),O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1326,and,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1327,Capsicum,B-AG.01.l.03,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1328,annum,I-AG.01.l.03,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1329,(,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1330,chili,B-AG.01.l.03,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1331,pepper,I-AG.01.l.03,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1332,),O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1333,",",O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1334,which,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1335,contained,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1336,several,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1337,important,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1338,bioactive,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1339,compounds,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1340,",",O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1341,such,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1342,as,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1343,curcumin,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1344,",",O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1345,thymoquinone,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1346,",",O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1347,piperine,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1348,and,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1349,capsaicin,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1350,.,O,40.0,"Several spices are potential sources for prevention and treatment of cancers , such as Curcuma longa ( tumeric ) , Nigella sativa ( black cumin ) , Zingiber officinale ( ginger ) , Allium sativum ( garlic ) , Crocus sativus ( saffron ) , Piper nigrum ( black pepper ) and Capsicum annum ( chili pepper ) , which contained several important bioactive compounds , such as curcumin , thymoquinone , piperine and capsaicin ."
1377,This,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1378,review,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1379,summarized,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1380,recent,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1381,studies,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1382,on,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1383,some,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1384,spices,B-AG.01.l.03,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1385,for,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1386,prevention,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1387,and,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1388,treatment,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1389,of,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1390,cancers,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1391,",",O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1392,and,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1393,special,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1394,attention,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1395,was,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1396,paid,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1397,to,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1398,bioactive,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1399,components,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1400,and,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1401,mechanisms,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1402,of,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1403,action,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
1404,.,O,42.0,"This review summarized recent studies on some spices for prevention and treatment of cancers , and special attention was paid to bioactive components and mechanisms of action ."
2032,Chocolate,O,61.0,Chocolate and other cocoa products are not all alike .
2033,and,O,61.0,Chocolate and other cocoa products are not all alike .
2034,other,O,61.0,Chocolate and other cocoa products are not all alike .
2035,cocoa,B-AG.01,61.0,Chocolate and other cocoa products are not all alike .
2036,products,I-AG.01,61.0,Chocolate and other cocoa products are not all alike .
2037,are,O,61.0,Chocolate and other cocoa products are not all alike .
2038,not,O,61.0,Chocolate and other cocoa products are not all alike .
2039,all,O,61.0,Chocolate and other cocoa products are not all alike .
2040,alike,O,61.0,Chocolate and other cocoa products are not all alike .
2041,.,O,61.0,Chocolate and other cocoa products are not all alike .
2252,The,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2253,present,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2254,study,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2255,aimed,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2256,to,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2257,examine,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2258,whether,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2259,the,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2260,antiobesity,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2261,effect,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2262,of,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2263,ginger,B-AG.01.l.03,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2264,is,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2265,associated,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2266,with,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2267,energy,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2268,metabolism,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2269,.,O,72.0,The present study aimed to examine whether the antiobesity effect of ginger is associated with energy metabolism .
2376,Moreover,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2377,",",O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2378,ginger,B-AG.01.l.03,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2379,enhanced,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2380,brown,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2381,adipose,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2382,tissue,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2383,function,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2384,and,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2385,activated,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2386,white,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2387,adipose,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2388,tissue,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2389,browning,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2390,by,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2391,altering,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2392,the,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2393,gene,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2394,expression,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2395,and,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2396,protein,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2397,levels,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2398,of,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2399,some,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2400,brown,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2401,and,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2402,beige,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2403,adipocyte,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2404,-,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2405,selective,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2406,markers,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2407,.,O,77.0,"Moreover , ginger enhanced brown adipose tissue function and activated white adipose tissue browning by altering the gene expression and protein levels of some brown and beige adipocyte - selective markers ."
2475,Thus,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2476,",",O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2477,ginger,B-AG.01.l.03,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2478,is,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2479,an,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2480,edible,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2481,plant,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2482,that,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2483,plays,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2484,a,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2485,role,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2486,in,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2487,the,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2488,therapeutic,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2489,treatment,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2490,of,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2491,obesity,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2492,and,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2493,related,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2494,disorders,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
2495,.,O,80.0,"Thus , ginger is an edible plant that plays a role in the therapeutic treatment of obesity and related disorders ."
3224,In,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3225,conclusion,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3226,",",O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3227,consumption,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3228,of,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3229,water,B-AG.01.z,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3230,",",O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3231,reduced,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3232,-,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3233,energy,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3234,OJ,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3235,",",O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3236,or,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3237,milk,B-AG.01.e,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3238,(,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3239,irrespective,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3240,of,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3241,fat,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3242,content,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3243,),O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3244,with,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3245,a,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3246,meal,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3247,may,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3248,be,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3249,preferable,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3250,to,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3251,consuming,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3252,sugar,B-AG.01.ad,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3253,-,I-AG.01.ad,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3254,sweetened,I-AG.01.ad,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3255,coffee,I-AG.01.ad,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3256,for,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3257,glucose,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3258,control,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3259,in,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3260,middle,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3261,-,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3262,aged,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3263,adults,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3264,who,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3265,are,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3266,overweight,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3267,and,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3268,obese,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3269,.,O,100.0,"In conclusion , consumption of water , reduced - energy OJ , or milk ( irrespective of fat content ) with a meal may be preferable to consuming sugar - sweetened coffee for glucose control in middle - aged adults who are overweight and obese ."
3270,To,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3271,assess,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3272,gastric,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3273,cancer,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3274,(,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3275,GC,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3276,),O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3277,risk,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3278,in,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3279,relation,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3280,to,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3281,dietary,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3282,intake,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3283,in,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3284,Korea,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3285,",",O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3286,a,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3287,case,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3288,-,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3289,control,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3290,study,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3291,was,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3292,performed,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3293,.,O,101.0,"To assess gastric cancer ( GC ) risk in relation to dietary intake in Korea , a case - control study was performed ."
3445,Intake,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3446,of,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3447,citrus,B-AG.01.h.01.a,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3448,fruits,I-AG.01.h.01.a,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3449,rather,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3450,than,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3451,total,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3452,fruits,B-AG.01.h.01,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3453,was,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3454,shown,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3455,to,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3456,have,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3457,a,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3458,protective,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3459,effect,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3460,on,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3461,the,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3462,risk,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3463,of,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3464,GC,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3465,",",O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3466,but,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3467,was,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3468,not,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3469,significant,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3470,.,O,108.0,"Intake of citrus fruits rather than total fruits was shown to have a protective effect on the risk of GC , but was not significant ."
3666,Recovery,O,117.0,"Recovery of milk components was accelerated in severe responders treated with bST , but not in moderate responders ."
3667,of,O,117.0,"Recovery of milk components was accelerated in severe responders treated with bST , but not in moderate responders ."
3668,milk,B-AG.01.e,117.0,"Recovery of milk components was accelerated in severe responders treated with bST , but not in moderate responders ."
3669,components,O,117.0,"Recovery of milk components was accelerated in severe responders treated with bST , but not in moderate responders ."
3670,was,O,117.0,"Recovery of milk components was accelerated in severe responders treated with bST , but not in moderate responders ."
3671,accelerated,O,117.0,"Recovery of milk components was accelerated in severe responders treated with bST , but not in moderate responders ."
3672,in,O,117.0,"Recovery of milk components was accelerated in severe responders treated with bST , but not in moderate responders ."
3673,severe,O,117.0,"Recovery of milk components was accelerated in severe responders treated with bST , but not in moderate responders ."
3674,responders,O,117.0,"Recovery of milk components was accelerated in severe responders treated with bST , but not in moderate responders ."
3675,treated,O,117.0,"Recovery of milk components was accelerated in severe responders treated with bST , but not in moderate responders ."
3676,with,O,117.0,"Recovery of milk components was accelerated in severe responders treated with bST , but not in moderate responders ."
3677,bST,O,117.0,"Recovery of milk components was accelerated in severe responders treated with bST , but not in moderate responders ."
3678,",",O,117.0,"Recovery of milk components was accelerated in severe responders treated with bST , but not in moderate responders ."
3679,but,O,117.0,"Recovery of milk components was accelerated in severe responders treated with bST , but not in moderate responders ."
3680,not,O,117.0,"Recovery of milk components was accelerated in severe responders treated with bST , but not in moderate responders ."
3681,in,O,117.0,"Recovery of milk components was accelerated in severe responders treated with bST , but not in moderate responders ."
3682,moderate,O,117.0,"Recovery of milk components was accelerated in severe responders treated with bST , but not in moderate responders ."
3683,responders,O,117.0,"Recovery of milk components was accelerated in severe responders treated with bST , but not in moderate responders ."
3684,.,O,117.0,"Recovery of milk components was accelerated in severe responders treated with bST , but not in moderate responders ."
3720,In,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3721,conclusion,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3722,",",O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3723,the,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3724,beneficial,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3725,effects,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3726,of,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3727,bST,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3728,upon,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3729,normalization,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3730,of,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3731,milk,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3732,production,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3733,and,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3734,composition,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3735,in,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3736,periparturient,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3737,cows,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3738,suffering,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3739,from,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3740,coliform,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3741,mastitis,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3742,seem,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3743,to,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3744,be,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3745,restricted,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3746,to,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3747,the,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3748,severe,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3749,responders,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3750,.,O,119.0,"In conclusion , the beneficial effects of bST upon normalization of milk production and composition in periparturient cows suffering from coliform mastitis seem to be restricted to the severe responders ."
3912,Canola,B-AG.01.f,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3913,and,I-AG.01.f,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3914,soybean,I-AG.01.f,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3915,oils,I-AG.01.f,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3916,significantly,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3917,lowered,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3918,serum,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3919,HDL,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3920,cholesterol,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3921,concentrations,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3922,relative,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3923,to,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3924,butter,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3925,.,O,124.0,Canola and soybean oils significantly lowered serum HDL cholesterol concentrations relative to butter .
3926,Canola,B-AG.01.f,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3927,oil,I-AG.01.f,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3928,",",O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3929,relative,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3930,to,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3931,butter,B-AG.01.e.01,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3932,",",O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3933,resulted,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3934,in,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3935,higher,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3936,exogenous,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3937,LCAT,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3938,activity,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3939,",",O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3940,and,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3941,both,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3942,soybean,B-AG.01.f,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3943,and,I-AG.01.f,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3944,canola,I-AG.01.f,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3945,oils,I-AG.01.f,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3946,significantly,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3947,increased,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3948,hepatic,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3949,apo,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3950,A,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3951,-,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3952,I,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3953,and,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3954,SR,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3955,-,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3956,B1,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3957,mRNA,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3958,abundance,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
3959,.,O,125.0,"Canola oil , relative to butter , resulted in higher exogenous LCAT activity , and both soybean and canola oils significantly increased hepatic apo A - I and SR - B1 mRNA abundance ."
4101,Stilbenes,O,130.0,Stilbenes have been shown to protect lipoproteins from oxidative damage and to have cancer chemopreventive activity .
4102,have,O,130.0,Stilbenes have been shown to protect lipoproteins from oxidative damage and to have cancer chemopreventive activity .
4103,been,O,130.0,Stilbenes have been shown to protect lipoproteins from oxidative damage and to have cancer chemopreventive activity .
4104,shown,O,130.0,Stilbenes have been shown to protect lipoproteins from oxidative damage and to have cancer chemopreventive activity .
4105,to,O,130.0,Stilbenes have been shown to protect lipoproteins from oxidative damage and to have cancer chemopreventive activity .
4106,protect,O,130.0,Stilbenes have been shown to protect lipoproteins from oxidative damage and to have cancer chemopreventive activity .
4107,lipoproteins,O,130.0,Stilbenes have been shown to protect lipoproteins from oxidative damage and to have cancer chemopreventive activity .
4108,from,O,130.0,Stilbenes have been shown to protect lipoproteins from oxidative damage and to have cancer chemopreventive activity .
4109,oxidative,O,130.0,Stilbenes have been shown to protect lipoproteins from oxidative damage and to have cancer chemopreventive activity .
4110,damage,O,130.0,Stilbenes have been shown to protect lipoproteins from oxidative damage and to have cancer chemopreventive activity .
4111,and,O,130.0,Stilbenes have been shown to protect lipoproteins from oxidative damage and to have cancer chemopreventive activity .
4112,to,O,130.0,Stilbenes have been shown to protect lipoproteins from oxidative damage and to have cancer chemopreventive activity .
4113,have,O,130.0,Stilbenes have been shown to protect lipoproteins from oxidative damage and to have cancer chemopreventive activity .
4114,cancer,O,130.0,Stilbenes have been shown to protect lipoproteins from oxidative damage and to have cancer chemopreventive activity .
4115,chemopreventive,O,130.0,Stilbenes have been shown to protect lipoproteins from oxidative damage and to have cancer chemopreventive activity .
4116,activity,O,130.0,Stilbenes have been shown to protect lipoproteins from oxidative damage and to have cancer chemopreventive activity .
4117,.,O,130.0,Stilbenes have been shown to protect lipoproteins from oxidative damage and to have cancer chemopreventive activity .
4474,All,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4475,street,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4476,food,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4477,vending,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4478,sites,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4479,(,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4480,single,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4481,point,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4482,of,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4483,sale,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4484,),O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4485,located,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4486,in,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4487,a,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4488,1,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4489,-,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4490,km,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4491,buffer,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4492,centred,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4493,on,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4494,the,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4495,main,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4496,public,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4497,market,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4498,were,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4499,systematically,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4500,selected,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4501,(,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4502,n,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4503,439,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4504,;,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4505,n,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4506,328,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4507,participants,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4508,),O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4509,.,O,141.0,All street food vending sites ( single point of sale ) located in a 1 - km buffer centred on the main public market were systematically selected ( n 439 ; n 328 participants ) .
4565,Macronutrients,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4566,",",O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4567,Na,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4568,and,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4569,K,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4570,were,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4571,quantified,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4572,through,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4573,chemical,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4574,analysis,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4575,.,O,144.0,"Macronutrients , Na and K were quantified through chemical analysis ."
4600,Among,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4601,the,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4602,latter,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4603,",",O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4604,664,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4605,%,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4606,sold,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4607,only,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4608,industrial,B-AG.01,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4609,foods,I-AG.01,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4610,(,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4611,e.g.,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4612,pretzels,B-AG.01.n,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4613,",",O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4614,biscuits,B-AG.01.n.14,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4615,",",O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4616,wafers,B-AG.01.n.17.a,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4617,",",O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4618,chocolate,B-AG.01.n.17.a,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4619,and,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4620,ice,B-AG.01.n.17.b,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4621,cream,I-AG.01.n.17.b,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4622,),O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4623,",",O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4624,215,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4625,%,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4626,only,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4627,home,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4628,-,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4629,made,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4630,(,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4631,e.g.,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4632,savoury,B-AG.01.n.15,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4633,and,I-AG.01.n.15,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4634,sweet,I-AG.01.n.15,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4635,pastries,I-AG.01.n.15,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4636,),O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4637,and,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4638,121,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4639,%,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4640,both,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
4641,.,O,146.0,"Among the latter , 664 % sold only industrial foods ( e.g. pretzels , biscuits , wafers , chocolate and ice cream ) , 215 % only home - made ( e.g. savoury and sweet pastries ) and 121 % both ."
5012,Use,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5013,of,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5014,canola,B-AG.01.f,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5015,oil,I-AG.01.f,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5016,instead,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5017,of,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5018,corn,B-AG.01.f,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5019,oil,I-AG.01.f,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5020,in,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5021,the,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5022,diet,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5023,may,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5024,be,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5025,a,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5026,reasonable,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5027,means,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5028,to,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5029,increase,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5030,consumption,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5031,of,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5032,n-3,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5033,fatty,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5034,acids,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5035,with,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5036,potential,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5037,significance,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5038,for,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5039,slowing,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5040,growth,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5041,of,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5042,residual,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5043,cancer,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5044,cells,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5045,in,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5046,cancer,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5047,survivors,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5048,.,O,159.0,Use of canola oil instead of corn oil in the diet may be a reasonable means to increase consumption of n-3 fatty acids with potential significance for slowing growth of residual cancer cells in cancer survivors .
5090,Thus,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5091,",",O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5092,we,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5093,aimed,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5094,to,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5095,investigate,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5096,the,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5097,effect,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5098,of,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5099,olive,B-AG.01.f,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5100,oil,I-AG.01.f,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5101,in,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5102,a,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5103,preclinical,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5104,model,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5105,of,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5106,colon,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5107,cancer,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5108,by,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5109,targeting,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5110,genetic,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5111,and,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5112,epigenetic,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5113,mechanisms,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5114,.,O,162.0,"Thus , we aimed to investigate the effect of olive oil in a preclinical model of colon cancer by targeting genetic and epigenetic mechanisms ."
5786,Results,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5787,from,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5788,our,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5789,study,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5790,suggest,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5791,that,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5792,water,B-AG.01.z,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5793,intake,B-X,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5794,may,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5795,be,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5796,associated,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5797,with,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5798,a,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5799,slight,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5800,reduction,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5801,in,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5802,bladder,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5803,cancer,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5804,risk,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
5805,.,O,187.0,Results from our study suggest that water intake may be associated with a slight reduction in bladder cancer risk .
7269,Due,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7270,to,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7271,the,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7272,overconsumption,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7273,of,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7274,exogenous,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7275,MG,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7276,",",O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7277,drinking,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7278,an,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7279,excess,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7280,of,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7281,any,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7282,type,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7283,of,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7284,coffee,B-AG.01.ad,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7285,poses,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7286,health,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7287,risks,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7288,.,O,240.0,"Due to the overconsumption of exogenous MG , drinking an excess of any type of coffee poses health risks ."
7444,Of,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7445,our,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7446,patients,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7447,",",O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7448,42.5,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7449,%,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7450,reported,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7451,allergic,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7452,symptoms,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7453,after,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7454,ingestion,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7455,of,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7456,these,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7457,fruits,B-AG.01.h.01,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7458,and,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7459,a,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7460,total,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7461,of,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7462,112,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7463,intolerance,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7464,reactions,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7465,were,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7466,recorded,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7467,.,O,247.0,"Of our patients , 42.5 % reported allergic symptoms after ingestion of these fruits and a total of 112 intolerance reactions were recorded ."
7648,No,O,254.0,No individual cruciferous vegetable made an important contribution to this effect .
7649,individual,O,254.0,No individual cruciferous vegetable made an important contribution to this effect .
7650,cruciferous,B-AG.01.h.02.d,254.0,No individual cruciferous vegetable made an important contribution to this effect .
7651,vegetable,I-AG.01.h.02.d,254.0,No individual cruciferous vegetable made an important contribution to this effect .
7652,made,O,254.0,No individual cruciferous vegetable made an important contribution to this effect .
7653,an,O,254.0,No individual cruciferous vegetable made an important contribution to this effect .
7654,important,O,254.0,No individual cruciferous vegetable made an important contribution to this effect .
7655,contribution,O,254.0,No individual cruciferous vegetable made an important contribution to this effect .
7656,to,O,254.0,No individual cruciferous vegetable made an important contribution to this effect .
7657,this,O,254.0,No individual cruciferous vegetable made an important contribution to this effect .
7658,effect,O,254.0,No individual cruciferous vegetable made an important contribution to this effect .
7659,.,O,254.0,No individual cruciferous vegetable made an important contribution to this effect .
8307,Under,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8308,the,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8309,realistic,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8310,scenario,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8311,",",O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8312,no,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8313,country,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8314,exceeded,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8315,100,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8316,%,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8317,of,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8318,the,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8319,UL,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8320,for,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8321,any,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8322,nutrient,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8323,.,O,276.0,"Under the realistic scenario , no country exceeded 100 % of the UL for any nutrient ."
8385,We,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8386,evaluated,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8387,the,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8388,relation,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8389,between,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8390,a,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8391,wide,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8392,range,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8393,of,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8394,foods,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8395,and,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8396,the,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8397,risk,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8398,of,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8399,RCC,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8400,in,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8401,an,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8402,Italian,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8403,case,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8404,-,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8405,control,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8406,study,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8407,including,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8408,767,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8409,patients,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8410,(,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8411,494,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8412,men,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8413,and,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8414,273,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8415,women,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8416,),O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8417,younger,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8418,than,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8419,79,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8420,years,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8421,with,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8422,incident,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8423,",",O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8424,histologically,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8425,confirmed,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8426,RCC,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8427,",",O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8428,and,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8429,"1,534",O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8430,controls,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8431,(,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8432,988,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8433,men,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8434,and,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8435,546,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8436,women,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8437,),O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8438,admitted,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8439,to,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8440,the,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8441,same,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8442,hospitals,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8443,as,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8444,cases,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8445,for,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8446,a,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8447,wide,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8448,spectrum,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8449,of,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8450,acute,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8451,",",O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8452,non,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8453,-,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8454,neoplastic,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8455,conditions,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8456,",",O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8457,not,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8458,related,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8459,to,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8460,long,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8461,term,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8462,diet,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8463,modifications,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
8464,.,O,279.0,"We evaluated the relation between a wide range of foods and the risk of RCC in an Italian case - control study including 767 patients ( 494 men and 273 women ) younger than 79 years with incident , histologically confirmed RCC , and 1,534 controls ( 988 men and 546 women ) admitted to the same hospitals as cases for a wide spectrum of acute , non - neoplastic conditions , not related to long term diet modifications ."
9038,Lactalbumin,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9039,and,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9040,lactoferrin,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9041,decreased,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9042,plasma,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9043,leptin,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9044,and,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9045,insulin,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9046,",",O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9047,and,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9048,lactalbumin,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9049,increased,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9050,peptide,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9051,YY,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9052,.,O,297.0,"Lactalbumin and lactoferrin decreased plasma leptin and insulin , and lactalbumin increased peptide YY ."
9811,Brain,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9812,-,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9813,derived,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9814,cell,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9815,cultures,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9816,from,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9817,rats,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9818,were,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9819,prepared,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9820,and,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9821,grown,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9822,for,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9823,about,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9824,2,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9825,weeks,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9826,.,O,327.0,Brain - derived cell cultures from rats were prepared and grown for about 2 weeks .
9890,Leaf,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9891,extracts,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9892,of,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9893,both,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9894,lingonberry,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9895,and,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9896,blueberry,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9897,showed,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9898,a,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9899,significant,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9900,neuroprotective,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9901,effect,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9902,.,O,331.0,Leaf extracts of both lingonberry and blueberry showed a significant neuroprotective effect .
9922,These,O,333.0,These findings suggest that berries or their components may contribute to protecting the brain from various pathologies .
9923,findings,O,333.0,These findings suggest that berries or their components may contribute to protecting the brain from various pathologies .
9924,suggest,O,333.0,These findings suggest that berries or their components may contribute to protecting the brain from various pathologies .
9925,that,O,333.0,These findings suggest that berries or their components may contribute to protecting the brain from various pathologies .
9926,berries,B-AG.01.h.01.b,333.0,These findings suggest that berries or their components may contribute to protecting the brain from various pathologies .
9927,or,O,333.0,These findings suggest that berries or their components may contribute to protecting the brain from various pathologies .
9928,their,O,333.0,These findings suggest that berries or their components may contribute to protecting the brain from various pathologies .
9929,components,O,333.0,These findings suggest that berries or their components may contribute to protecting the brain from various pathologies .
9930,may,O,333.0,These findings suggest that berries or their components may contribute to protecting the brain from various pathologies .
9931,contribute,O,333.0,These findings suggest that berries or their components may contribute to protecting the brain from various pathologies .
9932,to,O,333.0,These findings suggest that berries or their components may contribute to protecting the brain from various pathologies .
9933,protecting,O,333.0,These findings suggest that berries or their components may contribute to protecting the brain from various pathologies .
9934,the,O,333.0,These findings suggest that berries or their components may contribute to protecting the brain from various pathologies .
9935,brain,O,333.0,These findings suggest that berries or their components may contribute to protecting the brain from various pathologies .
9936,from,O,333.0,These findings suggest that berries or their components may contribute to protecting the brain from various pathologies .
9937,various,O,333.0,These findings suggest that berries or their components may contribute to protecting the brain from various pathologies .
9938,pathologies,O,333.0,These findings suggest that berries or their components may contribute to protecting the brain from various pathologies .
9939,.,O,333.0,These findings suggest that berries or their components may contribute to protecting the brain from various pathologies .
10230,For,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10231,these,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10232,effects,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10233,",",O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10234,the,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10235,CONTAM,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10236,Panel,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10237,,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10238,identified,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10239,a,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10240,lowest,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10241,-,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10242,observed,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10243,-,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10244,adverse,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10245,-,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10246,effect,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10247,level,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10248,of,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10249,1,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10250,mg,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10251,total,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10252,potato,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10253,GAs,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10254,/,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10255,kg,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10256,body,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10257,weight,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10258,(,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10259,bw,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10260,),O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10261,per,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10262,day,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10263,as,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10264,a,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10265,reference,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10266,point,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10267,for,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10268,the,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10269,risk,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10270,characterisation,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10271,following,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10272,acute,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10273,exposure,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10274,.,O,344.0,"For these effects , the CONTAM Panel  identified a lowest - observed - adverse - effect level of 1 mg total potato GAs / kg body weight ( bw ) per day as a reference point for the risk characterisation following acute exposure ."
10889,A,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10890,higher,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10891,modern,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10892,score,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10893,(,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10894,of,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10895,1,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10896,SD,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10897,),O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10898,predicted,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10899,an,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10900,annual,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10901,decrease,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10902,in,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10903,2h,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10904,-,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10905,PG,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10906,of,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10907,0.015,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10908,mmol,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10909,/,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10910,L,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10911,(,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10912,P,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10913,<,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10914,0.01,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10915,),O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10916,regardless,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10917,of,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10918,glucose,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10919,tolerance,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10920,status,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
10921,.,O,366.0,A higher modern score ( of 1 SD ) predicted an annual decrease in 2h - PG of 0.015 mmol / L ( P < 0.01 ) regardless of glucose tolerance status .
11571,In,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11572,addition,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11573,a,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11574,group,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11575,of,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11576,45,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11577,female,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11578,control,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11579,workers,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11580,matched,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11581,by,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11582,sex,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11583,",",O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11584,age,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11585,",",O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11586,and,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11587,smoking,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11588,habit,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11589,were,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11590,also,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11591,studied,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11592,.,O,387.0,"In addition a group of 45 female control workers matched by sex , age , and smoking habit were also studied ."
11948,Heat,O,402.0,Heat treatment in some cases can decrease this off - flavor .
11949,treatment,O,402.0,Heat treatment in some cases can decrease this off - flavor .
11950,in,O,402.0,Heat treatment in some cases can decrease this off - flavor .
11951,some,O,402.0,Heat treatment in some cases can decrease this off - flavor .
11952,cases,O,402.0,Heat treatment in some cases can decrease this off - flavor .
11953,can,O,402.0,Heat treatment in some cases can decrease this off - flavor .
11954,decrease,O,402.0,Heat treatment in some cases can decrease this off - flavor .
11955,this,O,402.0,Heat treatment in some cases can decrease this off - flavor .
11956,off,O,402.0,Heat treatment in some cases can decrease this off - flavor .
11957,-,O,402.0,Heat treatment in some cases can decrease this off - flavor .
11958,flavor,O,402.0,Heat treatment in some cases can decrease this off - flavor .
11959,.,O,402.0,Heat treatment in some cases can decrease this off - flavor .
12071,Attributes,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12072,associated,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12073,with,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12074,RT10,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12075,%,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12076,included,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12077,wheaty,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12078,",",O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12079,sweet,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12080,",",O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12081,and,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12082,yeast,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12083,aromas,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12084,and,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12085,wheaty,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12086,flavor,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12087,",",O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12088,whereas,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12089,attributes,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12090,associated,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12091,with,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12092,USYP,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12093,and,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12094,RT0,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12095,%,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12096,were,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12097,pea,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12098,and,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12099,nutty,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12100,aroma,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12101,and,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12102,flavor,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12103,.,O,405.0,"Attributes associated with RT10 % included wheaty , sweet , and yeast aromas and wheaty flavor , whereas attributes associated with USYP and RT0 % were pea and nutty aroma and flavor ."
12124,This,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12125,sample,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12126,contained,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12127,significantly,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12128,higher,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12129,protein,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12130,and,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12131,lower,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12132,carbohydrate,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12133,than,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12134,the,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12135,wheat,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12136,sample,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12137,.,O,407.0,This sample contained significantly higher protein and lower carbohydrate than the wheat sample .
12138,PRACTICAL,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12139,APPLICATION,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12140,:,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12141,Revtech,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12142,(,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12143,RT,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12144,),O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12145,",",O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12146,a,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12147,novel,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12148,thermal,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12149,process,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12150,",",O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12151,when,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12152,applied,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12153,at,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12154,140,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12155,,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12156,,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12157,C,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12158,with,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12159,steam,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12160,to,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12161,split,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12162,yellow,B-AG.01.h.02.g,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12163,pea,I-AG.01.h.02.g,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12164,(,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12165,SYP,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12166,),O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12167,flour,B-AG.01.h.02.g,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12168,successfully,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12169,increased,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12170,the,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12171,acceptability,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12172,of,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12173,white,B-AG.01.n.11,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12174,pan,I-AG.01.n.11,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12175,bread,I-AG.01.n.11,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12176,fortified,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12177,at,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12178,20,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12179,%,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12180,compared,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12181,to,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12182,bread,B-AG.01.n.11,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12183,fortified,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12184,with,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12185,RT,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12186,140,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12187,,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12188,,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12189,C,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12190,with,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12191,no,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12192,steam,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12193,",",O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12194,and,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12195,untreated,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12196,SYP,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12197,flours,B-AG.01.h.02.g,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12198,.,O,408.0,"PRACTICAL APPLICATION : Revtech ( RT ) , a novel thermal process , when applied at 140   C with steam to split yellow pea ( SYP ) flour successfully increased the acceptability of white pan bread fortified at 20 % compared to bread fortified with RT 140   C with no steam , and untreated SYP flours ."
12449,The,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12450,magnitude,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12451,estimation,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12452,scale,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12453,data,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12454,were,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12455,log,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12456,-,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12457,transformed,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12458,",",O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12459,and,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12460,all,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12461,data,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12462,were,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12463,analyzed,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12464,by,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12465,ANOVA,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12466,with,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12467,Fisher,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12468,'s,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12469,least,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12470,significant,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12471,difference,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12472,for,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12473,means,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12474,separation,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12475,.,O,417.0,"The magnitude estimation scale data were log - transformed , and all data were analyzed by ANOVA with Fisher 's least significant difference for means separation ."
12688,A,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12689,qualitative,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12690,reading,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12691,and,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12692,evaluation,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12693,of,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12694,relevant,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12695,articles,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12696,on,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12697,the,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12698,cancer,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12699,-,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12700,preventive,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12701,effect,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12702,of,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12703,the,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12704,consumption,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12705,of,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12706,fruits,B-AG.01.h.01,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12707,and,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12708,vegetables,B-AG.01.h.02,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12709,was,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12710,made,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12711,followed,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12712,by,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12713,the,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12714,calculation,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12715,of,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12716,the,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12717,mean,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12718,relative,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12719,risk,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12720,and,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12721,range,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12722,for,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12723,cohort,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12724,and,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12725,case,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12726,-,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12727,control,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12728,studies,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12729,separately,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12730,.,O,424.0,A qualitative reading and evaluation of relevant articles on the cancer - preventive effect of the consumption of fruits and vegetables was made followed by the calculation of the mean relative risk and range for cohort and case - control studies separately .
12731,The,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12732,possible,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12733,population,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12734,-,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12735,preventable,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12736,fraction,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12737,for,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12738,modifying,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12739,diet,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12740,in,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12741,relation,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12742,to,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12743,fruit,B-AG.01.h,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12744,and,I-AG.01.h,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12745,vegetable,I-AG.01.h,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12746,consumption,B-X,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12747,was,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12748,calculated,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12749,as,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12750,well,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12751,as,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12752,an,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12753,overall,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12754,statement,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12755,about,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12756,the,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12757,degree,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12758,of,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12759,evidence,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12760,for,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12761,the,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12762,cancer,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12763,-,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12764,preventive,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12765,effect,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12766,of,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12767,fruit,B-AG.01.h,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12768,and,I-AG.01.h,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12769,vegetable,I-AG.01.h,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12770,consumption,B-X,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12771,for,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12772,each,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12773,cancer,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12774,site,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12775,.,O,425.0,The possible population - preventable fraction for modifying diet in relation to fruit and vegetable consumption was calculated as well as an overall statement about the degree of evidence for the cancer - preventive effect of fruit and vegetable consumption for each cancer site .
12932,A,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12933,review,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12934,of,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12935,the,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12936,development,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12937,of,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12938,food,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12939,allergy,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12940,in,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12941,a,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12942,birth,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12943,cohort,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12944,of,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12945,620,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12946,Australian,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12947,infants,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12948,at,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12949,high,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12950,risk,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12951,for,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12952,development,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12953,of,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12954,atopic,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12955,disease,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12956,has,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12957,recently,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12958,been,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12959,completed,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
12960,.,O,430.0,A review of the development of food allergy in a birth cohort of 620 Australian infants at high risk for development of atopic disease has recently been completed .
13476,The,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13477,study,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13478,population,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13479,comprised,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13480,a,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13481,random,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13482,sample,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13483,of,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13484,1743,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13485,children,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13486,aged,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13487,6,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13488,-,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13489,36,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13490,months,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13491,",",O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13492,recruited,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13493,from,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13494,the,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13495,National,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13496,Danish,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13497,Civil,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13498,Registry,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13499,.,O,448.0,"The study population comprised a random sample of 1743 children aged 6 - 36 months , recruited from the National Danish Civil Registry ."
13500,The,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13501,protein,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13502,contents,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13503,from,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13504,wheat,B-AG.01.i,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13505,",",O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13506,rye,B-AG.01.i,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13507,",",O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13508,barley,B-AG.01.i,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13509,and,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13510,oats,B-AG.01.i,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13511,were,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13512,found,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13513,in,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13514,the,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13515,National,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13516,Danish,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13517,Food,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13518,Composition,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13519,Table,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13520,",",O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13521,and,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13522,multiplied,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13523,with,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13524,the,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13525,amounts,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13526,in,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13527,the,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13528,recipes,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13529,.,O,449.0,"The protein contents from wheat , rye , barley and oats were found in the National Danish Food Composition Table , and multiplied with the amounts in the recipes ."
13857,A,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13858,class,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13859,of,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13860,food,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13861,allergens,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13862,of,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13863,well,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13864,recognized,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13865,clinical,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13866,importance,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13867,is,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13868,that,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13869,of,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13870,seed,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13871,storage,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13872,2S,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13873,albumins,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13874,.,O,461.0,A class of food allergens of well recognized clinical importance is that of seed storage 2S albumins .
13875,They,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13876,have,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13877,been,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13878,identified,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13879,in,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13880,the,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13881,most,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13882,diffused,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13883,edible,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13884,seeds,B-AG.01,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13885,and,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13886,nuts,B-AG.01.h.01.f,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13887,",",O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13888,such,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13889,as,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13890,mustard,B-AG.01.l.03,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13891,",",O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13892,sesame,B-AG.01,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13893,",",O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13894,Brazil,B-AG.01.h.01.f,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13895,nut,I-AG.01.h.01.f,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13896,",",O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13897,walnut,B-AG.01.h.01.f,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13898,and,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13899,peanut,B-AG.01.h.01.f,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13900,.,O,462.0,"They have been identified in the most diffused edible seeds and nuts , such as mustard , sesame , Brazil nut , walnut and peanut ."
13929,Foods,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13930,contain,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13931,a,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13932,wide,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13933,range,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13934,of,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13935,food,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13936,ingredients,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13937,that,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13938,serve,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13939,numerous,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13940,technical,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13941,functions,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
13942,.,O,464.0,Foods contain a wide range of food ingredients that serve numerous technical functions .
14028,Other,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14029,food,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14030,ingredients,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14031,",",O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14032,including,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14033,starch,B-AG.01.l,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14034,",",O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14035,malt,B-AG.01.ae,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14036,",",O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14037,alcohol,B-AG.01.y.01,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14038,and,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14039,vinegar,B-AG.01.ae.01,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14040,",",O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14041,may,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14042,be,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14043,derived,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14044,in,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14045,some,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14046,cases,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14047,from,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14048,wheat,B-AG.01.i,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14049,",",O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14050,rye,B-AG.01.i,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14051,or,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14052,barley,B-AG.01.i,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14053,",",O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14054,the,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14055,grains,B-AG.01.i,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14056,that,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14057,are,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14058,implicated,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14059,in,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14060,the,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14061,causation,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14062,of,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14063,celiac,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14064,disease,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14065,.,O,468.0,"Other food ingredients , including starch , malt , alcohol and vinegar , may be derived in some cases from wheat , rye or barley , the grains that are implicated in the causation of celiac disease ."
14257,Apiaceae,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14258,-,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14259,positive,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14260,patients,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14261,showed,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14262,significantly,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14263,higher,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14264,birch,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14265,pollen,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14266,-,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14267,specific,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14268,IgE,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14269,levels,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14270,than,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14271,negative,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14272,ones,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14273,(,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14274,median,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14275,13,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14276,vs,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14277,7,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14278,AU,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14279,/,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14280,ml,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14281,;,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14282,P,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14283,<,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14284,0.0001,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14285,),O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14286,.,O,476.0,Apiaceae - positive patients showed significantly higher birch pollen - specific IgE levels than negative ones ( median 13 vs 7 AU / ml ; P < 0.0001 ) .
14821,If,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14822,untreated,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14823,",",O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14824,this,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14825,can,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14826,progress,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14827,to,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14828,liver,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14829,inflammation,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14830,(,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14831,nonalcoholic,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14832,steatohepatitis,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14833,),O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14834,",",O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14835,fibrosis,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14836,",",O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14837,cirrhosis,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14838,",",O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14839,and,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14840,hepatocellular,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14841,carcinoma,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14842,.,O,493.0,"If untreated , this can progress to liver inflammation ( nonalcoholic steatohepatitis ) , fibrosis , cirrhosis , and hepatocellular carcinoma ."
14938,Importantly,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14939,",",O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14940,whereas,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14941,cell,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14942,-,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14943,autonomous,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14944,clocks,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14945,have,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14946,been,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14947,identified,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14948,in,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14949,the,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14950,liver,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14951,",",O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14952,the,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14953,complete,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14954,circadian,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14955,programing,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14956,of,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14957,the,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14958,liver,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14959,transcriptome,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14960,and,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14961,posttranslational,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14962,modifications,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14963,of,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14964,essential,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14965,metabolic,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14966,proteins,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14967,is,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14968,strongly,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14969,dependent,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14970,on,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14971,nutrient,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14972,flux,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14973,and,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14974,circadian,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14975,signals,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14976,from,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14977,outside,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14978,the,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14979,liver,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
14980,.,O,498.0,"Importantly , whereas cell - autonomous clocks have been identified in the liver , the complete circadian programing of the liver transcriptome and posttranslational modifications of essential metabolic proteins is strongly dependent on nutrient flux and circadian signals from outside the liver ."
15358,However,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15359,",",O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15360,health,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15361,-,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15362,promoting,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15363,effects,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15364,are,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15365,associated,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15366,with,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15367,consumption,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15368,of,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15369,anhydrous,B-AG.01.f,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15370,milk,I-AG.01.f,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15371,fat,I-AG.01.f,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15372,(,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15373,AMF,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15374,),O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15375,and,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15376,ruminant,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15377,trans,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15378,fatty,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15379,acids,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15380,",",O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15381,such,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15382,as,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15383,conjugated,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15384,linoleic,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15385,acid,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15386,(,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15387,CLA,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15388,),O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15389,and,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15390,vaccenic,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15391,acid,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15392,(,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15393,VA,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15394,),O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15395,contained,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15396,in,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15397,the,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15398,lipid,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15399,fraction,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15400,of,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15401,milk,B-AG.01.e,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15402,and,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15403,dairy,B-AG.01.e,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15404,products,I-AG.01.e,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15405,.,O,513.0,"However , health - promoting effects are associated with consumption of anhydrous milk fat ( AMF ) and ruminant trans fatty acids , such as conjugated linoleic acid ( CLA ) and vaccenic acid ( VA ) contained in the lipid fraction of milk and dairy products ."
15406,The,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15407,purpose,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15408,of,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15409,this,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15410,study,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15411,was,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15412,to,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15413,evaluate,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15414,the,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15415,effect,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15416,of,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15417,AMF,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15418,naturally,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15419,enriched,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15420,with,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15421,CLA,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15422,and,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15423,VA,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15424,in,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15425,spontaneously,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15426,hypertensive,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15427,rats,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15428,(,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15429,SHR,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15430,),O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15431,",",O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15432,using,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15433,sterculic,B-AG.01.f,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15434,oil,I-AG.01.f,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15435,to,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15436,inhibit,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15437,the,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15438,conversion,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15439,of,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15440,VA,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15441,into,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15442,CLA,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
15443,.,O,514.0,"The purpose of this study was to evaluate the effect of AMF naturally enriched with CLA and VA in spontaneously hypertensive rats ( SHR ) , using sterculic oil to inhibit the conversion of VA into CLA ."
16099,The,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16100,RS,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16101,pattern,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16102,had,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16103,the,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16104,highest,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16105,contribution,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16106,of,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16107,alcohol,B-AG.01.y.01,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16108,(,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16109,9.4,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16110,%,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16111,),O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16112,",",O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16113,soft,B-AG.01.y,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16114,drinks,I-AG.01.y,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16115,(,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16116,9.4,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16117,%,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16118,),O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16119,",",O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16120,white,B-AG.01.n.11,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16121,bread,I-AG.01.n.11,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16122,(,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16123,7.7,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16124,%,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16125,),O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16126,",",O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16127,fast,B-AG.01,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16128,food,I-AG.01,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16129,",",O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16130,sweets,B-AG.01.n.17.a,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16131,",",O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16132,and,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16133,snacks,B-AG.01,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
16134,.,O,538.0,"The RS pattern had the highest contribution of alcohol ( 9.4 % ) , soft drinks ( 9.4 % ) , white bread ( 7.7 % ) , fast food , sweets , and snacks ."
17238,The,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17239,specificity,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17240,and,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17241,sensitivity,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17242,were,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17243,considered,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17244,to,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17245,be,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17246,sufficient,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17247,for,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17248,the,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17249,detection,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17250,of,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17251,trace,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17252,amounts,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17253,of,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17254,peach,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17255,or,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17256,apple,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17257,contamination,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17258,in,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17259,processed,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17260,foods,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17261,.,O,576.0,The specificity and sensitivity were considered to be sufficient for the detection of trace amounts of peach or apple contamination in processed foods .
17640,Excess,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17641,of,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17642,fat,B-AG.01.f,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17643,intake,B-X,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17644,leads,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17645,to,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17646,obesity,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17647,and,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17648,causes,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17649,a,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17650,variety,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17651,of,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17652,metabolic,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17653,diseases,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17654,and,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17655,cancer,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
17656,.,O,589.0,Excess of fat intake leads to obesity and causes a variety of metabolic diseases and cancer .
18147,This,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18148,review,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18149,provides,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18150,an,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18151,overview,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18152,of,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18153,the,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18154,nutritional,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18155,value,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18156,of,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18157,potatoes,B-AG.01.h.02.a,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18158,and,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18159,examines,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18160,the,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18161,evidence,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18162,for,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18163,associations,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18164,between,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18165,potato,B-AG.01.h.02.a,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18166,consumption,B-X,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18167,and,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18168,non,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18169,-,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18170,communicable,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18171,diseases,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18172,.,O,607.0,This review provides an overview of the nutritional value of potatoes and examines the evidence for associations between potato consumption and non - communicable diseases .
18271,Indeed,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18272,",",O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18273,potatoes,B-AG.01.h.02.a,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18274,have,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18275,been,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18276,reported,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18277,to,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18278,be,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18279,more,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18280,satiating,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18281,than,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18282,other,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18283,starchy,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18284,carbohydrates,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18285,",",O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18286,such,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18287,as,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18288,pasta,B-AG.01.i,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18289,and,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18290,rice,B-AG.01.i,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18291,",",O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18292,which,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18293,may,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18294,aid,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18295,weight,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18296,maintenance,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18297,.,O,612.0,"Indeed , potatoes have been reported to be more satiating than other starchy carbohydrates , such as pasta and rice , which may aid weight maintenance ."
18324,Night,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18325,-,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18326,workers,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18327,",",O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18328,transcontinental,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18329,travelers,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18330,and,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18331,individuals,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18332,that,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18333,regularly,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18334,shift,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18335,their,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18336,sleep,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18337,timing,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18338,",",O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18339,suffer,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18340,from,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18341,circadian,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18342,desynchrony,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18343,and,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18344,are,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18345,at,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18346,risk,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18347,to,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18348,develop,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18349,metabolic,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18350,disease,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18351,",",O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18352,cancer,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18353,",",O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18354,and,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18355,mood,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18356,disorders,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18357,",",O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18358,among,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18359,others,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18360,.,O,614.0,"Night - workers , transcontinental travelers and individuals that regularly shift their sleep timing , suffer from circadian desynchrony and are at risk to develop metabolic disease , cancer , and mood disorders , among others ."
18481,Furthermore,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18482,",",O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18483,in,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18484,a,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18485,rat,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18486,model,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18487,of,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18488,shift,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18489,-,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18490,work,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18491,",",O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18492,a,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18493,piece,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18494,of,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18495,chocolate,B-AG.01.n.17.a,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18496,for,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18497,breakfast,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18498,prevented,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18499,circadian,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18500,desynchrony,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18501,",",O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18502,by,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18503,increasing,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18504,the,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18505,amplitude,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18506,of,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18507,the,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18508,day,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18509,-,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18510,night,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18511,c,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18512,-,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18513,Fos,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18514,activation,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18515,in,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18516,the,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18517,SCN,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18518,.,O,618.0,"Furthermore , in a rat model of shift - work , a piece of chocolate for breakfast prevented circadian desynchrony , by increasing the amplitude of the day - night c - Fos activation in the SCN ."
18890,In,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18891,this,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18892,study,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18893,",",O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18894,we,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18895,examined,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18896,the,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18897,beneficial,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18898,effects,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18899,of,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18900,FA,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18901,in,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18902,minimizing,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18903,insulin,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18904,resistance,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18905,",",O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18906,vascular,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18907,dysfunction,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18908,and,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18909,remodeling,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18910,in,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18911,a,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18912,rat,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18913,model,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18914,of,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18915,high,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18916,-,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18917,carbohydrate,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18918,",",O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18919,high,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18920,-,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18921,fat,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18922,diet,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18923,-,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18924,induced,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18925,metabolic,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18926,changes,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18927,",",O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18928,which,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18929,is,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18930,regarded,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18931,as,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18932,an,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18933,analogue,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18934,of,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18935,metabolic,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18936,syndrome,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18937,(,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18938,MS,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18939,),O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18940,in,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18941,man,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
18942,.,O,630.0,"In this study , we examined the beneficial effects of FA in minimizing insulin resistance , vascular dysfunction and remodeling in a rat model of high - carbohydrate , high - fat diet - induced metabolic changes , which is regarded as an analogue of metabolic syndrome ( MS ) in man ."
19011,We,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19012,observed,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19013,that,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19014,FA,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19015,significantly,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19016,improved,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19017,insulin,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19018,sensitivity,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19019,and,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19020,lipid,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19021,profiles,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19022,",",O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19023,and,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19024,reduced,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19025,elevated,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19026,blood,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19027,pressure,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19028,",",O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19029,compared,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19030,to,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19031,untreated,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19032,controls,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19033,(,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19034,p,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19035,<,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19036,0.05,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19037,),O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19038,.,O,633.0,"We observed that FA significantly improved insulin sensitivity and lipid profiles , and reduced elevated blood pressure , compared to untreated controls ( p < 0.05 ) ."
19054,The,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19055,effects,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19056,of,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19057,FA,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19058,in,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19059,HCHF,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19060,-,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19061,induced,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19062,MS,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19063,may,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19064,be,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19065,realized,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19066,through,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19067,suppression,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19068,of,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19069,oxidative,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19070,stress,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19071,by,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19072,down,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19073,-,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19074,regulation,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19075,of,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19076,p47phox,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19077,",",O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19078,increased,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19079,nitric,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19080,oxide,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19081,(,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19082,NO,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19083,),O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19084,bioavailability,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19085,with,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19086,up,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19087,-,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19088,regulation,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19089,of,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19090,endothelial,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19091,nitric,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19092,oxide,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19093,synthase,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19094,(,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19095,eNOS,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19096,),O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19097,and,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19098,suppression,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19099,of,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19100,tumor,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19101,necrosis,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19102,factor,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19103,-,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19104,,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19105,(,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19106,TNF,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19107,-,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19108,,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19109,),O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19110,.,O,635.0,"The effects of FA in HCHF - induced MS may be realized through suppression of oxidative stress by down - regulation of p47phox , increased nitric oxide ( NO ) bioavailability with up - regulation of endothelial nitric oxide synthase ( eNOS ) and suppression of tumor necrosis factor -  ( TNF -  ) ."
19461,For,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19462,381,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19463,cases,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19464,(,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19465,81.9,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19466,%,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19467,men,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19468,),O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19469,and,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19470,371,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19471,controls,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19472,(,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19473,76.3,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19474,%,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19475,men,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19476,),O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19477,",",O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19478,total,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19479,fluid,B-AG.01.y,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19480,intake,B-X,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19481,could,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19482,be,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19483,calculated,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
19484,.,O,650.0,"For 381 cases ( 81.9 % men ) and 371 controls ( 76.3 % men ) , total fluid intake could be calculated ."
20137,Figs,B-AG.01.h.01,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20138,are,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20139,rich,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20140,in,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20141,fiber,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20142,",",O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20143,copper,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20144,",",O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20145,iron,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20146,",",O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20147,manganese,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20148,",",O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20149,magnesium,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20150,",",O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20151,potassium,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20152,",",O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20153,calcium,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20154,",",O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20155,vitamin,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20156,K,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20157,",",O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20158,and,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20159,are,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20160,a,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20161,good,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20162,source,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20163,of,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20164,proanthocyanidins,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20165,and,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20166,quercetin,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20167,which,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20168,demonstrate,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20169,potent,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20170,antioxidant,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20171,properties,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20172,.,O,673.0,"Figs are rich in fiber , copper , iron , manganese , magnesium , potassium , calcium , vitamin K , and are a good source of proanthocyanidins and quercetin which demonstrate potent antioxidant properties ."
20327,Our,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20328,results,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20329,suggest,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20330,that,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20331,dietary,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20332,supplementation,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20333,of,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20334,figs,B-AG.01.h.01,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20335,may,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20336,be,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20337,useful,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20338,for,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20339,the,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20340,improvement,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20341,of,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20342,cognitive,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20343,and,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20344,behavioral,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20345,deficits,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20346,in,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20347,AD,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20348,.,O,677.0,Our results suggest that dietary supplementation of figs may be useful for the improvement of cognitive and behavioral deficits in AD .
20601,From,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20602,this,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20603,reaction,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20604,",",O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20605,the,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20606,necessity,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20607,derived,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20608,to,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20609,appeal,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20610,to,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20611,the,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20612,reasons,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20613,of,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20614,health,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20615,",",O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20616,with,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20617,which,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20618,doctors,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20619,and,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20620,scientists,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20621,committed,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20622,themselves,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20623,to,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20624,explain,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20625,that,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20626,chocolate,B-AG.01.n.17.a,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20627,was,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20628,good,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20629,for,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20630,the,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20631,body,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20632,.,O,685.0,"From this reaction , the necessity derived to appeal to the reasons of health , with which doctors and scientists committed themselves to explain that chocolate was good for the body ."
20817,After,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20818,allowance,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20819,for,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20820,non,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20821,-,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20822,dietary,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20823,confounding,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20824,factors,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20825,and,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20826,total,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20827,energy,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20828,intake,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20829,",",O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20830,significant,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20831,trends,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20832,of,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20833,increasing,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20834,risk,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20835,of,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20836,colorectal,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20837,cancer,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20838,with,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20839,increasing,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20840,intake,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20841,emerged,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20842,for,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20843,bread,B-AG.01.n.11,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20844,and,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20845,cereal,B-AG.01.n.10,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20846,dishes,I-AG.01.n.10,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20847,(,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20848,odds,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20849,ratio,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20850,[,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20851,OR,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20852,],O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20853,in,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20854,highest,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20855,vs.,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20856,lowest,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20857,quintile,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20858,=,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20859,1.7,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20860,),O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20861,",",O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20862,potatoes,B-AG.01.h.02.a,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20863,(,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20864,OR,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20865,=,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20866,1.2,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20867,),O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20868,",",O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20869,cakes,B-AG.01.n.13,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20870,and,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20871,desserts,B-AG.01.n.17.a,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20872,(,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20873,OR,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20874,=,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20875,1.1,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20876,),O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20877,",",O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20878,and,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20879,refined,B-AG.01.l.02,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20880,sugar,I-AG.01.l.02,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20881,(,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20882,OR,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20883,=,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20884,1.4,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20885,),O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20886,.,O,691.0,"After allowance for non - dietary confounding factors and total energy intake , significant trends of increasing risk of colorectal cancer with increasing intake emerged for bread and cereal dishes ( odds ratio [ OR ] in highest vs. lowest quintile = 1.7 ) , potatoes ( OR = 1.2 ) , cakes and desserts ( OR = 1.1 ) , and refined sugar ( OR = 1.4 ) ."
20887,Intakes,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20888,of,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20889,fish,B-AG.01.d.07,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20890,(,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20891,OR,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20892,=,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20893,0.7,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20894,),O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20895,",",O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20896,raw,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20897,and,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20898,cooked,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20899,vegetables,B-AG.01.h.02,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20900,(,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20901,OR,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20902,=,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20903,0.6,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20904,for,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20905,both,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20906,),O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20907,and,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20908,fruit,B-AG.01.h.01,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20909,other,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20910,than,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20911,citrus,B-AG.01.h.01.a,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20912,fruit,I-AG.01.h.01.a,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20913,(,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20914,OR,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20915,=,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20916,0.7,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20917,),O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20918,showed,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20919,a,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20920,negative,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20921,association,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20922,with,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20923,risk,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20924,.,O,692.0,"Intakes of fish ( OR = 0.7 ) , raw and cooked vegetables ( OR = 0.6 for both ) and fruit other than citrus fruit ( OR = 0.7 ) showed a negative association with risk ."
20970,Our,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20971,findings,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20972,lead,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20973,us,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20974,to,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20975,reconsider,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20976,the,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20977,role,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20978,of,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20979,starchy,B-AG.01,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20980,foods,I-AG.01,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20981,and,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20982,refined,B-AG.01.l.02,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20983,sugar,I-AG.01.l.02,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20984,in,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20985,light,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20986,of,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20987,recent,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20988,knowledge,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20989,on,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20990,the,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20991,digestive,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20992,physiology,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20993,of,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20994,carbohydrates,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20995,and,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20996,the,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20997,insulin,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20998,/,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
20999,colon,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
21000,cancer,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
21001,hypothesis,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
21002,.,O,695.0,Our findings lead us to reconsider the role of starchy foods and refined sugar in light of recent knowledge on the digestive physiology of carbohydrates and the insulin / colon cancer hypothesis .
21591,Many,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21592,studies,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21593,have,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21594,shown,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21595,therapeutic,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21596,effects,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21597,of,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21598,cinnamon,B-AG.01.l.03,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21599,including,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21600,its,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21601,antimicrobial,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21602,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21603,antiviral,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21604,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21605,antifungal,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21606,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21607,antioxidant,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21608,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21609,antitumor,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21610,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21611,antihypertensive,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21612,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21613,antilipemic,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21614,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21615,antidiabetic,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21616,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21617,gastroprotective,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21618,",",O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21619,and,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21620,immunomodulatory,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21621,effects,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21622,.,O,718.0,"Many studies have shown therapeutic effects of cinnamon including its antimicrobial , antiviral , antifungal , antioxidant , antitumor , antihypertensive , antilipemic , antidiabetic , gastroprotective , and immunomodulatory effects ."
21752,The,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21753,most,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21754,frequent,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21755,adverse,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21756,events,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21757,were,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21758,gastrointestinal,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21759,disorders,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21760,and,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21761,allergic,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21762,reactions,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21763,which,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21764,were,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21765,self,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21766,-,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21767,limiting,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21768,in,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21769,the,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21770,majority,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21771,of,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21772,cases,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21773,.,O,724.0,The most frequent adverse events were gastrointestinal disorders and allergic reactions which were self - limiting in the majority of cases .
21906,The,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21907,formation,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21908,of,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21909,biogenic,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21910,amines,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21911,in,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21912,food,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21913,by,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21914,the,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21915,microbial,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21916,decarboxylation,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21917,of,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21918,amino,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21919,acids,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21920,can,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21921,result,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21922,in,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21923,consumers,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21924,suffering,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21925,allergic,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21926,reactions,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21927,",",O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21928,characterized,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21929,by,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21930,difficulty,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21931,in,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21932,breathing,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21933,",",O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21934,itching,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21935,",",O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21936,rash,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21937,",",O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21938,vomiting,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21939,",",O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21940,fever,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21941,",",O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21942,and,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21943,hypertension,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21944,.,O,730.0,"The formation of biogenic amines in food by the microbial decarboxylation of amino acids can result in consumers suffering allergic reactions , characterized by difficulty in breathing , itching , rash , vomiting , fever , and hypertension ."
21945,Traditionally,O,731.0,"Traditionally , biogenic amine formation in food has been prevented , primarily by limiting microbial growth through chilling and freezing ."
21946,",",O,731.0,"Traditionally , biogenic amine formation in food has been prevented , primarily by limiting microbial growth through chilling and freezing ."
21947,biogenic,O,731.0,"Traditionally , biogenic amine formation in food has been prevented , primarily by limiting microbial growth through chilling and freezing ."
21948,amine,O,731.0,"Traditionally , biogenic amine formation in food has been prevented , primarily by limiting microbial growth through chilling and freezing ."
21949,formation,O,731.0,"Traditionally , biogenic amine formation in food has been prevented , primarily by limiting microbial growth through chilling and freezing ."
21950,in,O,731.0,"Traditionally , biogenic amine formation in food has been prevented , primarily by limiting microbial growth through chilling and freezing ."
21951,food,O,731.0,"Traditionally , biogenic amine formation in food has been prevented , primarily by limiting microbial growth through chilling and freezing ."
21952,has,O,731.0,"Traditionally , biogenic amine formation in food has been prevented , primarily by limiting microbial growth through chilling and freezing ."
21953,been,O,731.0,"Traditionally , biogenic amine formation in food has been prevented , primarily by limiting microbial growth through chilling and freezing ."
21954,prevented,O,731.0,"Traditionally , biogenic amine formation in food has been prevented , primarily by limiting microbial growth through chilling and freezing ."
21955,",",O,731.0,"Traditionally , biogenic amine formation in food has been prevented , primarily by limiting microbial growth through chilling and freezing ."
21956,primarily,O,731.0,"Traditionally , biogenic amine formation in food has been prevented , primarily by limiting microbial growth through chilling and freezing ."
21957,by,O,731.0,"Traditionally , biogenic amine formation in food has been prevented , primarily by limiting microbial growth through chilling and freezing ."
21958,limiting,O,731.0,"Traditionally , biogenic amine formation in food has been prevented , primarily by limiting microbial growth through chilling and freezing ."
21959,microbial,O,731.0,"Traditionally , biogenic amine formation in food has been prevented , primarily by limiting microbial growth through chilling and freezing ."
21960,growth,O,731.0,"Traditionally , biogenic amine formation in food has been prevented , primarily by limiting microbial growth through chilling and freezing ."
21961,through,O,731.0,"Traditionally , biogenic amine formation in food has been prevented , primarily by limiting microbial growth through chilling and freezing ."
21962,chilling,O,731.0,"Traditionally , biogenic amine formation in food has been prevented , primarily by limiting microbial growth through chilling and freezing ."
21963,and,O,731.0,"Traditionally , biogenic amine formation in food has been prevented , primarily by limiting microbial growth through chilling and freezing ."
21964,freezing,O,731.0,"Traditionally , biogenic amine formation in food has been prevented , primarily by limiting microbial growth through chilling and freezing ."
21965,.,O,731.0,"Traditionally , biogenic amine formation in food has been prevented , primarily by limiting microbial growth through chilling and freezing ."
22499,Ice,B-AG.01.n.17.b,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22500,cream,I-AG.01.n.17.b,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22501,",",O,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22502,butter,B-AG.01.e.01,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22503,",",O,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22504,and,O,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22505,yogurt,B-AG.01.e,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22506,also,O,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22507,increased,O,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22508,the,O,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22509,activities,O,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22510,of,O,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22511,PPARalpha,O,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22512,and,O,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22513,PPARdelta,O,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22514,",",O,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22515,whereas,O,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22516,vegetable,B-AG.01,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22517,cream,I-AG.01,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22518,affected,O,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22519,activity,O,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22520,of,O,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22521,PPARdelta,O,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22522,but,O,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22523,not,O,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22524,PPARalpha,O,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22525,.,O,753.0,"Ice cream , butter , and yogurt also increased the activities of PPARalpha and PPARdelta , whereas vegetable cream affected activity of PPARdelta but not PPARalpha ."
22766,Slices,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22767,were,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22768,fried,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22769,using,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22770,equivalent,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22771,thermal,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22772,driving,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22773,forces,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22774,",",O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22775,maintaining,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22776,a,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22777,constant,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22778,difference,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22779,between,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22780,oil,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22781,temperature,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22782,and,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22783,the,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22784,boiling,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22785,point,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22786,of,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22787,water,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22788,at,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22789,the,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22790,working,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22791,pressure,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22792,(,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22793,T,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22794,=,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22795,60,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22796,and,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22797,80,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22798,,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22799,C,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22800,),O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22801,.,O,762.0,"Slices were fried using equivalent thermal driving forces , maintaining a constant difference between oil temperature and the boiling point of water at the working pressure ( T = 60 and 80  C ) ."
22829,Vacuum,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22830,-,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22831,fried,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22832,carrot,B-AG.01.n.09,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22833,and,I-AG.01.n.09,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22834,potato,I-AG.01.n.09,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22835,chips,I-AG.01.n.09,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22836,absorbed,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22837,about,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22838,50,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22839,%,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22840,less,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22841,oil,B-AG.01.f,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22842,than,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22843,atmospheric,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22844,-,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22845,fried,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22846,chips,B-AG.01.n.09,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22847,",",O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22848,whereas,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22849,vacuum,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22850,-,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22851,fried,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22852,apple,B-AG.01.n.08,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22853,chips,I-AG.01.n.08,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22854,reduced,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22855,oil,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22856,absorption,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22857,by,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22858,25,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22859,%,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
22860,.,O,764.0,"Vacuum - fried carrot and potato chips absorbed about 50 % less oil than atmospheric - fried chips , whereas vacuum - fried apple chips reduced oil absorption by 25 % ."
23247,The,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23248,Copenhagen,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23249,Prospective,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23250,Population,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23251,Studies,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23252,demonstrated,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23253,in,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23254,the,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23255,year,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23256,2000,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23257,that,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23258,wine,B-AG.01.y.01.a,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23259,intake,B-X,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23260,may,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23261,have,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23262,a,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23263,beneficial,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23264,effect,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23265,on,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23266,all,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23267,cause,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23268,mortality,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23269,that,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23270,is,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23271,additive,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23272,to,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23273,that,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23274,of,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23275,alcohol,B-AG.01.y.01,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23276,.,O,779.0,The Copenhagen Prospective Population Studies demonstrated in the year 2000 that wine intake may have a beneficial effect on all cause mortality that is additive to that of alcohol .
23596,The,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23597,most,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23598,recent,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23599,analysis,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23600,shows,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23601,a,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23602,14,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23603,%,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23604,lower,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23605,risk,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23606,of,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23607,type,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23608,2,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23609,diabetes,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23610,when,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23611,yogurt,B-AG.01.e,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23612,consumption,B-X,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23613,was,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23614,80,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23615,-,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23616,125,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23617,g,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23618,/,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23619,d,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23620,compared,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23621,with,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23622,no,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23623,yogurt,B-AG.01.e,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23624,consumption,B-X,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23625,.,O,791.0,The most recent analysis shows a 14 % lower risk of type 2 diabetes when yogurt consumption was 80 - 125 g / d compared with no yogurt consumption .
23721,Changes,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23722,in,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23723,our,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23724,understanding,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23725,of,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23726,diet,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23727,and,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23728,health,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23729,drive,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23730,changes,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23731,in,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23732,the,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23733,way,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23734,foods,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23735,are,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23736,processed,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
23737,.,O,796.0,Changes in our understanding of diet and health drive changes in the way foods are processed .
24503,In,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24504,this,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24505,review,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24506,",",O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24507,the,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24508,role,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24509,of,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24510,milk,B-AG.01.e,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24511,and,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24512,milk,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24513,components,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24514,in,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24515,improving,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24516,calcium,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24517,absorption,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24518,and,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24519,thereby,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24520,supporting,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24521,bone,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24522,health,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24523,is,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24524,discussed,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24525,.,O,826.0,"In this review , the role of milk and milk components in improving calcium absorption and thereby supporting bone health is discussed ."
24624,As,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24625,little,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24626,information,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24627,about,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24628,the,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24629,association,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24630,between,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24631,salt,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24632,tea,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24633,drinking,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24634,and,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24635,ESCC,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24636,was,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24637,available,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24638,",",O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24639,we,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24640,conducted,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24641,a,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24642,large,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24643,-,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24644,scale,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24645,case,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24646,-,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24647,control,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24648,study,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24649,to,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24650,investigate,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24651,this,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24652,association,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24653,in,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24654,Kashmir,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24655,.,O,831.0,"As little information about the association between salt tea drinking and ESCC was available , we conducted a large - scale case - control study to investigate this association in Kashmir ."
24821,When,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24822,analysis,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24823,was,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24824,limited,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24825,to,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24826,alkaline,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24827,tea,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24828,drinkers,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24829,only,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24830,",",O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24831,those,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24832,who,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24833,both,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24834,consumed,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24835,cereal,B-AG.01.n.10,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24836,paste,I-AG.01.n.10,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24837,with,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24838,salt,B-AG.01.ac,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24839,tea,I-AG.01.ac,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24840,and,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24841,used,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24842,samovar,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24843,vessel,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24844,were,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24845,at,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24846,the,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24847,highest,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24848,risk,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24849,(,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24850,OR,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24851,,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24852,=,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24853,,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24854,4.58,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24855,",",O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24856,95,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24857,%,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24858,CIs,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24859,,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24860,=,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24861,,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24862,2.04,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24863,-,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24864,10.28,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24865,),O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24866,.,O,836.0,"When analysis was limited to alkaline tea drinkers only , those who both consumed cereal paste with salt tea and used samovar vessel were at the highest risk ( OR  =  4.58 , 95 % CIs  =  2.04 - 10.28 ) ."
24935,This,O,840.0,This review examines the question whether there is a relation between cereal consumption and CHD .
24936,review,O,840.0,This review examines the question whether there is a relation between cereal consumption and CHD .
24937,examines,O,840.0,This review examines the question whether there is a relation between cereal consumption and CHD .
24938,the,O,840.0,This review examines the question whether there is a relation between cereal consumption and CHD .
24939,question,O,840.0,This review examines the question whether there is a relation between cereal consumption and CHD .
24940,whether,O,840.0,This review examines the question whether there is a relation between cereal consumption and CHD .
24941,there,O,840.0,This review examines the question whether there is a relation between cereal consumption and CHD .
24942,is,O,840.0,This review examines the question whether there is a relation between cereal consumption and CHD .
24943,a,O,840.0,This review examines the question whether there is a relation between cereal consumption and CHD .
24944,relation,O,840.0,This review examines the question whether there is a relation between cereal consumption and CHD .
24945,between,O,840.0,This review examines the question whether there is a relation between cereal consumption and CHD .
24946,cereal,B-AG.01.i,840.0,This review examines the question whether there is a relation between cereal consumption and CHD .
24947,consumption,B-X,840.0,This review examines the question whether there is a relation between cereal consumption and CHD .
24948,and,O,840.0,This review examines the question whether there is a relation between cereal consumption and CHD .
24949,CHD,O,840.0,This review examines the question whether there is a relation between cereal consumption and CHD .
24950,.,O,840.0,This review examines the question whether there is a relation between cereal consumption and CHD .
25111,Between,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25112,1996,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25113,and,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25114,2001,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25115,an,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25116,accumulation,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25117,of,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25118,five,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25119,very,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25120,large,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25121,cohort,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25122,studies,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25123,in,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25124,the,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25125,USA,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25126,",",O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25127,Finland,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25128,and,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25129,Norway,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25130,have,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25131,all,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25132,reported,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25133,that,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25134,subjects,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25135,consuming,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25136,relatively,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25137,large,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25138,amounts,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25139,of,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25140,whole,B-AG.01.i,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25141,grain,I-AG.01.i,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25142,cereals,I-AG.01.i,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25143,have,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25144,significantly,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25145,lower,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25146,rates,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25147,of,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25148,CHD,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25149,.,O,848.0,"Between 1996 and 2001 an accumulation of five very large cohort studies in the USA , Finland and Norway have all reported that subjects consuming relatively large amounts of whole grain cereals have significantly lower rates of CHD ."
25175,While,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25176,cohort,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25177,studies,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25178,have,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25179,shown,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25180,this,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25181,consistent,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25182,protective,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25183,effect,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25184,of,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25185,whole,B-AG.01.i,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25186,grain,I-AG.01.i,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25187,cereals,I-AG.01.i,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25188,",",O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25189,there,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25190,has,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25191,been,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25192,(,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25193,only,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25194,one,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25195,),O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25196,randomised,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25197,controlled,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25198,secondary,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25199,prevention,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25200,trial,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25201,of,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25202,advice,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25203,to,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25204,eat,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25205,more,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25206,cereal,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25207,fibre,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25208,.,O,851.0,"While cohort studies have shown this consistent protective effect of whole grain cereals , there has been ( only one ) randomised controlled secondary prevention trial of advice to eat more cereal fibre ."
25461,Asthma,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25462,induced,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25463,by,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25464,cereal,B-AG.01.k,857.0,Asthma induced by cereal flour is a long recognized entity .
25465,flour,I-AG.01.k,857.0,Asthma induced by cereal flour is a long recognized entity .
25466,is,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25467,a,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25468,long,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25469,recognized,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25470,entity,O,857.0,Asthma induced by cereal flour is a long recognized entity .
25471,.,O,857.0,Asthma induced by cereal flour is a long recognized entity .
26038,Since,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26039,ancient,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26040,times,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26041,",",O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26042,people,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26043,have,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26044,attributed,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26045,a,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26046,variety,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26047,of,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26048,health,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26049,benefits,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26050,to,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26051,moderate,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26052,consumption,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26053,of,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26054,fermented,B-AG.01.y,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26055,beverages,I-AG.01.y,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26056,such,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26057,as,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26058,wine,B-AG.01.y.01.a,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26059,and,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26060,beer,B-AG.01.y.01.b,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26061,",",O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26062,often,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26063,without,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26064,any,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26065,scientific,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26066,basis,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26067,.,O,883.0,"Since ancient times , people have attributed a variety of health benefits to moderate consumption of fermented beverages such as wine and beer , often without any scientific basis ."
26068,There,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26069,is,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26070,evidence,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26071,that,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26072,excessive,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26073,or,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26074,binge,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26075,alcohol,B-AG.01.y.01,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26076,consumption,B-X,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26077,is,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26078,associated,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26079,with,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26080,increased,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26081,morbidity,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26082,and,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26083,mortality,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26084,",",O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26085,as,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26086,well,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26087,as,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26088,with,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26089,work,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26090,related,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26091,and,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26092,traffic,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26093,accidents,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26094,.,O,884.0,"There is evidence that excessive or binge alcohol consumption is associated with increased morbidity and mortality , as well as with work related and traffic accidents ."
26597,Limiting,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26598,factors,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26599,to,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26600,improving,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26601,the,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26602,productivity,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26603,",",O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26604,quality,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26605,",",O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26606,and,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26607,safety,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26608,of,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26609,milk,B-AG.01.e,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26610,in,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26611,Rwanda,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26612,and,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26613,Nepal,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26614,were,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26615,a,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26616,combination,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26617,of,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26618,sometimes,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26619,limited,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26620,knowledge,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26621,in,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26622,areas,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26623,such,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26624,as,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26625,feeding,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26626,",",O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26627,mastitis,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26628,control,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26629,",",O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26630,and,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26631,hygiene,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26632,",",O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26633,and,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26634,a,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26635,lack,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26636,of,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26637,access,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26638,to,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26639,resources,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26640,such,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26641,as,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26642,quality,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26643,feeds,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26644,",",O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26645,transportation,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26646,",",O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26647,and,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26648,cooling,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26649,that,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26650,hindered,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26651,implementation,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26652,of,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26653,existing,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26654,knowledge,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
26655,.,O,903.0,"Limiting factors to improving the productivity , quality , and safety of milk in Rwanda and Nepal were a combination of sometimes limited knowledge in areas such as feeding , mastitis control , and hygiene , and a lack of access to resources such as quality feeds , transportation , and cooling that hindered implementation of existing knowledge ."
27148,Fish,B-AG.01.f,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27149,oil,I-AG.01.f,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27150,intensified,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27151,oxidation,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27152,associated,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27153,with,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27154,age,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27155,",",O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27156,lowered,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27157,electron,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27158,transport,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27159,chain,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27160,activity,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27161,and,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27162,enhanced,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27163,the,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27164,relative,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27165,telomere,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27166,length,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27167,.,O,922.0,"Fish oil intensified oxidation associated with age , lowered electron transport chain activity and enhanced the relative telomere length ."
27238,Non,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27239,-,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27240,selective,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27241,use,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27242,of,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27243,pesticide,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27244,to,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27245,increase,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27246,productivity,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27247,leaves,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27248,residues,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27249,on,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27250,crops,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27251,.,O,926.0,Non - selective use of pesticide to increase productivity leaves residues on crops .
27287,The,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27288,recent,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27289,study,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27290,was,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27291,designed,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27292,to,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27293,assess,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27294,the,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27295,effects,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27296,of,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27297,household,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27298,processing,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27299,treatments,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27300,such,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27301,as,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27302,acidic,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27303,solutions,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27304,(,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27305,acidic,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27306,acid,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27307,and,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27308,citric,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27309,acid,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27310,),O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27311,",",O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27312,alkaline,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27313,solutions,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27314,(,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27315,sodium,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27316,chloride,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27317,and,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27318,sodium,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27319,carbonate,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27320,),O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27321,and,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27322,biological,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27323,solutions,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27324,(,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27325,radish,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27326,",",O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27327,ginger,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27328,",",O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27329,garlic,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27330,",",O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27331,and,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27332,lemon,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27333,extracts,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27334,),O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27335,were,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27336,evaluated,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27337,for,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27338,their,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27339,efficiency,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27340,for,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27341,removal,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27342,of,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27343,pesticides,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27344,in,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27345,spinach,B-AG.01.h.02.c,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27346,by,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27347,gas,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27348,chromatography,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27349,with,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27350,electron,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27351,capture,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27352,detector,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27353,(,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27354,GC,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27355,-,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27356,ECD,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27357,),O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27358,.,O,928.0,"The recent study was designed to assess the effects of household processing treatments such as acidic solutions ( acidic acid and citric acid ) , alkaline solutions ( sodium chloride and sodium carbonate ) and biological solutions ( radish , ginger , garlic , and lemon extracts ) were evaluated for their efficiency for removal of pesticides in spinach by gas chromatography with electron capture detector ( GC - ECD ) ."
27919,Heavy,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27920,metals,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27921,in,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27922,the,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27923,edible,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27924,parts,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27925,of,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27926,vegetables,B-AG.01.h.02,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27927,also,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27928,exceeded,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27929,the,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27930,corresponding,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27931,standards,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
27932,.,O,948.0,Heavy metals in the edible parts of vegetables also exceeded the corresponding standards .
28523,In,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28524,recent,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28525,findings,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28526,on,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28527,food,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28528,science,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28529,research,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28530,gut,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28531,microbiota,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28532,plays,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28533,a,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28534,significant,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28535,role,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28536,and,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28537,vastly,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28538,studied,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28539,for,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28540,its,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28541,intermediate,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28542,role,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28543,in,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28544,regulating,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28545,health,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
28546,.,O,967.0,In recent findings on food science research gut microbiota plays a significant role and vastly studied for its intermediate role in regulating health .
29483,Subjects,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29484,rated,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29485,their,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29486,liking,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29487,of,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29488,French,B-AG.01.n,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29489,toast,I-AG.01.n,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29490,",",O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29491,sausage,B-AG.01.n.05,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29492,and,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29493,the,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29494,overall,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29495,meal,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29496,",",O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29497,or,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29498,chicken,B-AG.01.d.06,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29499,",",O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29500,vegetables,B-AG.01.h.02,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29501,",",O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29502,pasta,B-AG.01.i,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29503,",",O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29504,and,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29505,the,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29506,overall,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29507,meal,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29508,on,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29509,a,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29510,9,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29511,-,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29512,point,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29513,hedonic,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29514,Likert,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29515,scale,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29516,.,O,1000.0,"Subjects rated their liking of French toast , sausage and the overall meal , or chicken , vegetables , pasta , and the overall meal on a 9 - point hedonic Likert scale ."
29948,We,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29949,analyzed,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29950,22,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29951,sera,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29952,from,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29953,patients,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29954,with,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29955,the,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29956,mugwort,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29957,-,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29958,birch,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29959,-,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29960,celery,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29961,-,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29962,spice,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29963,syndrome,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29964,for,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29965,IgE,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29966,binding,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29967,to,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29968,the,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29969,spices,B-AG.01.l.03,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29970,pepper,I-AG.01.l.03,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29971,and,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29972,paprika,B-AG.01.l.03,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29973,by,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29974,immunoblotting,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
29975,.,O,1014.0,We analyzed 22 sera from patients with the mugwort - birch - celery - spice syndrome for IgE binding to the spices pepper and paprika by immunoblotting .
30063,N,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30064,-,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30065,terminal,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30066,sequence,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30067,analysis,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30068,of,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30069,the,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30070,14-,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30071,and,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30072,28,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30073,-,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30074,kDa,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30075,pepper,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30076,and,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30077,23,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30078,-,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30079,kDa,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30080,paprika,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30081,allergens,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30082,revealed,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30083,no,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30084,homology,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30085,to,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30086,known,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30087,allergens,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30088,.,O,1018.0,N - terminal sequence analysis of the 14- and 28 - kDa pepper and 23 - kDa paprika allergens revealed no homology to known allergens .
30333,Twice,O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30334,-,O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30335,monthly,O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30336,household,O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30337,visits,O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30338,provided,O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30339,information,O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30340,on,O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30341,chicken,O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30342,numbers,O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30343,",",O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30344,breastfeeding,O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30345,and,O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30346,child,O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30347,diarrhea,O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30348,",",O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30349,and,O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30350,anthropometry,O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30351,was,O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30352,collected,O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30353,six,O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30354,-,O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30355,monthly,O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30356,.,O,1027.0,"Twice - monthly household visits provided information on chicken numbers , breastfeeding and child diarrhea , and anthropometry was collected six - monthly ."
30400,Alongside,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30401,modest,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30402,contributions,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30403,of,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30404,chicken,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30405,-,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30406,keeping,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30407,to,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30408,some,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30409,improved,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30410,dietary,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30411,outcomes,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30412,",",O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30413,this,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30414,study,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30415,importantly,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30416,(,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30417,and,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30418,of,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30419,substantial,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30420,practical,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30421,significance,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30422,if,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30423,confirmed,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30424,),O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30425,found,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30426,no,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30427,indication,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30428,of,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30429,a,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30430,heightened,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30431,risk,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30432,of,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30433,stunting,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30434,or,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30435,greater,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30436,frequency,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30437,of,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30438,diarrhea,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30439,being,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30440,associated,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30441,with,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30442,chicken,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30443,-,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30444,keeping,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30445,or,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30446,the,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30447,practice,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30448,of,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30449,keeping,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30450,chickens,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30451,within,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30452,human,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30453,dwellings,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30454,overnight,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30455,.,O,1029.0,"Alongside modest contributions of chicken - keeping to some improved dietary outcomes , this study importantly ( and of substantial practical significance if confirmed ) found no indication of a heightened risk of stunting or greater frequency of diarrhea being associated with chicken - keeping or the practice of keeping chickens within human dwellings overnight ."
30542,Data,O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30543,were,O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30544,collected,O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30545,by,O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30546,an,O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30547,anonymous,O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30548,online,O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30549,questionnaire,O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30550,on,O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30551,food,O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30552,intake,O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30553,among,O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30554,820,O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30555,adolescents,O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30556,from,O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30557,Spain,O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30558,",",O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30559,Italy,O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30560,",",O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30561,Brazil,O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30562,",",O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30563,Colombia,O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30564,",",O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30565,and,O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30566,Chile,O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30567,.,O,1033.0,"Data were collected by an anonymous online questionnaire on food intake among 820 adolescents from Spain , Italy , Brazil , Colombia , and Chile ."
30568,The,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30569,results,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30570,show,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30571,that,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30572,COVID-19,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30573,confinement,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30574,did,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30575,influence,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30576,their,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30577,dietary,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30578,habits,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30579,.,O,1034.0,The results show that COVID-19 confinement did influence their dietary habits .
30660,There,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30661,is,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30662,abundant,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30663,epidemiological,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30664,evidence,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30665,that,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30666,vegetable,B-AG.01.h.02,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30667,consumption,B-X,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30668,decreases,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30669,colorectal,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30670,cancer,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30671,(,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30672,CRC,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30673,),O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30674,risk,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30675,.,O,1038.0,There is abundant epidemiological evidence that vegetable consumption decreases colorectal cancer ( CRC ) risk .
30713,Mice,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30714,were,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30715,fed,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30716,one,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30717,of,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30718,8,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30719,diets,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30720,:,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30721,a,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30722,control,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30723,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30724,containing,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30725,no,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30726,vegetables,B-AG.01.h.02,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30727,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30728,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30729,1,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30730,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30731,;,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30732,a,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30733,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30734,containing,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30735,100,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30736,g,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30737,/,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30738,kg,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30739,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30740,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30741,2,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30742,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30743,10,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30744,%,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30745,dose,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30746,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30747,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30748,200,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30749,g,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30750,/,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30751,kg,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30752,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30753,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30754,3,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30755,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30756,20,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30757,%,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30758,dose,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30759,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30760,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30761,or,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30762,400,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30763,g,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30764,/,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30765,kg,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30766,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30767,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30768,4,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30769,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30770,40,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30771,%,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30772,dose,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30773,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30774,of,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30775,a,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30776,vegetable,B-AG.01.h.02,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30777,mixture,I-AG.01.h.02,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30778,;,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30779,or,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30780,a,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30781,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30782,containing,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30783,70,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30784,g,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30785,/,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30786,kg,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30787,of,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30788,cauliflower,B-AG.01.h.02.d,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30789,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30790,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30791,5,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30792,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30793,7,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30794,%,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30795,dose,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30796,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30797,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30798,73,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30799,g,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30800,/,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30801,kg,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30802,of,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30803,carrots,B-AG.01.h.02.a,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30804,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30805,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30806,6,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30807,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30808,7.3,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30809,%,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30810,dose,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30811,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30812,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30813,226,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30814,g,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30815,/,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30816,kg,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30817,of,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30818,peas,B-AG.01.h.02.g,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30819,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30820,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30821,7,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30822,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30823,22.6,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30824,%,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30825,dose,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30826,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30827,;,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30828,or,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30829,31,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30830,g,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30831,/,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30832,kg,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30833,of,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30834,onions,B-AG.01.h.02.e,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30835,(,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30836,diet,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30837,8,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30838,",",O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30839,3.1,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30840,%,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30841,dose,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30842,),O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
30843,.,O,1041.0,"Mice were fed one of 8 diets : a control diet containing no vegetables ( diet 1 ) ; a diet containing 100 g / kg ( diet 2 , 10 % dose ) , 200 g / kg ( diet 3 , 20 % dose ) , or 400 g / kg ( diet 4 , 40 % dose ) of a vegetable mixture ; or a diet containing 70 g / kg of cauliflower ( diet 5 , 7 % dose ) , 73 g / kg of carrots ( diet 6 , 7.3 % dose ) , 226 g / kg of peas ( diet 7 , 22.6 % dose ) ; or 31 g / kg of onions ( diet 8 , 3.1 % dose ) ."
31041,Polyphenols,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31042,are,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31043,the,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31044,most,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31045,abundant,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31046,antioxidants,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31047,in,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31048,the,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31049,diet,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31050,and,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31051,are,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31052,widespread,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31053,constituents,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31054,of,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31055,fruits,B-AG.01.h.01,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31056,",",O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31057,vegetables,B-AG.01.h.02,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31058,",",O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31059,cereals,B-AG.01.i,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31060,",",O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31061,dry,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31062,legumes,B-AG.01.h.02.g,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31063,",",O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31064,chocolate,B-AG.01.n.17.a,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31065,",",O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31066,and,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31067,beverages,B-AG.01.y,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31068,",",O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31069,such,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31070,as,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31071,tea,B-AG.01.ac,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31072,",",O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31073,coffee,B-AG.01.ad,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31074,",",O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31075,or,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31076,wine,B-AG.01.y.01.a,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31077,.,O,1050.0,"Polyphenols are the most abundant antioxidants in the diet and are widespread constituents of fruits , vegetables , cereals , dry legumes , chocolate , and beverages , such as tea , coffee , or wine ."
31479,This,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31480,review,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31481,encompasses,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31482,epidemiologic,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31483,studies,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31484,of,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31485,stomach,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31486,",",O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31487,colon,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31488,",",O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31489,and,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31490,lung,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31491,cancer,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31492,as,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31493,well,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31494,as,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31495,the,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31496,evidence,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31497,of,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31498,a,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31499,relationship,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31500,between,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31501,tea,B-AG.01.ac,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31502,drinking,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31503,and,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31504,cancer,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31505,at,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31506,large,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31507,in,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31508,humans,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31509,.,O,1065.0,"This review encompasses epidemiologic studies of stomach , colon , and lung cancer as well as the evidence of a relationship between tea drinking and cancer at large in humans ."
31528,Site,O,1067.0,Site - specific studies reveal a more complex picture .
31529,-,O,1067.0,Site - specific studies reveal a more complex picture .
31530,specific,O,1067.0,Site - specific studies reveal a more complex picture .
31531,studies,O,1067.0,Site - specific studies reveal a more complex picture .
31532,reveal,O,1067.0,Site - specific studies reveal a more complex picture .
31533,a,O,1067.0,Site - specific studies reveal a more complex picture .
31534,more,O,1067.0,Site - specific studies reveal a more complex picture .
31535,complex,O,1067.0,Site - specific studies reveal a more complex picture .
31536,picture,O,1067.0,Site - specific studies reveal a more complex picture .
31537,.,O,1067.0,Site - specific studies reveal a more complex picture .
31538,The,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31539,epidemiologic,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31540,studies,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31541,on,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31542,tea,B-AG.01.ac,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31543,drinking,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31544,and,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31545,stomach,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31546,cancer,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31547,do,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31548,not,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31549,justify,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31550,claims,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31551,of,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31552,a,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31553,cancer,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31554,-,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31555,protective,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31556,effect,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
31557,.,O,1068.0,The epidemiologic studies on tea drinking and stomach cancer do not justify claims of a cancer - protective effect .
32106,Overall,O,1089.0,"Overall observational data suggest a benefit , but results are still equivocal and likely confounded by lifestyle and background dietary factors ."
32107,observational,O,1089.0,"Overall observational data suggest a benefit , but results are still equivocal and likely confounded by lifestyle and background dietary factors ."
32108,data,O,1089.0,"Overall observational data suggest a benefit , but results are still equivocal and likely confounded by lifestyle and background dietary factors ."
32109,suggest,O,1089.0,"Overall observational data suggest a benefit , but results are still equivocal and likely confounded by lifestyle and background dietary factors ."
32110,a,O,1089.0,"Overall observational data suggest a benefit , but results are still equivocal and likely confounded by lifestyle and background dietary factors ."
32111,benefit,O,1089.0,"Overall observational data suggest a benefit , but results are still equivocal and likely confounded by lifestyle and background dietary factors ."
32112,",",O,1089.0,"Overall observational data suggest a benefit , but results are still equivocal and likely confounded by lifestyle and background dietary factors ."
32113,but,O,1089.0,"Overall observational data suggest a benefit , but results are still equivocal and likely confounded by lifestyle and background dietary factors ."
32114,results,O,1089.0,"Overall observational data suggest a benefit , but results are still equivocal and likely confounded by lifestyle and background dietary factors ."
32115,are,O,1089.0,"Overall observational data suggest a benefit , but results are still equivocal and likely confounded by lifestyle and background dietary factors ."
32116,still,O,1089.0,"Overall observational data suggest a benefit , but results are still equivocal and likely confounded by lifestyle and background dietary factors ."
32117,equivocal,O,1089.0,"Overall observational data suggest a benefit , but results are still equivocal and likely confounded by lifestyle and background dietary factors ."
32118,and,O,1089.0,"Overall observational data suggest a benefit , but results are still equivocal and likely confounded by lifestyle and background dietary factors ."
32119,likely,O,1089.0,"Overall observational data suggest a benefit , but results are still equivocal and likely confounded by lifestyle and background dietary factors ."
32120,confounded,O,1089.0,"Overall observational data suggest a benefit , but results are still equivocal and likely confounded by lifestyle and background dietary factors ."
32121,by,O,1089.0,"Overall observational data suggest a benefit , but results are still equivocal and likely confounded by lifestyle and background dietary factors ."
32122,lifestyle,O,1089.0,"Overall observational data suggest a benefit , but results are still equivocal and likely confounded by lifestyle and background dietary factors ."
32123,and,O,1089.0,"Overall observational data suggest a benefit , but results are still equivocal and likely confounded by lifestyle and background dietary factors ."
32124,background,O,1089.0,"Overall observational data suggest a benefit , but results are still equivocal and likely confounded by lifestyle and background dietary factors ."
32125,dietary,O,1089.0,"Overall observational data suggest a benefit , but results are still equivocal and likely confounded by lifestyle and background dietary factors ."
32126,factors,O,1089.0,"Overall observational data suggest a benefit , but results are still equivocal and likely confounded by lifestyle and background dietary factors ."
32127,.,O,1089.0,"Overall observational data suggest a benefit , but results are still equivocal and likely confounded by lifestyle and background dietary factors ."
32436,The,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32437,allergenic,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32438,proteins,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32439,existing,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32440,in,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32441,the,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32442,buckwheat,B-AG.01.i,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32443,seeds,I-AG.01.i,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32444,and,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32445,their,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32446,derivatives,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32447,were,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32448,reviewed,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32449,with,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32450,respect,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32451,to,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32452,their,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32453,chemical,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32454,and,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32455,biochemical,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32456,characteristics,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32457,as,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32458,well,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32459,as,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32460,the,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32461,physiological,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32462,reactions,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32463,after,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32464,digestion,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32465,.,O,1103.0,The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion .
32970,At,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32971,4,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32972,y,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32973,",",O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32974,the,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32975,between,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32976,-,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32977,group,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32978,differences,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32979,were,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32980,65,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32981,%,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32982,for,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32983,vegetables,B-AG.01.h.02,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32984,(,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32985,including,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32986,juice,B-AG.01.ab,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32987,),O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32988,",",O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32989,25,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32990,%,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32991,fruit,B-AG.01.h.01,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32992,",",O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32993,30,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32994,%,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32995,fiber,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32996,",",O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32997,40,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32998,%,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
32999,legumes,B-AG.01.h.02.g,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33000,",",O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33001,30,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33002,%,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33003,whole,B-AG.01.i,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33004,grain,I-AG.01.i,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33005,foods,I-AG.01.i,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33006,",",O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33007,and,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33008,13,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33009,%,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33010,lower,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33011,intake,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33012,of,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33013,energy,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33014,from,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33015,fat,B-AG.01.f,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33016,.,O,1120.0,"At 4 y , the between - group differences were 65 % for vegetables ( including juice ) , 25 % fruit , 30 % fiber , 40 % legumes , 30 % whole grain foods , and 13 % lower intake of energy from fat ."
33368,Change,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33369,in,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33370,nutritional,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33371,composition,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33372,of,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33373,different,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33374,species,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33375,of,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33376,bamboo,B-AG.01,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33377,shoots,I-AG.01,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33378,with,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33379,processing,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33380,has,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33381,also,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33382,been,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33383,reviewed,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33384,.,O,1135.0,Change in nutritional composition of different species of bamboo shoots with processing has also been reviewed .
33688,Succinate,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33689,-,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33690,supported,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33691,state,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33692,3,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33693,respiration,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33694,was,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33695,not,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33696,affected,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33697,by,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33698,diet,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33699,",",O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33700,whereas,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33701,succinate,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33702,-,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33703,supported,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33704,state,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33705,4,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33706,respiration,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33707,was,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33708,higher,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33709,in,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33710,mitochondria,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33711,from,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33712,rats,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33713,fed,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33714,coconut,B-AG.01.f,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33715,oil,I-AG.01.f,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33716,than,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33717,in,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33718,rats,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33719,fed,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33720,corn,B-AG.01.f,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33721,oil,I-AG.01.f,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
33722,.,O,1150.0,"Succinate - supported state 3 respiration was not affected by diet , whereas succinate - supported state 4 respiration was higher in mitochondria from rats fed coconut oil than in rats fed corn oil ."
34168,Stepwise,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34169,-,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34170,multiple,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34171,-,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34172,regression,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34173,analysis,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34174,identified,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34175,milk,B-AG.01.e,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34176,+,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34177,cheese,B-AG.01.e.02,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34178,as,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34179,a,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34180,factor,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34181,contributing,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34182,to,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34183,the,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34184,incidence,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34185,of,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34186,prostatic,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34187,cancer,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34188,(,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34189,R,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34190,=,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34191,0.525,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34192,),O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34193,.,O,1165.0,Stepwise - multiple - regression analysis identified milk + cheese as a factor contributing to the incidence of prostatic cancer ( R = 0.525 ) .
34873,Areas,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34874,within,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34875,the,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34876,contour,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34877,plots,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34878,of,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34879,these,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34880,critical,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34881,sensory,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34882,attributes,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34883,",",O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34884,having,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34885,acceptability,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34886,scores,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34887,>,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34888,or,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34889,=,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34890,68,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34891,(,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34892,"""",O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34893,moderately,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34894,like,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34895,"""",O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34896,on,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34897,the,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34898,100,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34899,-,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34900,mm,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34901,bidirectional,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34902,labeled,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34903,affective,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34904,magnitude,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34905,scale,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34906,),O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34907,were,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34908,chosen,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34909,and,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34910,superimposed,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34911,to,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34912,obtain,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34913,a,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34914,predicted,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34915,optimum,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34916,formulation,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34917,range,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34918,(,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34919,37,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34920,%,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34921,to,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34922,43,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34923,%,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34924,RBO,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34925,",",O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34926,4,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34927,%,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34928,to,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34929,7,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34930,%,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34931,SPC,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34932,",",O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34933,and,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34934,52,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34935,%,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34936,to,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34937,57,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34938,%,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34939,water,B-AG.01.z,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34940,),O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
34941,.,O,1190.0,"Areas within the contour plots of these critical sensory attributes , having acceptability scores > or = 68 ( "" moderately like "" on the 100 - mm bidirectional labeled affective magnitude scale ) were chosen and superimposed to obtain a predicted optimum formulation range ( 37 % to 43 % RBO , 4 % to 7 % SPC , and 52 % to 57 % water ) ."
35035,Tree,O,1194.0,"Tree nuts , including walnuts , can be responsible for allergic reactions ."
35036,nuts,B-AG.01.h.01.f,1194.0,"Tree nuts , including walnuts , can be responsible for allergic reactions ."
35037,",",O,1194.0,"Tree nuts , including walnuts , can be responsible for allergic reactions ."
35038,including,O,1194.0,"Tree nuts , including walnuts , can be responsible for allergic reactions ."
35039,walnuts,B-AG.01.h.01.f,1194.0,"Tree nuts , including walnuts , can be responsible for allergic reactions ."
35040,",",O,1194.0,"Tree nuts , including walnuts , can be responsible for allergic reactions ."
35041,can,O,1194.0,"Tree nuts , including walnuts , can be responsible for allergic reactions ."
35042,be,O,1194.0,"Tree nuts , including walnuts , can be responsible for allergic reactions ."
35043,responsible,O,1194.0,"Tree nuts , including walnuts , can be responsible for allergic reactions ."
35044,for,O,1194.0,"Tree nuts , including walnuts , can be responsible for allergic reactions ."
35045,allergic,O,1194.0,"Tree nuts , including walnuts , can be responsible for allergic reactions ."
35046,reactions,O,1194.0,"Tree nuts , including walnuts , can be responsible for allergic reactions ."
35047,.,O,1194.0,"Tree nuts , including walnuts , can be responsible for allergic reactions ."
35114,Mixtures,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35115,of,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35116,raw,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35117,and,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35118,roasted,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35119,English,B-AG.01.h.01.f,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35120,walnuts,I-AG.01.h.01.f,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35121,of,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35122,several,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35123,varieties,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35124,were,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35125,defatted,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35126,",",O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35127,powdered,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35128,",",O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35129,and,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35130,used,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35131,as,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35132,separate,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35133,antigens,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35134,in,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35135,sheep,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35136,and,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35137,New,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35138,Zealand,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35139,white,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35140,rabbits,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35141,.,O,1197.0,"Mixtures of raw and roasted English walnuts of several varieties were defatted , powdered , and used as separate antigens in sheep and New Zealand white rabbits ."
35330,Researchers,O,1204.0,Researchers do not understand what causes ovarian cancer .
35331,do,O,1204.0,Researchers do not understand what causes ovarian cancer .
35332,not,O,1204.0,Researchers do not understand what causes ovarian cancer .
35333,understand,O,1204.0,Researchers do not understand what causes ovarian cancer .
35334,what,O,1204.0,Researchers do not understand what causes ovarian cancer .
35335,causes,O,1204.0,Researchers do not understand what causes ovarian cancer .
35336,ovarian,O,1204.0,Researchers do not understand what causes ovarian cancer .
35337,cancer,O,1204.0,Researchers do not understand what causes ovarian cancer .
35338,.,O,1204.0,Researchers do not understand what causes ovarian cancer .
35390, ,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35391,Denmark,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35392,",",O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35393,Sweden,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35394,",",O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35395,and,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35396,Switzerland,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35397,have,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35398,the,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35399,highest,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35400,risk,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35401,of,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35402,ovarian,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35403,cancer,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35404,in,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35405,the,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35406,world,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35407,.,O,1207.0,"  Denmark , Sweden , and Switzerland have the highest risk of ovarian cancer in the world ."
35618, ,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35619,1,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35620,problem,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35621,with,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35622,these,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35623,studies,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35624,is,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35625,that,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35626,dietary,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35627,fat,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35628,confounds,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35629,the,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35630,association,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35631,.,O,1217.0,  1 problem with these studies is that dietary fat confounds the association .
35673, ,O,1220.0,  Further research in nutritional epidemiology of ovarian cancer is needed .
35674,Further,O,1220.0,  Further research in nutritional epidemiology of ovarian cancer is needed .
35675,research,O,1220.0,  Further research in nutritional epidemiology of ovarian cancer is needed .
35676,in,O,1220.0,  Further research in nutritional epidemiology of ovarian cancer is needed .
35677,nutritional,O,1220.0,  Further research in nutritional epidemiology of ovarian cancer is needed .
35678,epidemiology,O,1220.0,  Further research in nutritional epidemiology of ovarian cancer is needed .
35679,of,O,1220.0,  Further research in nutritional epidemiology of ovarian cancer is needed .
35680,ovarian,O,1220.0,  Further research in nutritional epidemiology of ovarian cancer is needed .
35681,cancer,O,1220.0,  Further research in nutritional epidemiology of ovarian cancer is needed .
35682,is,O,1220.0,  Further research in nutritional epidemiology of ovarian cancer is needed .
35683,needed,O,1220.0,  Further research in nutritional epidemiology of ovarian cancer is needed .
35684,.,O,1220.0,  Further research in nutritional epidemiology of ovarian cancer is needed .
35837,Over,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35838,a,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35839,12,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35840,-,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35841,d,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35842,period,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35843,",",O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35844,cows,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35845,were,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35846,ruminally,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35847,infused,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35848,with,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35849,1,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35850,L,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35851,/,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35852,d,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35853,of,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35854,water,B-AG.01.z,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35855,or,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35856,water,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35857,containing,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35858,8,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35859,mg,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35860,of,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35861,perchlorate,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
35862,.,O,1227.0,"Over a 12 - d period , cows were ruminally infused with 1 L / d of water or water containing 8 mg of perchlorate ."
36168,The,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36169,vegetable,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36170,fibers,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36171,were,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36172,significantly,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36173,more,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36174,fermentable,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36175,than,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36176,were,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36177,the,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36178,cereal,B-AG.01.i,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36179,brans,I-AG.01.i,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36180,",",O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36181,as,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36182,evidenced,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36183,by,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36184,greater,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36185,NDF,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36186,digestibility,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36187,and,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36188,increased,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36189,productions,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36190,of,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36191,SCFA,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36192,",",O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36193,H2,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36194,",",O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36195,and,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36196,CH4,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36197,",",O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36198,despite,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36199,the,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36200,presence,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36201,of,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36202,fermentable,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36203,starch,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36204,and,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36205,protein,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36206,in,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36207,the,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36208,latter,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36209,.,O,1238.0,"The vegetable fibers were significantly more fermentable than were the cereal brans , as evidenced by greater NDF digestibility and increased productions of SCFA , H2 , and CH4 , despite the presence of fermentable starch and protein in the latter ."
36254,Effects,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36255,of,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36256,dietary,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36257,intervention,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36258,on,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36259,food,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36260,choice,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36261,were,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36262,studied,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36263,in,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36264,240,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36265,women,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36266,aged,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36267,50,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36268,-,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36269,65,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36270,years,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36271,who,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36272,had,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36273,been,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36274,operated,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36275,for,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36276,a,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36277,stage,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36278,I,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36279,-,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36280,II,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36281,breast,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36282,cancer,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36283,.,O,1241.0,Effects of dietary intervention on food choice were studied in 240 women aged 50 - 65 years who had been operated for a stage I - II breast cancer .
36574,This,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36575,study,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36576,showed,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36577,that,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36578,dietary,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36579,counselling,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36580,can,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36581,bring,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36582,about,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36583,significant,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36584,changes,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36585,in,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36586,consumption,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36587,of,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36588,high,B-AG.01,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36589,-,I-AG.01,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36590,fat,I-AG.01,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36591,foods,I-AG.01,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36592,for,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36593,at,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36594,least,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36595,a,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36596,2,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36597,-,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36598,year,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36599,period,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36600,for,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36601,women,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36602,operated,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36603,for,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36604,breast,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36605,cancer,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
36606,.,O,1250.0,This study showed that dietary counselling can bring about significant changes in consumption of high - fat foods for at least a 2 - year period for women operated for breast cancer .
37126,Overall,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37127,",",O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37128,data,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37129,in,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37130,literature,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37131,shows,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37132,that,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37133,QE,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37134,appears,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37135,to,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37136,be,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37137,a,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37138,promising,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37139,hepatoprotective,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37140,compound,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37141,.,O,1270.0,"Overall , data in literature shows that QE appears to be a promising hepatoprotective compound ."
37215,Statistical,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37216,dose,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37217,-,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37218,distribution,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37219,models,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37220,(,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37221,log,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37222,-,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37223,normal,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37224,",",O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37225,log,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37226,-,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37227,logistic,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37228,",",O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37229,Weibull,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37230,),O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37231,were,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37232,applied,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37233,to,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37234,the,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37235,individual,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37236,NOAELs,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37237,and,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37238,LOAELs,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37239,for,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37240,each,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37241,allergenic,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37242,food,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37243,.,O,1274.0,"Statistical dose - distribution models ( log - normal , log - logistic , Weibull ) were applied to the individual NOAELs and LOAELs for each allergenic food ."
37912,No,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37913,ACF,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37914,were,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37915,detected,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37916,in,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37917,the,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37918,colon,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37919,of,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37920,bacon,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37921,-,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37922,fed,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37923,uninitiated,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37924,rats,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
37925,.,O,1301.0,No ACF were detected in the colon of bacon - fed uninitiated rats .
38088,We,O,1308.0,We argue here that coffee as a plant food has similar beneficial properties to many vegetables and fruits .
38089,argue,O,1308.0,We argue here that coffee as a plant food has similar beneficial properties to many vegetables and fruits .
38090,here,O,1308.0,We argue here that coffee as a plant food has similar beneficial properties to many vegetables and fruits .
38091,that,O,1308.0,We argue here that coffee as a plant food has similar beneficial properties to many vegetables and fruits .
38092,coffee,B-AG.01.ad,1308.0,We argue here that coffee as a plant food has similar beneficial properties to many vegetables and fruits .
38093,as,O,1308.0,We argue here that coffee as a plant food has similar beneficial properties to many vegetables and fruits .
38094,a,O,1308.0,We argue here that coffee as a plant food has similar beneficial properties to many vegetables and fruits .
38095,plant,O,1308.0,We argue here that coffee as a plant food has similar beneficial properties to many vegetables and fruits .
38096,food,O,1308.0,We argue here that coffee as a plant food has similar beneficial properties to many vegetables and fruits .
38097,has,O,1308.0,We argue here that coffee as a plant food has similar beneficial properties to many vegetables and fruits .
38098,similar,O,1308.0,We argue here that coffee as a plant food has similar beneficial properties to many vegetables and fruits .
38099,beneficial,O,1308.0,We argue here that coffee as a plant food has similar beneficial properties to many vegetables and fruits .
38100,properties,O,1308.0,We argue here that coffee as a plant food has similar beneficial properties to many vegetables and fruits .
38101,to,O,1308.0,We argue here that coffee as a plant food has similar beneficial properties to many vegetables and fruits .
38102,many,O,1308.0,We argue here that coffee as a plant food has similar beneficial properties to many vegetables and fruits .
38103,vegetables,B-AG.01.h.02,1308.0,We argue here that coffee as a plant food has similar beneficial properties to many vegetables and fruits .
38104,and,O,1308.0,We argue here that coffee as a plant food has similar beneficial properties to many vegetables and fruits .
38105,fruits,B-AG.01.h.01,1308.0,We argue here that coffee as a plant food has similar beneficial properties to many vegetables and fruits .
38106,.,O,1308.0,We argue here that coffee as a plant food has similar beneficial properties to many vegetables and fruits .
38107,Recent,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38108,studies,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38109,have,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38110,identified,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38111,a,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38112,health,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38113,promoting,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38114,mechanism,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38115,common,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38116,to,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38117,coffee,B-AG.01.ad,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38118,",",O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38119,vegetables,B-AG.01.h.02,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38120,and,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38121,fruits,B-AG.01.h.01,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38122,",",O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38123,i.e.,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38124,",",O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38125,the,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38126,activation,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38127,of,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38128,an,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38129,adaptive,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38130,cellular,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38131,response,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38132,characterized,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38133,by,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38134,the,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38135,upregulation,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38136,of,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38137,proteins,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38138,involved,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38139,in,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38140,cell,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38141,protection,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38142,",",O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38143,notably,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38144,antioxidant,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38145,",",O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38146,detoxifying,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38147,and,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38148,repair,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38149,enzymes,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38150,.,O,1309.0,"Recent studies have identified a health promoting mechanism common to coffee , vegetables and fruits , i.e. , the activation of an adaptive cellular response characterized by the upregulation of proteins involved in cell protection , notably antioxidant , detoxifying and repair enzymes ."
38209,A,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38210,possible,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38211,supportive,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38212,action,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38213,may,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38214,be,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38215,the,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38216,modulation,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38217,of,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38218,the,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38219,gut,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38220,microbiota,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38221,by,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38222,non,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38223,-,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38224,digested,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38225,prebiotic,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38226,constituents,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38227,of,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38228,coffee,B-AG.01.ad,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38229,",",O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38230,but,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38231,the,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38232,available,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38233,data,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38234,are,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38235,still,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38236,scarce,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38237,.,O,1312.0,"A possible supportive action may be the modulation of the gut microbiota by non - digested prebiotic constituents of coffee , but the available data are still scarce ."
38390,Separate,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38391,analyses,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38392,relating,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38393,alcohol,B-AG.01.y.01,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38394,consumption,B-X,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38395,to,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38396,mortality,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38397,from,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38398,all,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38399,causes,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38400,showed,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38401,similar,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38402,effects,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38403,except,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38404,that,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38405,the,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38406,reduction,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38407,in,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38408,mortality,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38409,for,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38410,males,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38411,was,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38412,much,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38413,less,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38414,.,O,1319.0,Separate analyses relating alcohol consumption to mortality from all causes showed similar effects except that the reduction in mortality for males was much less .
38587,Only,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38588,the,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38589,papaya,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38590,extract,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38591,had,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38592,a,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38593,significant,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38594,antiproliferative,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38595,effect,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38596,measured,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38597,with,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38598,the,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38599,methylthiazolydiphenyl,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38600,-,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38601,tetrazolium,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38602,bromide,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38603,assay,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38604,.,O,1326.0,Only the papaya extract had a significant antiproliferative effect measured with the methylthiazolydiphenyl - tetrazolium bromide assay .
38651,Besides,O,1329.0,"Besides , papaya represents a very interesting fruit to explore its antineoplastic activities ."
38652,",",O,1329.0,"Besides , papaya represents a very interesting fruit to explore its antineoplastic activities ."
38653,papaya,B-AG.01.h.01,1329.0,"Besides , papaya represents a very interesting fruit to explore its antineoplastic activities ."
38654,represents,O,1329.0,"Besides , papaya represents a very interesting fruit to explore its antineoplastic activities ."
38655,a,O,1329.0,"Besides , papaya represents a very interesting fruit to explore its antineoplastic activities ."
38656,very,O,1329.0,"Besides , papaya represents a very interesting fruit to explore its antineoplastic activities ."
38657,interesting,O,1329.0,"Besides , papaya represents a very interesting fruit to explore its antineoplastic activities ."
38658,fruit,B-AG.01.h.01,1329.0,"Besides , papaya represents a very interesting fruit to explore its antineoplastic activities ."
38659,to,O,1329.0,"Besides , papaya represents a very interesting fruit to explore its antineoplastic activities ."
38660,explore,O,1329.0,"Besides , papaya represents a very interesting fruit to explore its antineoplastic activities ."
38661,its,O,1329.0,"Besides , papaya represents a very interesting fruit to explore its antineoplastic activities ."
38662,antineoplastic,O,1329.0,"Besides , papaya represents a very interesting fruit to explore its antineoplastic activities ."
38663,activities,O,1329.0,"Besides , papaya represents a very interesting fruit to explore its antineoplastic activities ."
38664,.,O,1329.0,"Besides , papaya represents a very interesting fruit to explore its antineoplastic activities ."
39058,Major,O,1343.0,Major pollen allergens were not involved .
39059,pollen,O,1343.0,Major pollen allergens were not involved .
39060,allergens,O,1343.0,Major pollen allergens were not involved .
39061,were,O,1343.0,Major pollen allergens were not involved .
39062,not,O,1343.0,Major pollen allergens were not involved .
39063,involved,O,1343.0,Major pollen allergens were not involved .
39064,.,O,1343.0,Major pollen allergens were not involved .
39065,Structural,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39066,similarities,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39067,were,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39068,also,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39069,noticed,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39070,in,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39071,some,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39072,mugwort,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39073,pollen,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39074,antigens,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39075,and,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39076,antigens,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39077,in,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39078,apple,B-AG.01.h.01.c,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39079,",",O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39080,carrot,B-AG.01.h.02.a,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39081,and,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39082,celery,B-AG.01.h.02.a,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39083,",",O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39084,but,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39085,none,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39086,of,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39087,these,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39088,mugwort,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39089,antigens,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39090,acted,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39091,as,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39092,an,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39093,allergen,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39094,.,O,1344.0,"Structural similarities were also noticed in some mugwort pollen antigens and antigens in apple , carrot and celery , but none of these mugwort antigens acted as an allergen ."
39472,New,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39473,funding,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39474,arrangements,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39475,for,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39476,general,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39477,practitioners,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39478,will,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39479,be,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39480,required,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39481,if,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39482,these,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39483,proposals,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39484,are,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39485,to,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39486,be,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39487,taken,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39488,up,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39489,more,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39490,widely,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39491,around,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39492,the,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39493,country,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39494,.,O,1356.0,New funding arrangements for general practitioners will be required if these proposals are to be taken up more widely around the country .
39640,Ghee,B-AG.01.e.01,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39641,contains,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39642,high,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39643,levels,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39644,of,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39645,saturated,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39646,fatty,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39647,acids,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39648,and,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39649,cholesterol,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39650,",",O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39651,which,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39652,are,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39653,considered,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39654,risk,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39655,factors,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39656,for,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39657,cardiovascular,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39658,diseases,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
39659,.,O,1363.0,"Ghee contains high levels of saturated fatty acids and cholesterol , which are considered risk factors for cardiovascular diseases ."
40751,In,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40752,rats,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40753,fed,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40754,the,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40755,low,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40756,and,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40757,high,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40758,calcium,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40759,phosphate,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40760,diets,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40761,",",O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40762,fecal,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40763,excretion,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40764,of,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40765,fatty,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40766,acids,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40767,diminished,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40768,in,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40769,the,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40770,order,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40771,palm,B-AG.01.f,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40772,oil,I-AG.01.f,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40773,>,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40774,milk,B-AG.01.e,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40775,fat,I-AG.01.e,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40776,>,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40777,corn,B-AG.01.f,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40778,oil,I-AG.01.f,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40779,.,O,1397.0,"In rats fed the low and high calcium phosphate diets , fecal excretion of fatty acids diminished in the order palm oil > milk fat > corn oil ."
40899,The,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40900,concentration,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40901,of,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40902,surfactants,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40903,in,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40904,fecal,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40905,water,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40906,and,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40907,cytotoxicity,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40908,were,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40909,correlated,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40910,by,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40911,multiple,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40912,regression,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40913,analysis,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40914,(,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40915,R,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40916,=,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40917,0.89,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40918,),O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
40919,.,O,1402.0,The concentration of surfactants in fecal water and cytotoxicity were correlated by multiple regression analysis ( R = 0.89 ) .
41295,Strategies,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41296,that,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41297,decrease,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41298,postprandial,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41299,glucose,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41300,excursions,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41301,",",O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41302,including,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41303,digestive,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41304,enzyme,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41305,inhibition,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41306,",",O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41307,and,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41308,low,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41309,glycemic,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41310,index,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41311,diets,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41312,result,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41313,in,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41314,lower,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41315,diabetes,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41316,incidence,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41317,and,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41318,coronary,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41319,heart,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41320,disease,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41321,(,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41322,CHD,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41323,),O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41324,risk,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41325,",",O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41326,possibly,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41327,through,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41328,lower,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41329,postprandial,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41330,oxidative,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41331,damage,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41332,to,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41333,lipids,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41334,and,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41335,proteins,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41336,.,O,1416.0,"Strategies that decrease postprandial glucose excursions , including digestive enzyme inhibition , and low glycemic index diets result in lower diabetes incidence and coronary heart disease ( CHD ) risk , possibly through lower postprandial oxidative damage to lipids and proteins ."
41583,Therefore,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41584,",",O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41585,lowering,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41586,postprandial,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41587,glucose,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41588,excursions,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41589,may,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41590,decrease,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41591,the,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41592,risk,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41593,of,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41594,oxidative,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41595,damage,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41596,to,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41597,proteins,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
41598,.,O,1424.0,"Therefore , lowering postprandial glucose excursions may decrease the risk of oxidative damage to proteins ."
42016,A,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42017,total,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42018,of,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42019,"13,609",O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42020,subjects,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42021,aged,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42022,between,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42023,20,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42024,and,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42025,50,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42026,years,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42027,were,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42028,selected,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42029,.,O,1441.0,"A total of 13,609 subjects aged between 20 and 50 years were selected ."
42323,Male,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42324,Wistar,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42325,rats,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42326,were,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42327,fed,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42328,by,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42329,standard,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42330,pellet,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42331,diet,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42332,(,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42333,group,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42334,I,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42335,),O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42336,",",O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42337,standard,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42338,diet,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42339,supplemented,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42340,with,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42341,4,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42342,%,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42343,garlic,B-AG.01.h.02.e,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42344,(,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42345,group,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42346,II,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42347,),O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42348,",",O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42349,lipogenic,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42350,diet,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42351,(,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42352,containing,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42353,sunflower,B-AG.01.f,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42354,oil,I-AG.01.f,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42355,",",O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42356,cholesterol,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42357,and,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42358,ethanol,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42359,),O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42360,plus,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42361,4,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42362,%,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42363,garlic,B-AG.01.h.02.e,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42364,(,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42365,group,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42366,III,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42367,),O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42368,and,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42369,only,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42370,lipogenic,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42371,diet,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42372,(,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42373,group,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42374,IV,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42375,),O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42376,.,O,1451.0,"Male Wistar rats were fed by standard pellet diet ( group I ) , standard diet supplemented with 4 % garlic ( group II ) , lipogenic diet ( containing sunflower oil , cholesterol and ethanol ) plus 4 % garlic ( group III ) and only lipogenic diet ( group IV ) ."
42435,Also,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42436,",",O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42437,liver,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42438,PAP,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42439,activity,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42440,was,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42441,decreased,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42442,in,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42443,group,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42444,II,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42445,than,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42446,group,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42447,I,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42448,whereas,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42449,",",O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42450,the,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42451,decrease,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42452,in,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42453,its,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42454,activity,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42455,in,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42456,groups,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42457,III,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42458,and,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42459,IV,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42460,was,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42461,due,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42462,to,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42463,the,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42464,accumulation,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42465,of,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42466,triglyceride,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42467,in,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42468,liver,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42469,.,O,1453.0,"Also , liver PAP activity was decreased in group II than group I whereas , the decrease in its activity in groups III and IV was due to the accumulation of triglyceride in liver ."
42491,A,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42492,multi,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42493,-,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42494,centre,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42495,case,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42496,-,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42497,control,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42498,study,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42499,of,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42500,diet,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42501,and,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42502,gastric,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42503,cancer,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42504,was,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42505,carried,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42506,out,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42507,in,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42508,4,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42509,regions,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42510,of,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42511,Spain,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42512,(,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42513,Aragon,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42514,",",O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42515,Castile,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42516,",",O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42517,Catalonia,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42518,and,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42519,Galicia,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42520,),O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42521,.,O,1455.0,"A multi - centre case - control study of diet and gastric cancer was carried out in 4 regions of Spain ( Aragon , Castile , Catalonia and Galicia ) ."
42979,A,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42980,more,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42981,complete,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42982,profile,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42983,of,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42984,phenolic,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42985,distributions,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42986,",",O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42987,including,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42988,both,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42989,free,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42990,and,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42991,bound,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42992,phenolics,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42993,in,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42994,these,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42995,vegetables,B-AG.01.h.02,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42996,",",O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42997,is,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42998,reported,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
42999,here,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
43000,using,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
43001,new,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
43002,and,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
43003,modified,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
43004,methods,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
43005,.,O,1475.0,"A more complete profile of phenolic distributions , including both free and bound phenolics in these vegetables , is reported here using new and modified methods ."
43006,Broccoli,B-AG.01.h.02.d,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43007,possessed,O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43008,the,O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43009,highest,O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43010,total,O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43011,phenolic,O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43012,content,O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43013,",",O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43014,followed,O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43015,by,O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43016,spinach,B-AG.01.h.02.c,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43017,",",O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43018,yellow,B-AG.01.h.02.e,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43019,onion,I-AG.01.h.02.e,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43020,",",O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43021,red,B-AG.01.h.02.f,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43022,pepper,I-AG.01.h.02.f,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43023,",",O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43024,carrot,B-AG.01.h.02.a,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43025,",",O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43026,cabbage,B-AG.01.h.02.d,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43027,",",O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43028,potato,B-AG.01.h.02.a,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43029,",",O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43030,lettuce,B-AG.01.h.02.c,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43031,",",O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43032,celery,B-AG.01.h.02.b,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43033,",",O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43034,and,O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43035,cucumber,B-AG.01.h.02.f,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43036,.,O,1476.0,"Broccoli possessed the highest total phenolic content , followed by spinach , yellow onion , red pepper , carrot , cabbage , potato , lettuce , celery , and cucumber ."
43037,Red,B-AG.01.h.02.f,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43038,pepper,I-AG.01.h.02.f,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43039,had,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43040,the,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43041,highest,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43042,total,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43043,antioxidant,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43044,activity,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43045,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43046,followed,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43047,by,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43048,broccoli,B-AG.01.h.02.d,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43049,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43050,carrot,B-AG.01.h.02.a,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43051,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43052,spinach,B-AG.01.h.02.c,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43053,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43054,cabbage,B-AG.01.h.02.d,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43055,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43056,yellow,B-AG.01.h.02.e,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43057,onion,I-AG.01.h.02.e,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43058,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43059,celery,B-AG.01.h.02.b,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43060,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43061,potato,B-AG.01.h.02.a,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43062,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43063,lettuce,B-AG.01.h.02.c,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43064,",",O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43065,and,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43066,cucumber,B-AG.01.h.02.f,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43067,.,O,1477.0,"Red pepper had the highest total antioxidant activity , followed by broccoli , carrot , spinach , cabbage , yellow onion , celery , potato , lettuce , and cucumber ."
43119,Spinach,B-AG.01.h.02.c,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43120,showed,O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43121,the,O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43122,highest,O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43123,inhibitory,O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43124,effect,O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43125,",",O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43126,followed,O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43127,by,O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43128,cabbage,B-AG.01.h.02.d,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43129,",",O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43130,red,O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43131,pepper,O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43132,",",O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43133,onion,B-AG.01.h.02.e,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43134,",",O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43135,and,O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43136,broccoli,B-AG.01.h.02.d,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43137,.,O,1480.0,"Spinach showed the highest inhibitory effect , followed by cabbage , red pepper , onion , and broccoli ."
43578,Rice,B-AG.01.i,1496.0,Rice intake was assessed by food frequency questionnaire .
43579,intake,B-X,1496.0,Rice intake was assessed by food frequency questionnaire .
43580,was,O,1496.0,Rice intake was assessed by food frequency questionnaire .
43581,assessed,O,1496.0,Rice intake was assessed by food frequency questionnaire .
43582,by,O,1496.0,Rice intake was assessed by food frequency questionnaire .
43583,food,O,1496.0,Rice intake was assessed by food frequency questionnaire .
43584,frequency,O,1496.0,Rice intake was assessed by food frequency questionnaire .
43585,questionnaire,O,1496.0,Rice intake was assessed by food frequency questionnaire .
43586,.,O,1496.0,Rice intake was assessed by food frequency questionnaire .
43705,Conclusions,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43706,Rice,B-AG.01.i,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43707,intake,B-X,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43708,was,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43709,not,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43710,associated,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43711,with,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43712,subclinical,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43713,CVD,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43714,markers,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43715,in,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43716,a,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43717,multiethnic,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43718,US,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43719,population,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43720,.,O,1501.0,Conclusions Rice intake was not associated with subclinical CVD markers in a multiethnic US population .
43817,Many,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43818,of,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43819,these,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43820,antioxidants,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43821,cooperate,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43822,in,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43823,oxidative,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43824,stress,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43825,reduction,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43826,in,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43827,plants,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43828,",",O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43829,and,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43830,we,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43831,hypothesize,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43832,that,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43833,many,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43834,different,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43835,antioxidants,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43836,may,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43837,also,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43838,be,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43839,needed,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43840,for,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43841,the,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43842,proper,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43843,protection,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43844,of,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43845,animal,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43846,cells,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
43847,.,O,1507.0,"Many of these antioxidants cooperate in oxidative stress reduction in plants , and we hypothesize that many different antioxidants may also be needed for the proper protection of animal cells ."
44548,By,O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44549,ELISA,O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44550,",",O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44551,specific,O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44552,IgE,O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44553,antibodies,O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44554,to,O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44555,paprika,B-AG.01.l.03,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44556,",",O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44557,coriander,B-AG.01.l.03,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44558,",",O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44559,and,O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44560,mace,B-AG.01.l.03,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44561,were,O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44562,demonstrated,O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44563,.,O,1535.0,"By ELISA , specific IgE antibodies to paprika , coriander , and mace were demonstrated ."
44622,No,O,1538.0,No bands were detected from paprika extract .
44623,bands,O,1538.0,No bands were detected from paprika extract .
44624,were,O,1538.0,No bands were detected from paprika extract .
44625,detected,O,1538.0,No bands were detected from paprika extract .
44626,from,O,1538.0,No bands were detected from paprika extract .
44627,paprika,O,1538.0,No bands were detected from paprika extract .
44628,extract,O,1538.0,No bands were detected from paprika extract .
44629,.,O,1538.0,No bands were detected from paprika extract .
45062,Thus,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45063,the,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45064,hypothesis,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45065,that,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45066,colonic,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45067,iron,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45068,",",O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45069,bile,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45070,acids,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45071,",",O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45072,or,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45073,total,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45074,fatty,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45075,acids,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45076,can,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45077,promote,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45078,colon,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45079,tumors,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45080,is,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45081,not,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45082,supported,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45083,by,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45084,this,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45085,study,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45086,.,O,1555.0,"Thus the hypothesis that colonic iron , bile acids , or total fatty acids can promote colon tumors is not supported by this study ."
45087,The,O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45088,results,O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45089,suggest,O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45090,that,O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45091,",",O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45092,in,O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45093,rats,O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45094,",",O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45095,beef,B-AG.01.d.03,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45096,does,O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45097,not,O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45098,promote,O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45099,the,O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45100,growth,O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45101,of,O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45102,ACF,O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45103,and,O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45104,chicken,B-AG.01.d.06,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45105,does,O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45106,not,O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45107,protect,O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45108,against,O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45109,colon,O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45110,carcinogenesis,O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45111,.,O,1556.0,"The results suggest that , in rats , beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis ."
45138,Dairy,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45139,products,B-AG.01.e,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45140,are,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45141,the,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45142,main,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45143,source,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45144,of,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45145,calcium,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45146,(,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45147,Ca,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45148,),O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45149,",",O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45150,but,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45151,the,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45152,loss,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45153,of,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45154,the,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45155,consumption,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45156,habit,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45157,contributes,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45158,to,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45159,low,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45160,consumption,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45161,in,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45162,adulthood,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45163,",",O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45164,which,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45165,leads,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45166,to,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45167,osteoporosis,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45168,and,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45169,increased,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45170,fracture,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45171,risk,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45172,.,O,1558.0,"Dairy products are the main source of calcium ( Ca ) , but the loss of the consumption habit contributes to low consumption in adulthood , which leads to osteoporosis and increased fracture risk ."
45293,This,O,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45294,study,O,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45295,provides,O,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45296,a,O,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45297,methodology,O,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45298,to,O,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45299,prepare,O,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45300,at,O,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45301,home,O,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45302,a,O,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45303,dairy,B-AG.01.e,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45304,product,I-AG.01.e,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45305,that,O,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45306,could,O,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45307,contribute,O,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45308,to,O,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45309,improve,O,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45310,the,O,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45311,Ca,O,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45312,intake,O,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45313,in,O,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45314,adults,O,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45315,.,O,1566.0,This study provides a methodology to prepare at home a dairy product that could contribute to improve the Ca intake in adults .
45495,etc,O,1573.0,etc .
45496,.,O,1573.0,etc .
45649,These,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45650,associations,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45651,warrant,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45652,further,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45653,investigation,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45654,and,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45655,",",O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45656,if,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45657,confirmed,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45658,",",O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45659,they,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45660,might,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45661,have,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45662,important,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45663,public,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45664,health,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45665,implications,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45666,for,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45667,the,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45668,reduction,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45669,of,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45670,melanoma,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45671,incidence,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45672,through,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45673,dietary,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45674,modification,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45675,.,O,1578.0,"These associations warrant further investigation and , if confirmed , they might have important public health implications for the reduction of melanoma incidence through dietary modification ."
45676,We,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45677,succeeded,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45678,in,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45679,purifying,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45680,the,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45681,fraction,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45682,containing,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45683,the,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45684,major,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45685,glycolipids,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45686,in,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45687,monogalactosyl,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45688,diacylglycerol,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45689,",",O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45690,digalactosyl,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45691,diacylglycerol,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45692,and,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45693,sulfoquinovosyl,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45694,diacylglycerol,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45695,(,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45696,SQDG,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45697,),O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45698,from,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45699,dried,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45700,vegetables,B-AG.01.h.02,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
45701,.,O,1579.0,"We succeeded in purifying the fraction containing the major glycolipids in monogalactosyl diacylglycerol , digalactosyl diacylglycerol and sulfoquinovosyl diacylglycerol ( SQDG ) from dried vegetables ."
46070,Regular,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46071,consumption,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46072,of,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46073,fruit,B-AG.01.h.01,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46074,and,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46075,vegetables,B-AG.01.h.02,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46076,is,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46077,associated,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46078,with,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46079,reduced,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46080,risks,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46081,of,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46082,cancer,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46083,",",O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46084,cardiovascular,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46085,disease,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46086,",",O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46087,stroke,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46088,",",O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46089,Alzheimer,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46090,disease,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46091,",",O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46092,cataracts,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46093,",",O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46094,and,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46095,some,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46096,of,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46097,the,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46098,functional,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46099,declines,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46100,associated,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46101,with,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46102,aging,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46103,.,O,1593.0,"Regular consumption of fruit and vegetables is associated with reduced risks of cancer , cardiovascular disease , stroke , Alzheimer disease , cataracts , and some of the functional declines associated with aging ."
46117,Functional,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46118,foods,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46119,that,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46120,contain,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46121,significant,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46122,amounts,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46123,of,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46124,bioactive,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46125,components,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46126,may,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46127,provide,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46128,desirable,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46129,health,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46130,benefits,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46131,beyond,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46132,basic,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46133,nutrition,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46134,and,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46135,play,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46136,important,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46137,roles,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46138,in,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46139,the,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46140,prevention,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46141,of,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46142,chronic,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46143,diseases,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46144,.,O,1595.0,Functional foods that contain significant amounts of bioactive components may provide desirable health benefits beyond basic nutrition and play important roles in the prevention of chronic diseases .
46174,Our,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46175,group,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46176,found,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46177,",",O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46178,for,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46179,example,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46180,",",O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46181,that,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46182,the,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46183,vitamin,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46184,C,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46185,in,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46186,apples,B-AG.01.h.01.c,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46187,with,I-AG.01.h.01.c,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46188,skin,I-AG.01.h.01.c,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46189,accounts,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46190,for,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46191,only,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46192,0.4,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46193,%,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46194,of,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46195,the,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46196,total,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46197,antioxidant,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46198,activity,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46199,",",O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46200,suggesting,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46201,that,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46202,most,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46203,of,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46204,the,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46205,antioxidant,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46206,activity,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46207,of,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46208,fruit,B-AG.01.h.01,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46209,and,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46210,vegetables,B-AG.01.h.02,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46211,may,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46212,come,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46213,from,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46214,phenolics,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46215,and,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46216,flavonoids,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46217,in,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46218,apples,B-AG.01.h.01.c,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46219,.,O,1597.0,"Our group found , for example , that the vitamin C in apples with skin accounts for only 0.4 % of the total antioxidant activity , suggesting that most of the antioxidant activity of fruit and vegetables may come from phenolics and flavonoids in apples ."
46974,Epidemiological,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46975,studies,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46976,suggest,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46977,that,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46978,the,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46979,consumption,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46980,of,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46981,tea,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46982,flavonoids,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46983,may,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46984,be,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46985,associated,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46986,with,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46987,reduced,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46988,risk,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46989,of,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46990,coronary,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46991,heart,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46992,disease,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46993,",",O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46994,stroke,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46995,and,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46996,cancer,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46997,-,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46998,related,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
46999,deaths,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
47000,.,O,1625.0,"Epidemiological studies suggest that the consumption of tea flavonoids may be associated with reduced risk of coronary heart disease , stroke and cancer - related deaths ."
47599,We,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47600,identified,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47601,three,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47602,interpretable,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47603,dietary,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47604,patterns,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47605,:,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47606,',O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47607,high,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47608,fat,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47609,/,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47610,low,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47611,fibre,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47612,',O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47613,(,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47614,high,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47615,in,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47616,red,B-AG.01.d,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47617,meat,I-AG.01.d,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47618,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47619,meat,B-AG.01.d,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47620,products,I-AG.01.d,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47621,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47622,white,B-AG.01.n.11,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47623,bread,I-AG.01.n.11,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47624,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47625,fried,B-AG.01.n.09,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47626,potato,I-AG.01.n.09,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47627,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47628,eggs,B-AG.01.g,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47629,),O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47630,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47631,',O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47632,prudent,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47633,',O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47634,(,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47635,high,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47636,in,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47637,poultry,B-AG.01.d.06,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47638,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47639,fish,B-AG.01.d.07,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47640,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47641,fruits,B-AG.01.h.01,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47642,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47643,vegetables,B-AG.01.h.02,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47644,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47645,legumes,B-AG.01.h.02.g,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47646,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47647,pasta,B-AG.01.i,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47648,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47649,rice,B-AG.01.i,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47650,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47651,wholemeal,B-AG.01.n.11,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47652,bread,I-AG.01.n.11,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47653,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47654,eggs,B-AG.01.g,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47655,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47656,olive,B-AG.01.f,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47657,oil,I-AG.01.f,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47658,),O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47659,and,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47660,',O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47661,high,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47662,sugar,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47663,',O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47664,(,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47665,high,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47666,in,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47667,biscuits,B-AG.01.n.14,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47668,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47669,puddings,B-AG.01.n.03,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47670,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47671,chocolates,B-AG.01.n.17.a,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47672,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47673,sweets,B-AG.01.n.17.a,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47674,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47675,sweet,B-AG.01.n.17.a,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47676,spreads,I-AG.01.n.17.a,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47677,",",O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47678,breakfast,B-AG.01.n.10,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47679,cereals,I-AG.01.n.10,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47680,),O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47681,.,O,1647.0,"We identified three interpretable dietary patterns : ' high fat / low fibre ' ( high in red meat , meat products , white bread , fried potato , eggs ) , ' prudent ' ( high in poultry , fish , fruits , vegetables , legumes , pasta , rice , wholemeal bread , eggs , olive oil ) and ' high sugar ' ( high in biscuits , puddings , chocolates , sweets , sweet spreads , breakfast cereals ) ."
47755,Adherence,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47756,to,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47757,a,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47758,',O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47759,high,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47760,-,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47761,sugar,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47762,',O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47763,diet,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47764,was,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47765,associated,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47766,with,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47767,a,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47768,borderline,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47769,significant,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47770,trend,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47771,for,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47772,an,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47773,increased,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47774,risk,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47775,of,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47776,CVD,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47777,and,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47778,CHD,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47779,events,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47780,.,O,1650.0,Adherence to a ' high - sugar ' diet was associated with a borderline significant trend for an increased risk of CVD and CHD events .
47781,The,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47782,',O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47783,prudent,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47784,',O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47785,diet,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47786,did,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47787,not,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47788,show,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47789,a,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47790,significant,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47791,trend,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47792,with,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47793,cardiovascular,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47794,outcomes,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47795,or,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47796,mortality,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
47797,.,O,1651.0,The ' prudent ' diet did not show a significant trend with cardiovascular outcomes or mortality .
48271,After,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48272,proper,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48273,adjustment,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48274,for,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48275,drinking,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48276,and,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48277,smoking,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48278,",",O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48279,high,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48280,consumption,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48281,of,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48282,butter,B-AG.01.e.01,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48283,and,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48284,low,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48285,consumption,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48286,of,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48287,fresh,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48288,fish,B-AG.01.d.07,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48289,",",O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48290,vegetables,B-AG.01.h.02,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48291,and,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48292,fruits,B-AG.01.h.01,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48293,were,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48294,associated,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48295,strongly,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48296,and,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48297,independently,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48298,with,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48299,an,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48300,increase,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48301,in,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48302,oesophageal,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48303,-,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48304,cancer,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48305,risk,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48306,.,O,1669.0,"After proper adjustment for drinking and smoking , high consumption of butter and low consumption of fresh fish , vegetables and fruits were associated strongly and independently with an increase in oesophageal - cancer risk ."
48499,The,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48500,objective,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48501,of,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48502,this,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48503,study,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48504,was,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48505,to,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48506,identify,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48507,drivers,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48508,of,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48509,liking,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48510,for,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48511,potato,B-AG.01.n.09,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48512,chip,I-AG.01.n.09,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48513,and,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48514,puffed,B-AG.01.n.10,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48515,rice,I-AG.01.n.10,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48516,samples,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48517,seasoned,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48518,with,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48519,differing,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48520,sodium,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48521,and,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48522,flavor,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48523,enhancer,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48524,concentrations,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48525,using,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48526,sensory,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48527,descriptive,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48528,analysis,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48529,and,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48530,acceptance,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48531,data,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48532,.,O,1676.0,The objective of this study was to identify drivers of liking for potato chip and puffed rice samples seasoned with differing sodium and flavor enhancer concentrations using sensory descriptive analysis and acceptance data .
48613,Consumers,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48614,disliked,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48615,samples,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48616,with,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48617,a,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48618,strong,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48619,raw,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48620,potato,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48621,aroma,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
48622,.,O,1680.0,Consumers disliked samples with a strong raw potato aroma .
49128,Their,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49129,common,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49130,central,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49131,feature,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49132,is,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49133,the,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49134,usage,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49135,of,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49136,olive,B-AG.01.f,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49137,oil,I-AG.01.f,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49138,as,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49139,the,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49140,main,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49141,source,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49142,of,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49143,fat,B-AG.01.f,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49144,.,O,1697.0,Their common central feature is the usage of olive oil as the main source of fat .
49441,Overall,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49442,",",O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49443,NAS,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49444,IMI,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49445,in,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49446,early,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49447,lactation,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49448,caused,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49449,only,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49450,a,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49451,slight,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49452,but,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49453,significant,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49454,increase,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49455,in,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49456,qSCC,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49457,compared,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49458,with,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49459,milk,B-AG.01.e,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49460,from,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49461,noninfected,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49462,quarters,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49463,during,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49464,the,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49465,first,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49466,4,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49467,mo,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49468,in,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49469,lactation,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49470,",",O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49471,whereas,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49472,no,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49473,significant,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49474,difference,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49475,in,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49476,daily,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49477,qMY,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49478,was,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49479,present,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49480,between,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49481,NAS,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49482,-,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49483,infected,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49484,and,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49485,noninfected,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49486,quarters,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49487,.,O,1707.0,"Overall , NAS IMI in early lactation caused only a slight but significant increase in qSCC compared with milk from noninfected quarters during the first 4 mo in lactation , whereas no significant difference in daily qMY was present between NAS - infected and noninfected quarters ."
49565,The,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49566,main,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49567,operators,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49568,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49569,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49570,olive,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49571,oil,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49572,sector,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49573,are,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49574,continuously,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49575,involved,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49576,in,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49577,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49578,development,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49579,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49580,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49581,olive,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49582,oil,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49583,mechanical,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49584,extraction,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49585,process,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49586,with,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49587,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49588,common,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49589,aim,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49590,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49591,increasing,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49592,both,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49593,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49594,quality,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49595,and,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49596,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49597,oil,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49598,extraction,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49599,yield,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49600,coupled,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49601,with,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49602,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49603,potential,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49604,enhancement,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49605,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49606,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49607,working,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49608,efficiency,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49609,of,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49610,the,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49611,olive,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49612,mill,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
49613,.,O,1711.0,The main operators of the olive oil sector are continuously involved in the development of the olive oil mechanical extraction process with the common aim of increasing both the quality and the oil extraction yield coupled with the potential enhancement of the working efficiency of the olive mill .
50075,Peanut,B-AG.01.h.01.f,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50076,and,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50077,peanut,B-AG.01.h.01.f,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50078,component,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50079,diets,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50080,retarded,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50081,an,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50082,increase,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50083,in,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50084,TC,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50085,and,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50086,CE,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50087,.,O,1726.0,Peanut and peanut component diets retarded an increase in TC and CE .
50202,However,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50203,",",O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50204,recent,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50205,studies,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50206,using,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50207,salt,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50208,-,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50209,sensitive,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50210,hypertensive,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50211,models,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50212,have,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50213,revealed,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50214,that,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50215,miso,B-AG.01.n.02,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50216,lessens,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50217,the,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50218,effects,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50219,of,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50220,salt,B-AG.01.l.01,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50221,on,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50222,blood,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50223,pressure,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50224,.,O,1732.0,"However , recent studies using salt - sensitive hypertensive models have revealed that miso lessens the effects of salt on blood pressure ."
50225,In,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50226,other,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50227,word,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50228,",",O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50229,the,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50230,intake,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50231,of,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50232,miso,B-AG.01.n.02,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50233,dose,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50234,not,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50235,increase,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50236,the,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50237,blood,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50238,pressure,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50239,compared,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50240,to,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50241,the,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50242,equivalent,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50243,intake,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50244,of,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50245,salt,B-AG.01.l.01,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50246,.,O,1733.0,"In other word , the intake of miso dose not increase the blood pressure compared to the equivalent intake of salt ."
50464,Repeated,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50465,measure,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50466,mixed,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50467,model,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50468,analysis,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50469,compared,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50470,reported,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50471,food,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50472,PS,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50473,at,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50474,the,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50475,total,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50476,population,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50477,level,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50478,as,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50479,well,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50480,as,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50481,subdivided,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50482,by,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50483,sex,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50484,",",O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50485,age,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50486,",",O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50487,BMI,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50488,and,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50489,social,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50490,class,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50491,.,O,1740.0,"Repeated measure mixed model analysis compared reported food PS at the total population level as well as subdivided by sex , age , BMI and social class ."
50839,Broccoli,B-AG.01.h.02.d,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50840,(,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50841,Hepa,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50842,1c1c7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50843,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50844,ratio=5.5,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50845,;,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50846,BPrC1,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50847,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50848,ratio=2.3,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50849,),O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50850,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50851,calcot,B-AG.01.h.02.e,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50852,(,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50853,Allium,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50854,cepa,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50855,L.,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50856,),O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50857,(,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50858,Hepa,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50859,1c1c7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50860,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50861,ratio=4.7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50862,;,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50863,BPrC1,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50864,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50865,ratio=.5,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50866,),O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50867,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50868,green,B-AG.01.h.02.e,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50869,onion,I-AG.01.h.02.e,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50870,(,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50871,Hepa,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50872,1c1c7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50873,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50874,ratio=4.6,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50875,;,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50876,BPrC1,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50877,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50878,ratio=2,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50879,),O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50880,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50881,green,B-AG.01.h.02.d,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50882,cabbage,I-AG.01.h.02.d,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50883,(,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50884,Hepa,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50885,1c1c7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50886,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50887,ratio=3.6,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50888,;,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50889,BPrC1,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50890,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50891,ratio=2.7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50892,),O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50893,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50894,purple,B-AG.01.h.02.d,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50895,cabbage,I-AG.01.h.02.d,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50896,(,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50897,Hepa,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50898,1c1c7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50899,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50900,ratio=3.4,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50901,;,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50902,BPrC1,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50903,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50904,ratio=2,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50905,),O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50906,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50907,and,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50908,black,B-AG.01.h.02.d,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50909,cabbage,I-AG.01.h.02.d,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50910,(,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50911,Hepa,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50912,1c1c7,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50913,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50914,ratio=3,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50915,;,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50916,BPrC1,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50917,",",O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50918,ratio=3,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50919,),O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50920,were,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50921,active,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50922,NQO1,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50923,inducers,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50924,in,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50925,both,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50926,murine,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50927,hepatoma,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50928,cell,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50929,lines,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
50930,.,O,1749.0,"Broccoli ( Hepa 1c1c7 , ratio=5.5 ; BPrC1 , ratio=2.3 ) , calcot ( Allium cepa L. ) ( Hepa 1c1c7 , ratio=4.7 ; BPrC1 , ratio=.5 ) , green onion ( Hepa 1c1c7 , ratio=4.6 ; BPrC1 , ratio=2 ) , green cabbage ( Hepa 1c1c7 , ratio=3.6 ; BPrC1 , ratio=2.7 ) , purple cabbage ( Hepa 1c1c7 , ratio=3.4 ; BPrC1 , ratio=2 ) , and black cabbage ( Hepa 1c1c7 , ratio=3 ; BPrC1 , ratio=3 ) were active NQO1 inducers in both murine hepatoma cell lines ."
51027,This,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51028,cross,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51029,-,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51030,sectional,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51031,study,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51032,investigated,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51033,the,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51034,relationship,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51035,between,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51036,dietary,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51037,patterns,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51038,and,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51039,body,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51040,mass,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51041,index,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51042,among,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51043,514,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51044,women,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51045,with,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51046,different,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51047,ethnic,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51048,backgrounds,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51049,who,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51050,completed,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51051,a,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51052,validated,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51053,food,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51054,-,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51055,frequency,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51056,questionnaire,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51057,.,O,1752.0,This cross - sectional study investigated the relationship between dietary patterns and body mass index among 514 women with different ethnic backgrounds who completed a validated food - frequency questionnaire .
51304,The,O,1760.0,The associations were similar in direction and magnitude for all ethnic groups .
51305,associations,O,1760.0,The associations were similar in direction and magnitude for all ethnic groups .
51306,were,O,1760.0,The associations were similar in direction and magnitude for all ethnic groups .
51307,similar,O,1760.0,The associations were similar in direction and magnitude for all ethnic groups .
51308,in,O,1760.0,The associations were similar in direction and magnitude for all ethnic groups .
51309,direction,O,1760.0,The associations were similar in direction and magnitude for all ethnic groups .
51310,and,O,1760.0,The associations were similar in direction and magnitude for all ethnic groups .
51311,magnitude,O,1760.0,The associations were similar in direction and magnitude for all ethnic groups .
51312,for,O,1760.0,The associations were similar in direction and magnitude for all ethnic groups .
51313,all,O,1760.0,The associations were similar in direction and magnitude for all ethnic groups .
51314,ethnic,O,1760.0,The associations were similar in direction and magnitude for all ethnic groups .
51315,groups,O,1760.0,The associations were similar in direction and magnitude for all ethnic groups .
51316,.,O,1760.0,The associations were similar in direction and magnitude for all ethnic groups .
51958,The,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51959,prefortification,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51960,folate,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51961,status,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51962,of,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51963,751,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51964,healthy,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51965,women,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51966,of,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51967,reproductive,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51968,age,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51969,was,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51970,assessed,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
51971,.,O,1781.0,The prefortification folate status of 751 healthy women of reproductive age was assessed .
52159,Fortification,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52160,of,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52161,wheat,B-AG.01.k,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52162,flour,I-AG.01.k,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52163,substantially,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52164,improved,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52165,folate,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52166,status,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52167,in,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52168,a,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52169,population,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52170,of,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52171,women,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52172,of,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52173,reproductive,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52174,age,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52175,in,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52176,Chile,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52177,.,O,1788.0,Fortification of wheat flour substantially improved folate status in a population of women of reproductive age in Chile .
52266,Details,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52267,of,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52268,the,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52269,studies,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52270,are,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52271,presented,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52272,",",O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52273,and,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52274,the,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52275,potential,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52276,impact,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52277,of,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52278,measurement,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52279,error,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52280,",",O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52281,publication,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52282,bias,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52283,",",O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52284,the,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52285,form,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52286,of,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52287,tea,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52288,consumed,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52289,",",O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52290,the,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52291,appropriateness,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52292,of,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52293,the,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52294,outcomes,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52295,studied,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52296,and,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52297,the,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52298,adjustment,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52299,of,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52300,confounders,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52301,related,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52302,to,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52303,both,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52304,tea,B-AG.01.ac,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52305,consumption,B-X,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52306,and,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52307,risk,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52308,of,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52309,colorectal,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52310,cancer,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52311,or,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52312,polyps,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52313,in,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52314,various,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52315,countries,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52316,are,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52317,explored,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52318,.,O,1793.0,"Details of the studies are presented , and the potential impact of measurement error , publication bias , the form of tea consumed , the appropriateness of the outcomes studied and the adjustment of confounders related to both tea consumption and risk of colorectal cancer or polyps in various countries are explored ."
52843,A,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52844,total,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52845,of,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52846,14,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52847,phenolic,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52848,compounds,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52849,",",O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52850,a,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52851,piperine,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52852,",",O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52853,cinnamic,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52854,acid,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52855,",",O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52856,and,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52857,cinnamaldehyde,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52858,were,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52859,identified,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52860,and,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52861,quantitated,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52862,.,O,1813.0,"A total of 14 phenolic compounds , a piperine , cinnamic acid , and cinnamaldehyde were identified and quantitated ."
52936,Some,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52937,spices,B-AG.01.l.03,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52938,displayed,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52939,prebiotic,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52940,-,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52941,like,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52942,activity,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52943,by,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52944,promoting,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52945,the,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52946,growth,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52947,of,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52948,beneficial,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52949,bacteria,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52950,and,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52951,suppressing,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52952,the,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52953,growth,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52954,of,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52955,pathogenic,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52956,bacteria,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52957,",",O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52958,suggesting,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52959,their,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52960,potential,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52961,role,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52962,in,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52963,the,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52964,regulation,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52965,of,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52966,intestinal,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52967,microbiota,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52968,and,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52969,the,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52970,enhancement,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52971,of,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52972,gastrointestinal,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52973,health,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
52974,.,O,1819.0,"Some spices displayed prebiotic - like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria , suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health ."
53591,Moreover,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53592,",",O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53593,higher,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53594,intakes,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53595,of,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53596,food,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53597,of,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53598,MD,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53599,",",O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53600,may,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53601,represent,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53602,a,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53603,potential,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53604,tool,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53605,for,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53606,prevention,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53607,of,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53608,tumor,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53609,aggressiveness,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53610,.,O,1844.0,"Moreover , higher intakes of food of MD , may represent a potential tool for prevention of tumor aggressiveness ."
53631,For,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53632,>,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53633,50,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53634,y,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53635,",",O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53636,dietary,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53637,guidelines,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53638,in,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53639,the,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53640,United,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53641,States,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53642,have,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53643,focused,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53644,on,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53645,reducing,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53646,intakes,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53647,of,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53648,saturated,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53649,and,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53650,total,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53651,fat,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53652,.,O,1846.0,"For > 50 y , dietary guidelines in the United States have focused on reducing intakes of saturated and total fat ."
53919,Almond,B-AG.01.h.01.f,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53920,consumption,B-X,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53921,",",O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53922,together,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53923,with,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53924,other,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53925,nuts,B-AG.01.h.01.f,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53926,",",O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53927,has,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53928,been,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53929,widely,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53930,associated,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53931,with,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53932,improvements,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53933,in,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53934,cardiovascular,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53935,health,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53936,",",O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53937,metabolic,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53938,syndrome,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53939,and,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53940,diabetes,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53941,owing,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53942,to,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53943,their,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53944,bioactive,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53945,compounds,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53946,such,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53947,as,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53948,polyphenols,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
53949,.,O,1858.0,"Almond consumption , together with other nuts , has been widely associated with improvements in cardiovascular health , metabolic syndrome and diabetes owing to their bioactive compounds such as polyphenols ."
54200,It,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54201,was,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54202,suggested,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54203,that,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54204,urothelial,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54205,cancer,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54206,death,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54207,could,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54208,be,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54209,potentially,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54210,preventable,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54211,by,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54212,smoking,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54213,cessation,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54214,and,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54215,regular,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54216,intake,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54217,of,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54218,milk,B-AG.01.e,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54219,and,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54220,fruit,B-AG.01.h.01,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54221,.,O,1871.0,It was suggested that urothelial cancer death could be potentially preventable by smoking cessation and regular intake of milk and fruit .
54320,We,O,1875.0,We found the main incidence to be in women ( 70.2 % ) .
54321,found,O,1875.0,We found the main incidence to be in women ( 70.2 % ) .
54322,the,O,1875.0,We found the main incidence to be in women ( 70.2 % ) .
54323,main,O,1875.0,We found the main incidence to be in women ( 70.2 % ) .
54324,incidence,O,1875.0,We found the main incidence to be in women ( 70.2 % ) .
54325,to,O,1875.0,We found the main incidence to be in women ( 70.2 % ) .
54326,be,O,1875.0,We found the main incidence to be in women ( 70.2 % ) .
54327,in,O,1875.0,We found the main incidence to be in women ( 70.2 % ) .
54328,women,O,1875.0,We found the main incidence to be in women ( 70.2 % ) .
54329,(,O,1875.0,We found the main incidence to be in women ( 70.2 % ) .
54330,70.2,O,1875.0,We found the main incidence to be in women ( 70.2 % ) .
54331,%,O,1875.0,We found the main incidence to be in women ( 70.2 % ) .
54332,),O,1875.0,We found the main incidence to be in women ( 70.2 % ) .
54333,.,O,1875.0,We found the main incidence to be in women ( 70.2 % ) .
54487,Results,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54488,showed,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54489,the,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54490,existence,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54491,of,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54492,common,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54493,antigenic,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54494,epitopes,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54495,in,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54496,pistachio,B-AG.01.h.01.f,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54497,and,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54498,Artemisia,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54499,pollen,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54500,for,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54501,this,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54502,patient,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54503,.,O,1881.0,Results showed the existence of common antigenic epitopes in pistachio and Artemisia pollen for this patient .
54692,Among,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54693,women,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54694,and,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54695,",",O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54696,to,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54697,a,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54698,lesser,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54699,extent,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54700,",",O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54701,among,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54702,men,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54703,",",O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54704,inverse,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54705,associations,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54706,were,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54707,stronger,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54708,for,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54709,distal,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54710,colonic,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54711,tumors,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54712,than,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54713,for,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54714,proximal,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54715,colonic,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54716,tumors,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54717,.,O,1889.0,"Among women and , to a lesser extent , among men , inverse associations were stronger for distal colonic tumors than for proximal colonic tumors ."
54785,Diet,O,1892.0,Diet has been recognized as a corner stone in the management of diabetes mellitus .
54786,has,O,1892.0,Diet has been recognized as a corner stone in the management of diabetes mellitus .
54787,been,O,1892.0,Diet has been recognized as a corner stone in the management of diabetes mellitus .
54788,recognized,O,1892.0,Diet has been recognized as a corner stone in the management of diabetes mellitus .
54789,as,O,1892.0,Diet has been recognized as a corner stone in the management of diabetes mellitus .
54790,a,O,1892.0,Diet has been recognized as a corner stone in the management of diabetes mellitus .
54791,corner,O,1892.0,Diet has been recognized as a corner stone in the management of diabetes mellitus .
54792,stone,O,1892.0,Diet has been recognized as a corner stone in the management of diabetes mellitus .
54793,in,O,1892.0,Diet has been recognized as a corner stone in the management of diabetes mellitus .
54794,the,O,1892.0,Diet has been recognized as a corner stone in the management of diabetes mellitus .
54795,management,O,1892.0,Diet has been recognized as a corner stone in the management of diabetes mellitus .
54796,of,O,1892.0,Diet has been recognized as a corner stone in the management of diabetes mellitus .
54797,diabetes,O,1892.0,Diet has been recognized as a corner stone in the management of diabetes mellitus .
54798,mellitus,O,1892.0,Diet has been recognized as a corner stone in the management of diabetes mellitus .
54799,.,O,1892.0,Diet has been recognized as a corner stone in the management of diabetes mellitus .
54800,Spices,B-AG.01.l.03,1893.0,Spices are the common dietary adjuncts that contribute to the taste and flavour of foods .
54801,are,O,1893.0,Spices are the common dietary adjuncts that contribute to the taste and flavour of foods .
54802,the,O,1893.0,Spices are the common dietary adjuncts that contribute to the taste and flavour of foods .
54803,common,O,1893.0,Spices are the common dietary adjuncts that contribute to the taste and flavour of foods .
54804,dietary,O,1893.0,Spices are the common dietary adjuncts that contribute to the taste and flavour of foods .
54805,adjuncts,O,1893.0,Spices are the common dietary adjuncts that contribute to the taste and flavour of foods .
54806,that,O,1893.0,Spices are the common dietary adjuncts that contribute to the taste and flavour of foods .
54807,contribute,O,1893.0,Spices are the common dietary adjuncts that contribute to the taste and flavour of foods .
54808,to,O,1893.0,Spices are the common dietary adjuncts that contribute to the taste and flavour of foods .
54809,the,O,1893.0,Spices are the common dietary adjuncts that contribute to the taste and flavour of foods .
54810,taste,O,1893.0,Spices are the common dietary adjuncts that contribute to the taste and flavour of foods .
54811,and,O,1893.0,Spices are the common dietary adjuncts that contribute to the taste and flavour of foods .
54812,flavour,O,1893.0,Spices are the common dietary adjuncts that contribute to the taste and flavour of foods .
54813,of,O,1893.0,Spices are the common dietary adjuncts that contribute to the taste and flavour of foods .
54814,foods,O,1893.0,Spices are the common dietary adjuncts that contribute to the taste and flavour of foods .
54815,.,O,1893.0,Spices are the common dietary adjuncts that contribute to the taste and flavour of foods .
54902,In,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54903,a,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54904,limited,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54905,number,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54906,of,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54907,studies,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54908,",",O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54909,cumin,B-AG.01.l.03,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54910,seeds,I-AG.01.l.03,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54911,(,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54912,Cuminum,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54913,cyminum,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54914,),O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54915,",",O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54916,ginger,B-AG.01.l.03,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54917,(,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54918,Zingiber,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54919,officinale,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54920,),O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54921,",",O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54922,mustard,B-AG.01.l.03,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54923,(,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54924,Brassica,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54925,nigra,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54926,),O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54927,",",O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54928,curry,B-AG.01.l.03,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54929,leaves,I-AG.01.l.03,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54930,(,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54931,Murraya,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54932,koenigii,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54933,),O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54934,and,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54935,coriander,B-AG.01.l.03,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54936,(,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54937,Coriandrum,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54938,sativum,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54939,),O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54940,have,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54941,been,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54942,reported,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54943,to,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54944,be,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54945,hypoglycaemic,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54946,.,O,1897.0,"In a limited number of studies , cumin seeds ( Cuminum cyminum ) , ginger ( Zingiber officinale ) , mustard ( Brassica nigra ) , curry leaves ( Murraya koenigii ) and coriander ( Coriandrum sativum ) have been reported to be hypoglycaemic ."
54947,Myosmine,O,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54948,has,O,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54949,been,O,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54950,regarded,O,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54951,as,O,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54952,a,O,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54953,specific,O,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54954,tobacco,O,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54955,alkaloid,O,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54956,until,O,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54957,investigations,O,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54958,pointed,O,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54959,out,O,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54960,that,O,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54961,nuts,B-AG.01.h.01.f,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54962,and,O,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54963,nut,B-AG.01.h.01.f,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54964,products,I-AG.01.h.01.f,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54965,constitute,O,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54966,a,O,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54967,significant,O,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54968,source,O,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54969,of,O,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54970,myosmine,O,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
54971,.,O,1898.0,Myosmine has been regarded as a specific tobacco alkaloid until investigations pointed out that nuts and nut products constitute a significant source of myosmine .
55081,Myosmine,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55082,is,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55083,easily,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55084,nitrosated,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55085,giving,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55086,rise,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55087,to,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55088,a,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55089,DNA,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55090,adduct,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55091,identical,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55092,to,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55093,the,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55094,esophageal,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55095,tobacco,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55096,carcinogen,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55097,N,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55098,-,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55099,nitrosonornicotine,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55100,.,O,1903.0,Myosmine is easily nitrosated giving rise to a DNA adduct identical to the esophageal tobacco carcinogen N - nitrosonornicotine .
55296,The,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55297,usual,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55298,choice,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55299,of,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55300,spread,B-AG.01,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55301,used,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55302,on,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55303,bread,B-AG.01.n.11,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55304,",",O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55305,and,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55306,the,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55307,calculated,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55308,total,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55309,amount,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55310,of,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55311,fat,B-AG.01,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55312,spread,I-AG.01,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55313,on,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55314,bread,B-AG.01.n.11,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55315,per,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55316,day,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55317,",",O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55318,were,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55319,related,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55320,to,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55321,socio,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55322,-,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55323,economic,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55324,and,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55325,coronary,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55326,artery,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55327,disease,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55328,risk,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55329,factors,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55330,in,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55331,9003,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55332,respondents,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55333,in,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55334,the,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55335,Health,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55336,and,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55337,Lifestyle,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55338,Survey,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55339,.,O,1912.0,"The usual choice of spread used on bread , and the calculated total amount of fat spread on bread per day , were related to socio - economic and coronary artery disease risk factors in 9003 respondents in the Health and Lifestyle Survey ."
55433,Overweight,O,1917.0,Overweight and obese respondents were a little more likely than lean respondents to choose low fat spread or no spread .
55434,and,O,1917.0,Overweight and obese respondents were a little more likely than lean respondents to choose low fat spread or no spread .
55435,obese,O,1917.0,Overweight and obese respondents were a little more likely than lean respondents to choose low fat spread or no spread .
55436,respondents,O,1917.0,Overweight and obese respondents were a little more likely than lean respondents to choose low fat spread or no spread .
55437,were,O,1917.0,Overweight and obese respondents were a little more likely than lean respondents to choose low fat spread or no spread .
55438,a,O,1917.0,Overweight and obese respondents were a little more likely than lean respondents to choose low fat spread or no spread .
55439,little,O,1917.0,Overweight and obese respondents were a little more likely than lean respondents to choose low fat spread or no spread .
55440,more,O,1917.0,Overweight and obese respondents were a little more likely than lean respondents to choose low fat spread or no spread .
55441,likely,O,1917.0,Overweight and obese respondents were a little more likely than lean respondents to choose low fat spread or no spread .
55442,than,O,1917.0,Overweight and obese respondents were a little more likely than lean respondents to choose low fat spread or no spread .
55443,lean,O,1917.0,Overweight and obese respondents were a little more likely than lean respondents to choose low fat spread or no spread .
55444,respondents,O,1917.0,Overweight and obese respondents were a little more likely than lean respondents to choose low fat spread or no spread .
55445,to,O,1917.0,Overweight and obese respondents were a little more likely than lean respondents to choose low fat spread or no spread .
55446,choose,O,1917.0,Overweight and obese respondents were a little more likely than lean respondents to choose low fat spread or no spread .
55447,low,B-AG.01,1917.0,Overweight and obese respondents were a little more likely than lean respondents to choose low fat spread or no spread .
55448,fat,I-AG.01,1917.0,Overweight and obese respondents were a little more likely than lean respondents to choose low fat spread or no spread .
55449,spread,I-AG.01,1917.0,Overweight and obese respondents were a little more likely than lean respondents to choose low fat spread or no spread .
55450,or,O,1917.0,Overweight and obese respondents were a little more likely than lean respondents to choose low fat spread or no spread .
55451,no,O,1917.0,Overweight and obese respondents were a little more likely than lean respondents to choose low fat spread or no spread .
55452,spread,B-AG.01,1917.0,Overweight and obese respondents were a little more likely than lean respondents to choose low fat spread or no spread .
55453,.,O,1917.0,Overweight and obese respondents were a little more likely than lean respondents to choose low fat spread or no spread .
55781,In,O,1928.0,"In a separate experiment , serum antibody levels specific to orally administered ovalbumin were lower in mice fed Yukihikari ."
55782,a,O,1928.0,"In a separate experiment , serum antibody levels specific to orally administered ovalbumin were lower in mice fed Yukihikari ."
55783,separate,O,1928.0,"In a separate experiment , serum antibody levels specific to orally administered ovalbumin were lower in mice fed Yukihikari ."
55784,experiment,O,1928.0,"In a separate experiment , serum antibody levels specific to orally administered ovalbumin were lower in mice fed Yukihikari ."
55785,",",O,1928.0,"In a separate experiment , serum antibody levels specific to orally administered ovalbumin were lower in mice fed Yukihikari ."
55786,serum,O,1928.0,"In a separate experiment , serum antibody levels specific to orally administered ovalbumin were lower in mice fed Yukihikari ."
55787,antibody,O,1928.0,"In a separate experiment , serum antibody levels specific to orally administered ovalbumin were lower in mice fed Yukihikari ."
55788,levels,O,1928.0,"In a separate experiment , serum antibody levels specific to orally administered ovalbumin were lower in mice fed Yukihikari ."
55789,specific,O,1928.0,"In a separate experiment , serum antibody levels specific to orally administered ovalbumin were lower in mice fed Yukihikari ."
55790,to,O,1928.0,"In a separate experiment , serum antibody levels specific to orally administered ovalbumin were lower in mice fed Yukihikari ."
55791,orally,O,1928.0,"In a separate experiment , serum antibody levels specific to orally administered ovalbumin were lower in mice fed Yukihikari ."
55792,administered,O,1928.0,"In a separate experiment , serum antibody levels specific to orally administered ovalbumin were lower in mice fed Yukihikari ."
55793,ovalbumin,O,1928.0,"In a separate experiment , serum antibody levels specific to orally administered ovalbumin were lower in mice fed Yukihikari ."
55794,were,O,1928.0,"In a separate experiment , serum antibody levels specific to orally administered ovalbumin were lower in mice fed Yukihikari ."
55795,lower,O,1928.0,"In a separate experiment , serum antibody levels specific to orally administered ovalbumin were lower in mice fed Yukihikari ."
55796,in,O,1928.0,"In a separate experiment , serum antibody levels specific to orally administered ovalbumin were lower in mice fed Yukihikari ."
55797,mice,O,1928.0,"In a separate experiment , serum antibody levels specific to orally administered ovalbumin were lower in mice fed Yukihikari ."
55798,fed,O,1928.0,"In a separate experiment , serum antibody levels specific to orally administered ovalbumin were lower in mice fed Yukihikari ."
55799,Yukihikari,B-AG.01.i,1928.0,"In a separate experiment , serum antibody levels specific to orally administered ovalbumin were lower in mice fed Yukihikari ."
55800,.,O,1928.0,"In a separate experiment , serum antibody levels specific to orally administered ovalbumin were lower in mice fed Yukihikari ."
56222,In,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56223,subgroup,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56224,analyses,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56225,restricted,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56226,to,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56227,38,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56228,normal,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56229,weight,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56230,women,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56231,",",O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56232,women,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56233,in,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56234,the,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56235,intervention,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56236,group,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56237,compared,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56238,to,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56239,control,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56240,group,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56241,had,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56242,a,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56243,significant,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56244,decline,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56245,in,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56246,estrone,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56247,(,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56248,pg,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56249,/,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56250,mL,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56251,),O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56252,and,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56253,testosterone,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56254,levels,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56255,(,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56256,pg,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56257,/,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56258,mL,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56259,):,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56260,pomegranate,B-AG.01.h.01,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56261,:,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56262,-61.6,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56263,[,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56264,95,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56265,%,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56266,confidence,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56267,interval,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56268,(,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56269,CI,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56270,):,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56271,-175.8,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56272,to,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56273,52.6,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56274,),O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56275,",",O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56276,apple,B-AG.01.h.01.c,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56277,:,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56278,1.1,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56279,(,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56280,95,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56281,%,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56282,CI,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56283,:,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56284,-5.4,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56285,to,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56286,7.7,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56287,),O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56288,",",O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56289,P,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56290,=,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56291,0.05,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56292,",",O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56293,and,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56294,pomegranate,B-AG.01.h.01,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56295,:,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56296,-289.1,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56297,(,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56298,95,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56299,%,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56300,CI,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56301,:,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56302,-630.7,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56303,to,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56304,52.5,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56305,),O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56306,",",O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56307,apple,B-AG.01.h.01.c,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56308,:,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56309,79.6,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56310,(,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56311,95,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56312,%,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56313,CI,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56314,:,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56315,-77.8,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56316,to,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56317,236.9,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56318,),O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56319,",",O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56320,P,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56321,=,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56322,0.03,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56323,",",O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56324,respectively,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56325,.,O,1942.0,"In subgroup analyses restricted to 38 normal weight women , women in the intervention group compared to control group had a significant decline in estrone ( pg / mL ) and testosterone levels ( pg / mL ): pomegranate : -61.6 [ 95 % confidence interval ( CI ): -175.8 to 52.6 ) , apple : 1.1 ( 95 % CI : -5.4 to 7.7 ) , P = 0.05 , and pomegranate : -289.1 ( 95 % CI : -630.7 to 52.5 ) , apple : 79.6 ( 95 % CI : -77.8 to 236.9 ) , P = 0.03 , respectively ."
56405,This,O,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56406,study,O,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56407,investigated,O,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56408,the,O,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56409,application,O,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56410,of,O,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56411,oxidized,O,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56412,starch,O,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56413,in,O,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56414,bake,B-AG.01.n.06,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56415,-,I-AG.01.n.06,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56416,only,I-AG.01.n.06,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56417,chicken,I-AG.01.n.06,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56418,nuggets,I-AG.01.n.06,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56419,.,O,1948.0,This study investigated the application of oxidized starch in bake - only chicken nuggets .
56892,The,O,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56893,CVD,O,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56894,burden,O,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56895,is,O,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56896,reduced,O,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56897,by,O,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56898,optimum,O,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56899,diet,O,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56900,through,O,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56901,replacement,O,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56902,of,O,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56903,unprocessed,B-AG.01.d,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56904,meat,I-AG.01.d,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56905,with,O,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56906,low,O,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56907,saturated,O,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56908,fat,O,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56909,",",O,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56910,animal,O,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56911,proteins,O,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56912,and,O,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56913,plant,O,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56914,proteins,O,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
56915,.,O,1963.0,"The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat , animal proteins and plant proteins ."
57018,The,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57019,aim,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57020,of,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57021,this,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57022,expert,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57023,opinion,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57024,recommendation,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57025,was,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57026,to,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57027,elucidate,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57028,the,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57029,different,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57030,impact,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57031,of,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57032,animal,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57033,vs,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57034,vegetable,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57035,protein,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57036,on,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57037,modifying,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57038,cardiometabolic,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57039,risk,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57040,factors,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57041,.,O,1969.0,The aim of this expert opinion recommendation was to elucidate the different impact of animal vs vegetable protein on modifying cardiometabolic risk factors .
57334,One,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57335,hundred,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57336,forty,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57337,-,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57338,two,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57339,of,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57340,195,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57341,participants,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57342,(,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57343,73,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57344,%,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57345,),O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57346,completed,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57347,the,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57348,course,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57349,and,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57350,the,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57351,evaluation,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57352,.,O,1982.0,One hundred forty - two of 195 participants ( 73 % ) completed the course and the evaluation .
57514,However,O,1989.0,"However , the dietary habits of Saharawi diabetic women are unknown ."
57515,",",O,1989.0,"However , the dietary habits of Saharawi diabetic women are unknown ."
57516,the,O,1989.0,"However , the dietary habits of Saharawi diabetic women are unknown ."
57517,dietary,O,1989.0,"However , the dietary habits of Saharawi diabetic women are unknown ."
57518,habits,O,1989.0,"However , the dietary habits of Saharawi diabetic women are unknown ."
57519,of,O,1989.0,"However , the dietary habits of Saharawi diabetic women are unknown ."
57520,Saharawi,O,1989.0,"However , the dietary habits of Saharawi diabetic women are unknown ."
57521,diabetic,O,1989.0,"However , the dietary habits of Saharawi diabetic women are unknown ."
57522,women,O,1989.0,"However , the dietary habits of Saharawi diabetic women are unknown ."
57523,are,O,1989.0,"However , the dietary habits of Saharawi diabetic women are unknown ."
57524,unknown,O,1989.0,"However , the dietary habits of Saharawi diabetic women are unknown ."
57525,.,O,1989.0,"However , the dietary habits of Saharawi diabetic women are unknown ."
58302,Higher,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58303,intake,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58304,of,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58305,ultraprocessed,B-AG.01,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58306,foods,I-AG.01,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58307,(,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58308,UPF,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58309,),O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58310,",",O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58311,which,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58312,have,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58313,undergone,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58314,multiple,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58315,processes,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58316,and,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58317,have,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58318,poor,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58319,nutrient,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58320,quality,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58321,",",O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58322,is,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58323,associated,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58324,with,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58325,higher,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58326,incidence,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58327,of,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58328,non,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58329,-,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58330,communicable,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58331,diseases,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58332,.,O,2011.0,"Higher intake of ultraprocessed foods ( UPF ) , which have undergone multiple processes and have poor nutrient quality , is associated with higher incidence of non - communicable diseases ."
58356,We,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58357,aimed,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58358,to,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58359,estimate,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58360,the,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58361,associations,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58362,between,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58363,consumption,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58364,of,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58365,UPF,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58366,(,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58367,total,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58368,",",O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58369,liquid,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58370,and,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58371,solid,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58372,),O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58373,and,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58374,UPF,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58375,subgroups,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58376,and,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58377,incident,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58378,hypertension,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58379,in,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58380,a,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58381,prospective,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58382,cohort,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58383,study,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58384,.,O,2013.0,"We aimed to estimate the associations between consumption of UPF ( total , liquid and solid ) and UPF subgroups and incident hypertension in a prospective cohort study ."
58385,We,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged 25 years at baseline .
58386,used,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged 25 years at baseline .
58387,data,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged 25 years at baseline .
58388,from,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged 25 years at baseline .
58389,the,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged 25 years at baseline .
58390,Mexican,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged 25 years at baseline .
58391,Teachers,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged 25 years at baseline .
58392,',O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged 25 years at baseline .
58393,Cohort,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged 25 years at baseline .
58394,including,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged 25 years at baseline .
58395,64,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged 25 years at baseline .
58396,934,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged 25 years at baseline .
58397,disease,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged 25 years at baseline .
58398,-,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged 25 years at baseline .
58399,free,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged 25 years at baseline .
58400,women,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged 25 years at baseline .
58401,aged,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged 25 years at baseline .
58402,25,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged 25 years at baseline .
58403,years,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged 25 years at baseline .
58404,at,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged 25 years at baseline .
58405,baseline,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged 25 years at baseline .
58406,.,O,2014.0,We used data from the Mexican Teachers ' Cohort including 64 934 disease - free women aged 25 years at baseline .
58566,However,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58567,",",O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58568,liquid,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58569,UPF,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58570,and,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58571,processed,B-AG.01.d,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58572,meats,I-AG.01.d,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58573,were,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58574,associated,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58575,with,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58576,increased,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58577,hypertension,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58578,(,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58579,IRR,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58580,132,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58581,",",O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58582,95,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58583,%,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58584,CI,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58585,110,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58586,",",O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58587,165,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58588,;,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58589,IRR,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58590,117,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58591,",",O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58592,95,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58593,%,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58594,CI,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58595,101,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58596,",",O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58597,136,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58598,",",O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58599,respectively,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58600,),O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58601,.,O,2022.0,"However , liquid UPF and processed meats were associated with increased hypertension ( IRR 132 , 95 % CI 110 , 165 ; IRR 117 , 95 % CI 101 , 136 , respectively ) ."
58640,Milk,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58641,proteins,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58642,are,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58643,currently,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58644,the,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58645,main,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58646,source,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58647,of,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58648,a,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58649,range,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58650,of,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58651,biologically,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58652,active,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58653,peptides,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58654,.,O,2025.0,Milk proteins are currently the main source of a range of biologically active peptides .
58655,Concentrates,O,2026.0,Concentrates of these peptides are potential health - enhancing nutraceuticals for food and pharmaceutical applications .
58656,of,O,2026.0,Concentrates of these peptides are potential health - enhancing nutraceuticals for food and pharmaceutical applications .
58657,these,O,2026.0,Concentrates of these peptides are potential health - enhancing nutraceuticals for food and pharmaceutical applications .
58658,peptides,O,2026.0,Concentrates of these peptides are potential health - enhancing nutraceuticals for food and pharmaceutical applications .
58659,are,O,2026.0,Concentrates of these peptides are potential health - enhancing nutraceuticals for food and pharmaceutical applications .
58660,potential,O,2026.0,Concentrates of these peptides are potential health - enhancing nutraceuticals for food and pharmaceutical applications .
58661,health,O,2026.0,Concentrates of these peptides are potential health - enhancing nutraceuticals for food and pharmaceutical applications .
58662,-,O,2026.0,Concentrates of these peptides are potential health - enhancing nutraceuticals for food and pharmaceutical applications .
58663,enhancing,O,2026.0,Concentrates of these peptides are potential health - enhancing nutraceuticals for food and pharmaceutical applications .
58664,nutraceuticals,O,2026.0,Concentrates of these peptides are potential health - enhancing nutraceuticals for food and pharmaceutical applications .
58665,for,O,2026.0,Concentrates of these peptides are potential health - enhancing nutraceuticals for food and pharmaceutical applications .
58666,food,O,2026.0,Concentrates of these peptides are potential health - enhancing nutraceuticals for food and pharmaceutical applications .
58667,and,O,2026.0,Concentrates of these peptides are potential health - enhancing nutraceuticals for food and pharmaceutical applications .
58668,pharmaceutical,O,2026.0,Concentrates of these peptides are potential health - enhancing nutraceuticals for food and pharmaceutical applications .
58669,applications,O,2026.0,Concentrates of these peptides are potential health - enhancing nutraceuticals for food and pharmaceutical applications .
58670,.,O,2026.0,Concentrates of these peptides are potential health - enhancing nutraceuticals for food and pharmaceutical applications .
58913,GI,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58914,testing,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58915,of,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58916,pilsner,B-AG.01.y.01.b,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58917,beer,I-AG.01.y.01.b,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58918,(,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58919,Pilsner,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58920,Urquell,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58921,),O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58922,was,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58923,conducted,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58924,at,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58925,The,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58926,University,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58927,of,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58928,Sydney,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58929,according,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58930,to,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58931,ISO,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58932,international,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58933,standards,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58934,with,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58935,glucose,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58936,as,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58937,the,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58938,reference,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58939,food,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
58940,.,O,2037.0,GI testing of pilsner beer ( Pilsner Urquell ) was conducted at The University of Sydney according to ISO international standards with glucose as the reference food .
59039,Other,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59040,foods,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59041,that,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59042,contributed,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59043,to,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59044,the,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59045,inter,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59046,-,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59047,individual,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59048,variation,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59049,in,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59050,GI,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59051,and,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59052,GL,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59053,included,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59054,potatoes,B-AG.01.h.02.a,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59055,",",O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59056,bread,B-AG.01.n.11,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59057,",",O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59058,soft,B-AG.01.y,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59059,drinks,I-AG.01.y,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59060,",",O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59061,sugar,B-AG.01.l.02,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59062,",",O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59063,candy,B-AG.01.n.17.a,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59064,",",O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59065,wine,B-AG.01.y.01.a,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59066,",",O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59067,coffee,B-AG.01.ad,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59068,and,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59069,tea,B-AG.01.ac,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59070,.,O,2043.0,"Other foods that contributed to the inter - individual variation in GI and GL included potatoes , bread , soft drinks , sugar , candy , wine , coffee and tea ."
59628,With,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59629,increasing,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59630,content,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59631,of,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59632,iron,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59633,compounds,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59634,",",O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59635,up,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59636,to,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59637,25,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59638,-,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59639,fold,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59640,higher,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59641,concentrations,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59642,of,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59643,the,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59644,toxic,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59645,lipid,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59646,oxidation,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59647,products,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59648,malondialdehyde,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59649,",",O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59650,4,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59651,-,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59652,hydroxy-2,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59653,-,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59654,nonenal,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59655,",",O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59656,and,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59657,other,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59658,volatile,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59659,aldehydes,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59660,were,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59661,formed,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59662,during,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59663,digestion,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59664,",",O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59665,together,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59666,with,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59667,increased,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59668,protein,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59669,carbonyl,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59670,compounds,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59671,as,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59672,measurement,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59673,of,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59674,protein,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59675,oxidation,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59676,.,O,2064.0,"With increasing content of iron compounds , up to 25 - fold higher concentrations of the toxic lipid oxidation products malondialdehyde , 4 - hydroxy-2 - nonenal , and other volatile aldehydes were formed during digestion , together with increased protein carbonyl compounds as measurement of protein oxidation ."
59818,To,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59819,examine,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59820,these,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59821,relations,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59822,",",O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59823,the,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59824,authors,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59825,performed,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59826,a,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59827,cohort,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59828,study,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59829,of,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59830,participants,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59831,in,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59832,a,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59833,large,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59834,Northern,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59835,California,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59836,prepaid,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59837,health,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59838,care,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59839,program,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
59840,.,O,2070.0,"To examine these relations , the authors performed a cohort study of participants in a large Northern California prepaid health care program ."
60059,In,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60060,the,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60061,process,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60062,",",O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60063,consumption,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60064,of,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60065,animal,B-AG.01.d,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60066,products,I-AG.01.d,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60067,increases,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60068,the,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60069,risk,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60070,for,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60071,cardiovascular,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60072,disease,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60073,",",O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60074,cancer,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60075,",",O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60076,diabetes,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60077,",",O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60078,obesity,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60079,",",O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60080,and,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60081,other,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60082,disorders,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60083,.,O,2079.0,"In the process , consumption of animal products increases the risk for cardiovascular disease , cancer , diabetes , obesity , and other disorders ."
60162,However,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60163,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60164,a,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60165,diet,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60166,based,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60167,on,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60168,vegetables,B-AG.01.h.02,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60169,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60170,fruits,B-AG.01.h.01,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60171,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60172,whole,B-AG.01.i,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60173,grains,I-AG.01.i,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60174,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60175,and,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60176,legumes,B-AG.01.h.02.g,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60177,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60178,supplemented,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60179,with,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60180,vitamin,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60181,B-12,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60182,",",O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60183,is,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60184,nutritionally,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60185,superior,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60186,to,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60187,diets,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60188,including,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60189,animal,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60190,products,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60191,and,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60192,is,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60193,healthful,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60194,for,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60195,children,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60196,and,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60197,adults,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60198,.,O,2083.0,"However , a diet based on vegetables , fruits , whole grains , and legumes , supplemented with vitamin B-12 , is nutritionally superior to diets including animal products and is healthful for children and adults ."
60349,Hazard,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60350,ratio,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60351,(,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60352,HR,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60353,),O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60354,estimates,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60355,for,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60356,consuming,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60357,<,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60358,1,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60359,drink,B-AG.01.y,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60360,/,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60361,week,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60362,",",O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60363,>,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60364,or,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60365,=,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60366,1,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60367,drink,B-AG.01.y,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60368,/,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60369,week,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60370,but,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60371,<,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60372,1,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60373,drink,B-AG.01.y,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60374,/,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60375,day,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60376,and,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60377,>,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60378,or,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60379,=,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60380,1,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60381,drink,B-AG.01.y,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60382,/,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60383,day,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60384,were,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60385,0.89,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60386,",",O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60387,95,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60388,%,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60389,confidence,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60390,interval,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60391,(,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60392,0.74,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60393,-,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60394,1.07,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60395,),O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60396,",",O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60397,0.99,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60398,(,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60399,0.83,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60400,-,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60401,1.17,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60402,),O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60403,and,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60404,0.88,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60405,(,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60406,0.70,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60407,-,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60408,1.12,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60409,),O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60410,",",O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60411,respectively,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60412,.,O,2091.0,"Hazard ratio ( HR ) estimates for consuming < 1 drink / week , > or = 1 drink / week but < 1 drink / day and > or = 1 drink / day were 0.89 , 95 % confidence interval ( 0.74 - 1.07 ) , 0.99 ( 0.83 - 1.17 ) and 0.88 ( 0.70 - 1.12 ) , respectively ."
60517,In,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60518,general,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60519,beer,B-AG.01.y.01.b,2096.0,In general beer has not been portrayed as part of a balanced diet .
60520,has,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60521,not,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60522,been,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60523,portrayed,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60524,as,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60525,part,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60526,of,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60527,a,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60528,balanced,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60529,diet,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60530,.,O,2096.0,In general beer has not been portrayed as part of a balanced diet .
60930,No,O,2113.0,No silymarin residues were detected in colostrum and all milk samples .
60931,silymarin,O,2113.0,No silymarin residues were detected in colostrum and all milk samples .
60932,residues,O,2113.0,No silymarin residues were detected in colostrum and all milk samples .
60933,were,O,2113.0,No silymarin residues were detected in colostrum and all milk samples .
60934,detected,O,2113.0,No silymarin residues were detected in colostrum and all milk samples .
60935,in,O,2113.0,No silymarin residues were detected in colostrum and all milk samples .
60936,colostrum,O,2113.0,No silymarin residues were detected in colostrum and all milk samples .
60937,and,O,2113.0,No silymarin residues were detected in colostrum and all milk samples .
60938,all,O,2113.0,No silymarin residues were detected in colostrum and all milk samples .
60939,milk,O,2113.0,No silymarin residues were detected in colostrum and all milk samples .
60940,samples,O,2113.0,No silymarin residues were detected in colostrum and all milk samples .
60941,.,O,2113.0,No silymarin residues were detected in colostrum and all milk samples .
61807,It,O,2144.0,It is considered a safe herbal medicine with only few and insignificant adverse / side effects .
61808,is,O,2144.0,It is considered a safe herbal medicine with only few and insignificant adverse / side effects .
61809,considered,O,2144.0,It is considered a safe herbal medicine with only few and insignificant adverse / side effects .
61810,a,O,2144.0,It is considered a safe herbal medicine with only few and insignificant adverse / side effects .
61811,safe,O,2144.0,It is considered a safe herbal medicine with only few and insignificant adverse / side effects .
61812,herbal,O,2144.0,It is considered a safe herbal medicine with only few and insignificant adverse / side effects .
61813,medicine,O,2144.0,It is considered a safe herbal medicine with only few and insignificant adverse / side effects .
61814,with,O,2144.0,It is considered a safe herbal medicine with only few and insignificant adverse / side effects .
61815,only,O,2144.0,It is considered a safe herbal medicine with only few and insignificant adverse / side effects .
61816,few,O,2144.0,It is considered a safe herbal medicine with only few and insignificant adverse / side effects .
61817,and,O,2144.0,It is considered a safe herbal medicine with only few and insignificant adverse / side effects .
61818,insignificant,O,2144.0,It is considered a safe herbal medicine with only few and insignificant adverse / side effects .
61819,adverse,O,2144.0,It is considered a safe herbal medicine with only few and insignificant adverse / side effects .
61820,/,O,2144.0,It is considered a safe herbal medicine with only few and insignificant adverse / side effects .
61821,side,O,2144.0,It is considered a safe herbal medicine with only few and insignificant adverse / side effects .
61822,effects,O,2144.0,It is considered a safe herbal medicine with only few and insignificant adverse / side effects .
61823,.,O,2144.0,It is considered a safe herbal medicine with only few and insignificant adverse / side effects .
63415,Results,O,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63416,from,O,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63417,our,O,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63418,study,O,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63419,suggest,O,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63420,that,O,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63421,the,O,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63422,relation,O,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63423,of,O,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63424,fruit,B-AG.01.h,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63425,and,I-AG.01.h,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63426,vegetable,I-AG.01.h,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63427,intake,B-X,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63428,and,O,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63429,esophageal,O,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63430,cancer,O,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63431,risk,O,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63432,may,O,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63433,vary,O,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63434,by,O,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63435,histologic,O,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63436,type,O,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63437,.,O,2201.0,Results from our study suggest that the relation of fruit and vegetable intake and esophageal cancer risk may vary by histologic type .
63850,Dietary,O,2217.0,Dietary patterns were identified by principal component analysis .
63851,patterns,O,2217.0,Dietary patterns were identified by principal component analysis .
63852,were,O,2217.0,Dietary patterns were identified by principal component analysis .
63853,identified,O,2217.0,Dietary patterns were identified by principal component analysis .
63854,by,O,2217.0,Dietary patterns were identified by principal component analysis .
63855,principal,O,2217.0,Dietary patterns were identified by principal component analysis .
63856,component,O,2217.0,Dietary patterns were identified by principal component analysis .
63857,analysis,O,2217.0,Dietary patterns were identified by principal component analysis .
63858,.,O,2217.0,Dietary patterns were identified by principal component analysis .
64264,The,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64265,evidence,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64266,reviewed,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64267,provides,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64268,additional,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64269,support,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64270,for,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64271,increased,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64272,consumption,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64273,of,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64274,a,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64275,wide,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64276,variety,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64277,of,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64278,vegetables,B-AG.01.h.02,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64279,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64280,in,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64281,particular,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64282,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64283,dark,B-AG.01.h.02.c,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64284,-,I-AG.01.h.02.c,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64285,green,I-AG.01.h.02.c,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64286,leafy,I-AG.01.h.02.c,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64287,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64288,cruciferous,B-AG.01.h.02.d,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64289,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64290,and,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64291,deep,B-AG.01.h.02,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64292,-,I-AG.01.h.02,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64293,yellow,I-AG.01.h.02,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64294,-,I-AG.01.h.02,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64295,orange,I-AG.01.h.02,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64296,ones,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64297,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64298,and,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64299,a,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64300,wide,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64301,variety,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64302,of,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64303,fruits,B-AG.01.h.01,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64304,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64305,in,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64306,particular,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64307,",",O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64308,citrus,B-AG.01.h.01.a,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64309,and,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64310,deep,B-AG.01.h.01,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64311,-,I-AG.01.h.01,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64312,yellow,I-AG.01.h.01,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64313,-,I-AG.01.h.01,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64314,orange,I-AG.01.h.01,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64315,ones,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64316,.,O,2234.0,"The evidence reviewed provides additional support for increased consumption of a wide variety of vegetables , in particular , dark - green leafy , cruciferous , and deep - yellow - orange ones , and a wide variety of fruits , in particular , citrus and deep - yellow - orange ones ."
64592,The,O,2246.0,The minimum milk temperature was estimated to be 8  C .
64593,minimum,O,2246.0,The minimum milk temperature was estimated to be 8  C .
64594,milk,O,2246.0,The minimum milk temperature was estimated to be 8  C .
64595,temperature,O,2246.0,The minimum milk temperature was estimated to be 8  C .
64596,was,O,2246.0,The minimum milk temperature was estimated to be 8  C .
64597,estimated,O,2246.0,The minimum milk temperature was estimated to be 8  C .
64598,to,O,2246.0,The minimum milk temperature was estimated to be 8  C .
64599,be,O,2246.0,The minimum milk temperature was estimated to be 8  C .
64600,8,O,2246.0,The minimum milk temperature was estimated to be 8  C .
64601,,O,2246.0,The minimum milk temperature was estimated to be 8  C .
64602,C,O,2246.0,The minimum milk temperature was estimated to be 8  C .
64603,.,O,2246.0,The minimum milk temperature was estimated to be 8  C .
64710,The,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64711,soil,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64712,was,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64713,treated,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64714,with,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64715,10,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64716,%,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64717,of,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64718,ISWs,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64719,and,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64720,5,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64721,%,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64722,of,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64723,organic,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64724,wastes,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
64725,.,O,2250.0,The soil was treated with 10 % of ISWs and 5 % of organic wastes .
65024,A,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65025,dietary,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65026,history,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65027,questionnaire,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65028,was,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65029,used,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65030,to,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65031,determine,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65032,the,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65033,usual,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65034,eating,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65035,habits,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65036,during,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65037,the,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65038,year,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65039,preceding,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65040,diagnosis,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65041,for,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65042,cases,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65043,",",O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65044,or,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65045,preceding,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65046,interview,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65047,for,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65048,controls,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65049,.,O,2263.0,"A dietary history questionnaire was used to determine the usual eating habits during the year preceding diagnosis for cases , or preceding interview for controls ."
65329,We,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65330,conclude,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65331,that,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65332,ethanol,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65333,",",O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65334,particularly,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65335,wine,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65336,ethanol,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65337,",",O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65338,is,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65339,inversely,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65340,related,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65341,to,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65342,CHD,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65343,but,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65344,not,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65345,to,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65346,longevity,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65347,in,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65348,populations,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
65349,.,O,2278.0,"We conclude that ethanol , particularly wine ethanol , is inversely related to CHD but not to longevity in populations ."
66156,Cerebral,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66157,ischemia,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66158,/,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66159,reperfusion,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66160,(,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66161,I,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66162,/,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66163,R,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66164,),O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66165,injury,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66166,",",O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66167,expression,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66168,of,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66169,adhesion,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66170,molecules,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66171,and,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66172,pro-,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66173,and,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66174,anti,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66175,-,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66176,inflammatory,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66177,cytokines,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66178,/,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66179,chemokines,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66180,",",O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66181,microglial,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66182,activation,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66183,and,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66184,neutrophil,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66185,infiltration,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66186,were,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66187,evaluated,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66188,.,O,2308.0,"Cerebral ischemia / reperfusion ( I / R ) injury , expression of adhesion molecules and pro- and anti - inflammatory cytokines / chemokines , microglial activation and neutrophil infiltration were evaluated ."
66189,The,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66190,total,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66191,infarct,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66192,volume,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66193,and,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66194,neurological,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66195,deficits,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66196,were,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66197,significantly,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66198,reduced,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66199,in,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66200,red,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66201,wine-,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66202,and,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66203,ethanol,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66204,-,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66205,fed,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66206,rats,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66207,compared,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66208,to,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66209,control,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66210,rats,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66211,.,O,2309.0,The total infarct volume and neurological deficits were significantly reduced in red wine- and ethanol - fed rats compared to control rats .
66212,Both,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66213,red,B-AG.01.y.01.a,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66214,wine,I-AG.01.y.01.a,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66215,and,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66216,ethanol,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66217,suppressed,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66218,post,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66219,-,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66220,ischemic,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66221,expression,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66222,of,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66223,adhesion,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66224,molecules,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66225,and,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66226,microglial,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66227,activation,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66228,.,O,2310.0,Both red wine and ethanol suppressed post - ischemic expression of adhesion molecules and microglial activation .
66332,There,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66333,is,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66334,accumulating,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66335,evidence,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66336,that,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66337,much,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66338,of,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66339,the,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66340,health,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66341,-,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66342,promoting,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66343,potential,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66344,of,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66345,these,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66346,plant,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66347,foods,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66348,may,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66349,come,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66350,from,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66351,phytochemicals,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66352,",",O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66353,bioactive,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66354,compounds,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66355,not,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66356,designated,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66357,as,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66358,traditional,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66359,nutrients,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66360,.,O,2315.0,"There is accumulating evidence that much of the health - promoting potential of these plant foods may come from phytochemicals , bioactive compounds not designated as traditional nutrients ."
66394,Antioxidants,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66395,help,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66396,lower,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66397,risk,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66398,of,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66399,cardiovascular,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66400,events,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66401,by,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66402,inhibition,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66403,of,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66404,LDL,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66405,-,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66406,cholesterol,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66407,oxidation,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66408,",",O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66409,promotion,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66410,of,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66411,plaque,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66412,stability,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66413,",",O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66414,improved,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66415,vascular,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66416,endothelial,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66417,function,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66418,",",O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66419,and,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66420,decreased,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66421,tendency,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66422,for,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66423,thrombosis,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66424,.,O,2318.0,"Antioxidants help lower risk of cardiovascular events by inhibition of LDL - cholesterol oxidation , promotion of plaque stability , improved vascular endothelial function , and decreased tendency for thrombosis ."
66539,Genotoxins,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66540,are,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66541,also,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66542,involved,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66543,in,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66544,the,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66545,pathogenesis,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66546,of,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66547,several,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66548,chronic,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66549,degenerative,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66550,diseases,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66551,",",O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66552,including,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66553,hepatic,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66554,",",O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66555,neurodegenerative,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66556,",",O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66557,and,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66558,cardiovascular,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66559,disorders,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66560,;,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66561,diabetes,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66562,;,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66563,arthritis,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66564,;,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66565,cancer,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66566,;,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66567,chronic,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66568,inflammation,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66569,;,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66570,and,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66571,ageing,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66572,.,O,2324.0,"Genotoxins are also involved in the pathogenesis of several chronic degenerative diseases , including hepatic , neurodegenerative , and cardiovascular disorders ; diabetes ; arthritis ; cancer ; chronic inflammation ; and ageing ."
66750,We,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66751,examined,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66752,the,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66753,association,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66754,between,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66755,alcohol,B-AG.01.y.01,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66756,use,B-X,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66757,and,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66758,prostate,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66759,cancer,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66760,among,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66761,"34,565",O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66762,men,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66763,",",O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66764,50,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66765,-,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66766,76,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66767,yr,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66768,old,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66769,",",O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66770,in,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66771,the,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66772,Vitamins,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66773,and,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66774,Lifestyle,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66775,(,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66776,VITAL,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66777,),O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66778,cohort,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66779,in,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66780,Washington,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66781,State,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
66782,.,O,2331.0,"We examined the association between alcohol use and prostate cancer among 34,565 men , 50 - 76 yr old , in the Vitamins and Lifestyle ( VITAL ) cohort in Washington State ."
67054,Red,B-AG.01.i,2341.0,Red rice produced a slower digestion rate than white rice .
67055,rice,I-AG.01.i,2341.0,Red rice produced a slower digestion rate than white rice .
67056,produced,O,2341.0,Red rice produced a slower digestion rate than white rice .
67057,a,O,2341.0,Red rice produced a slower digestion rate than white rice .
67058,slower,O,2341.0,Red rice produced a slower digestion rate than white rice .
67059,digestion,O,2341.0,Red rice produced a slower digestion rate than white rice .
67060,rate,O,2341.0,Red rice produced a slower digestion rate than white rice .
67061,than,O,2341.0,Red rice produced a slower digestion rate than white rice .
67062,white,B-AG.01.i,2341.0,Red rice produced a slower digestion rate than white rice .
67063,rice,I-AG.01.i,2341.0,Red rice produced a slower digestion rate than white rice .
67064,.,O,2341.0,Red rice produced a slower digestion rate than white rice .
67065,White,O,2342.0,"White rice digestibility was not affected by oil type , but was affected by addition time of oil ."
67066,rice,O,2342.0,"White rice digestibility was not affected by oil type , but was affected by addition time of oil ."
67067,digestibility,O,2342.0,"White rice digestibility was not affected by oil type , but was affected by addition time of oil ."
67068,was,O,2342.0,"White rice digestibility was not affected by oil type , but was affected by addition time of oil ."
67069,not,O,2342.0,"White rice digestibility was not affected by oil type , but was affected by addition time of oil ."
67070,affected,O,2342.0,"White rice digestibility was not affected by oil type , but was affected by addition time of oil ."
67071,by,O,2342.0,"White rice digestibility was not affected by oil type , but was affected by addition time of oil ."
67072,oil,O,2342.0,"White rice digestibility was not affected by oil type , but was affected by addition time of oil ."
67073,type,O,2342.0,"White rice digestibility was not affected by oil type , but was affected by addition time of oil ."
67074,",",O,2342.0,"White rice digestibility was not affected by oil type , but was affected by addition time of oil ."
67075,but,O,2342.0,"White rice digestibility was not affected by oil type , but was affected by addition time of oil ."
67076,was,O,2342.0,"White rice digestibility was not affected by oil type , but was affected by addition time of oil ."
67077,affected,O,2342.0,"White rice digestibility was not affected by oil type , but was affected by addition time of oil ."
67078,by,O,2342.0,"White rice digestibility was not affected by oil type , but was affected by addition time of oil ."
67079,addition,O,2342.0,"White rice digestibility was not affected by oil type , but was affected by addition time of oil ."
67080,time,O,2342.0,"White rice digestibility was not affected by oil type , but was affected by addition time of oil ."
67081,of,O,2342.0,"White rice digestibility was not affected by oil type , but was affected by addition time of oil ."
67082,oil,B-AG.01.f,2342.0,"White rice digestibility was not affected by oil type , but was affected by addition time of oil ."
67083,.,O,2342.0,"White rice digestibility was not affected by oil type , but was affected by addition time of oil ."
67482,Among,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67483,women,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67484,",",O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67485,an,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67486,80,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67487,%,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67488,increase,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67489,in,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67490,risk,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67491,was,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67492,observed,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67493,in,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67494,both,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67495,current,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67496,and,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67497,former,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67498,smokers,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67499,but,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67500,dose,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67501,-,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67502,response,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67503,trends,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67504,were,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67505,less,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67506,consistent,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67507,than,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67508,among,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67509,men,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67510,.,O,2357.0,"Among women , an 80 % increase in risk was observed in both current and former smokers but dose - response trends were less consistent than among men ."
67832,In,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67833,addition,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67834,",",O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67835,the,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67836,increase,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67837,of,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67838,celiac,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67839,patients,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67840,worldwide,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67841,has,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67842,motivated,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67843,the,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67844,development,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67845,of,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67846,gluten,B-AG.01,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67847,-,I-AG.01,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67848,free,I-AG.01,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67849,foods,I-AG.01,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67850,using,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67851,alternative,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67852,flour,B-AG.01.k,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67853,types,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67854,to,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67855,wheat,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67856,such,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67857,as,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67858,rice,B-AG.01.i,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67859,",",O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67860,corn,B-AG.01.i,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67861,",",O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67862,cassava,B-AG.01.h.02.a,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67863,",",O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67864,soybean,B-AG.01.h.02.g,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67865,",",O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67866,and,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67867,pseudocereals,B-AG.01.i,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67868,(,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67869,amaranth,B-AG.01.i,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67870,",",O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67871,quinoa,B-AG.01.i,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67872,",",O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67873,and,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67874,buckwheat,B-AG.01.i,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67875,),O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67876,.,O,2370.0,"In addition , the increase of celiac patients worldwide has motivated the development of gluten - free foods using alternative flour types to wheat such as rice , corn , cassava , soybean , and pseudocereals ( amaranth , quinoa , and buckwheat ) ."
67963,Fermentation,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67964,is,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67965,one,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67966,of,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67967,the,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67968,most,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67969,antique,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67970,and,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67971,economical,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67972,methods,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67973,of,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67974,producing,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67975,and,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67976,preserving,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67977,foods,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67978,and,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67979,can,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67980,be,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67981,easily,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67982,employed,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67983,for,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67984,cereal,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67985,processing,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
67986,.,O,2374.0,Fermentation is one of the most antique and economical methods of producing and preserving foods and can be easily employed for cereal processing .
68007,This,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68008,review,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68009,provides,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68010,an,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68011,overview,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68012,on,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68013,pseudocereal,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68014,fermentation,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68015,by,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68016,LAB,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68017,emphasizing,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68018,the,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68019,capacity,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68020,of,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68021,these,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68022,bacteria,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68023,to,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68024,decrease,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68025,antinutritional,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68026,factors,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68027,such,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68028,as,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68029,phytic,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68030,acid,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68031,",",O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68032,increase,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68033,the,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68034,functional,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68035,value,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68036,of,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68037,phytochemicals,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68038,such,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68039,as,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68040,phenolic,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68041,compounds,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68042,",",O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68043,and,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68044,produce,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68045,nutritional,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68046,ingredients,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68047,such,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68048,as,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68049,B,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68050,-,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68051,group,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68052,vitamins,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68053,.,O,2376.0,"This review provides an overview on pseudocereal fermentation by LAB emphasizing the capacity of these bacteria to decrease antinutritional factors such as phytic acid , increase the functional value of phytochemicals such as phenolic compounds , and produce nutritional ingredients such as B - group vitamins ."
68163,The,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68164,literature,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68165,on,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68166,wheat,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68167,gluten,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68168,is,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68169,vast,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68170,and,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68171,extends,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68172,back,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68173,over,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68174,two,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68175,centuries,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68176,",",O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68177,with,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68178,most,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68179,studies,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68180,focusing,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68181,on,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68182,the,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68183,structures,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68184,of,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68185,gluten,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68186,proteins,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68187,and,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68188,their,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68189,role,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68190,in,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68191,determining,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68192,the,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68193,functional,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68194,properties,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68195,of,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68196,wheat,B-AG.01.k,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68197,flour,I-AG.01.k,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68198,and,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68199,dough,B-AG.01.n,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68200,.,O,2380.0,"The literature on wheat gluten is vast and extends back over two centuries , with most studies focusing on the structures of gluten proteins and their role in determining the functional properties of wheat flour and dough ."
68654,While,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68655,many,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68656,health,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68657,promotion,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68658,efforts,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68659,seek,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68660,to,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68661,limit,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68662,discretionary,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68663,food,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68664,intake,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68665,",",O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68666,the,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68667,population,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68668,health,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68669,impact,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68670,of,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68671,reductions,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68672,in,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68673,the,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68674,consumption,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68675,of,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68676,different,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68677,types,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68678,of,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68679,discretionary,B-AG.01,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68680,foods,I-AG.01,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68681,(,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68682,e.g.,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68683,",",O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68684,sugar,B-AG.01.y,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68685,-,I-AG.01.y,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68686,sweetened,I-AG.01.y,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68687,beverages,I-AG.01.y,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68688,(,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68689,SSBs,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68690,),O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68691,",",O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68692,confectionery,B-AG.01.n.17,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68693,",",O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68694,sweet,B-AG.01.n.14,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68695,biscuits,I-AG.01.n.14,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68696,),O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68697,has,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68698,not,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68699,been,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68700,quantified,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
68701,.,O,2396.0,"While many health promotion efforts seek to limit discretionary food intake , the population health impact of reductions in the consumption of different types of discretionary foods ( e.g. , sugar - sweetened beverages ( SSBs ) , confectionery , sweet biscuits ) has not been quantified ."
69563,Among,O,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69564,the,O,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69565,Hausas,O,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69566,",",O,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69567,meat,B-AG.01.d,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69568,is,O,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69569,usually,O,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69570,reserved,O,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69571,for,O,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69572,special,O,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69573,occasions,O,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69574,.,O,2425.0,"Among the Hausas , meat is usually reserved for special occasions ."
69688,One,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69689,of,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69690,these,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69691,",",O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69692,Listeria,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69693,monocytogenes,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69694,",",O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69695,has,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69696,attracted,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69697,considerable,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69698,attention,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69699,because,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69700,of,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69701,two,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69702,major,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69703,cheese,B-AG.01.e.02,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69704,-,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69705,related,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69706,outbreaks,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69707,of,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69708,listeriosis,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69709,that,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69710,were,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69711,characterized,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69712,by,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69713,cases,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69714,of,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69715,meningitis,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69716,",",O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69717,abortion,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69718,",",O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69719,and,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69720,perinatal,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69721,septicemia,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
69722,.,O,2430.0,"One of these , Listeria monocytogenes , has attracted considerable attention because of two major cheese - related outbreaks of listeriosis that were characterized by cases of meningitis , abortion , and perinatal septicemia ."
70269,The,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70270,meal,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70271,comprised,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70272,29,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70273,%,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70274,of,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70275,total,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70276,daily,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70277,caloric,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70278,intake,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70279,and,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70280,contained,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70281,green,B-AG.01.h.02.g,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70282,beans,I-AG.01.h.02.g,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70283,",",O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70284,rice,B-AG.01.i,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70285,",",O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70286,turkey,B-AG.01.d.06,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70287,",",O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70288,and,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70289,margarine,B-AG.01.f,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70290,(,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70291,50,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70292,%,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70293,carbohydrate,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70294,",",O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70295,20,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70296,%,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70297,protein,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70298,",",O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70299,and,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70300,30,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70301,%,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70302,fat,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70303,),O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70304,.,O,2449.0,"The meal comprised 29 % of total daily caloric intake and contained green beans , rice , turkey , and margarine ( 50 % carbohydrate , 20 % protein , and 30 % fat ) ."
70826,We,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70827,computed,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70828,flavonol,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70829,intakes,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70830,from,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70831,dietary,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70832,data,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70833,collected,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70834,by,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70835,validated,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70836,food,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70837,frequency,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70838,questionnaires,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70839,in,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70840,1991,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70841,and,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70842,1995,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70843,from,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70844,"90,630",O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70845,women,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70846,in,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70847,the,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70848,Nurses,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70849,Health,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70850,Study,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70851,II,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
70852,.,O,2469.0,"We computed flavonol intakes from dietary data collected by validated food frequency questionnaires in 1991 and 1995 from 90,630 women in the Nurses Health Study II ."
71641,Participants,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71642,in,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71643,T3,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71644,of,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71645,the,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71646,Western,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71647,pattern,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71648,had,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71649,a,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71650,higher,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71651,prevalence,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71652,of,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71653,low,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71654,BMD,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71655,(,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71656,PR=168,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71657,;,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71658,95,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71659,%,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71660,CI,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71661,102,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71662,",",O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71663,277,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71664,),O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71665,compared,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71666,with,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71667,those,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71668,in,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71669,T1,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71670,.,O,2491.0,"Participants in T3 of the Western pattern had a higher prevalence of low BMD ( PR=168 ; 95 % CI 102 , 277 ) compared with those in T1 ."
71820,In,O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
71821,the,O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
71822,third,O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
71823,group,O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
71824,",",O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
71825,soybean,O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
71826,hulls,O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
71827,were,O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
71828,replaced,O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
71829,with,O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
71830,100,O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
71831,g,O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
71832,of,O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
71833,CH,O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
71834,/,O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
71835,d,O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
71836,per,O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
71837,head,O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
71838,(,O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
71839,CH100,O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
71840,group,O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
71841,),O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
71842,.,O,2498.0,"In the third group , soybean hulls were replaced with 100 g of CH / d per head ( CH100 group ) ."
72289,Principal,O,2514.0,Principal component analysis was used to identify dietary patterns .
72290,component,O,2514.0,Principal component analysis was used to identify dietary patterns .
72291,analysis,O,2514.0,Principal component analysis was used to identify dietary patterns .
72292,was,O,2514.0,Principal component analysis was used to identify dietary patterns .
72293,used,O,2514.0,Principal component analysis was used to identify dietary patterns .
72294,to,O,2514.0,Principal component analysis was used to identify dietary patterns .
72295,identify,O,2514.0,Principal component analysis was used to identify dietary patterns .
72296,dietary,O,2514.0,Principal component analysis was used to identify dietary patterns .
72297,patterns,O,2514.0,Principal component analysis was used to identify dietary patterns .
72298,.,O,2514.0,Principal component analysis was used to identify dietary patterns .
73092,Based,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73093,on,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73094,some,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73095,double,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73096,-,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73097,blind,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73098,",",O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73099,randomized,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73100,",",O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73101,placebo,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73102,-,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73103,controlled,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73104,clinical,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73105,trials,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73106,which,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73107,denied,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73108,the,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73109,hypolipidemic,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73110,effects,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73111,of,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73112,garlic,B-AG.01.h.02.e,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73113,",",O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73114,some,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73115,meta,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73116,-,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73117,analysis,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73118,concluded,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73119,that,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73120,garlic,B-AG.01.h.02.e,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73121,did,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73122,not,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73123,possess,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73124,beneficial,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73125,effects,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73126,for,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73127,hyperlipidemia,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73128,.,O,2538.0,"Based on some double - blind , randomized , placebo - controlled clinical trials which denied the hypolipidemic effects of garlic , some meta - analysis concluded that garlic did not possess beneficial effects for hyperlipidemia ."
73592,The,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73593,circulating,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73594,insulin,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73595,and,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73596,glucose,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73597,responses,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73598,in,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73599,type,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73600,II,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73601,diabetic,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73602,subjects,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73603,were,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73604,determined,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73605,for,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73606,5,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73607,h,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73608,after,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73609,ingestion,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73610,of,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73611,various,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73612,meals,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73613,",",O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73614,each,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73615,containing,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73616,50,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73617,g,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73618,carbohydrate,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73619,.,O,2557.0,"The circulating insulin and glucose responses in type II diabetic subjects were determined for 5 h after ingestion of various meals , each containing 50 g carbohydrate ."
73620,The,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73621,purpose,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73622,of,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73623,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73624,study,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73625,was,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73626,to,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73627,1,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73628,),O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73629,systematically,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73630,study,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73631,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73632,insulin,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73633,response,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73634,to,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73635,several,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73636,different,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73637,high,B-AG.01,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73638,-,I-AG.01,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73639,starch,I-AG.01,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73640,foods,I-AG.01,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73641,",",O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73642,2,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73643,),O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73644,determine,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73645,whether,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73646,this,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73647,insulin,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73648,response,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73649,could,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73650,be,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73651,predicted,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73652,by,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73653,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73654,glucose,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73655,response,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73656,",",O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73657,and,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73658,3,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73659,),O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73660,determine,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73661,whether,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73662,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73663,glucose,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73664,response,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73665,could,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73666,be,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73667,predicted,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73668,by,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73669,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73670,physical,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73671,structure,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73672,and,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73673,digestibility,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73674,of,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73675,the,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73676,ingested,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73677,carbohydrate,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
73678,.,O,2558.0,"The purpose of the study was to 1 ) systematically study the insulin response to several different high - starch foods , 2 ) determine whether this insulin response could be predicted by the glucose response , and 3 ) determine whether the glucose response could be predicted by the physical structure and digestibility of the ingested carbohydrate ."
74098,A,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74099,1,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74100,-,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74101,SD,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74102,increase,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74103,in,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74104,the,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74105,scores,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74106,on,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74107,the,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74108,high,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74109,fat,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74110,/,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74111,sugar,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74112,/,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74113,takeaway,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74114,pattern,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74115,was,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74116,also,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74117,associated,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74118,with,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74119,shorter,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74120,gestation,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74121,(,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74122,adjusted,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74123,regression,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74124,coefficient,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74125,:,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74126,-2.7,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74127,;,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74128,95,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74129,%,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74130,CI,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74131,:,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74132,-4.3,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74133,",",O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74134,-1.1,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74135,;,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74136,P,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74137,=,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74138,0.001,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74139,),O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74140,and,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74141,birth,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74142,length,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74143,(,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74144,adjusted,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74145,regression,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74146,coefficient,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74147,:,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74148,-0.5,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74149,;,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74150,95,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74151,%,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74152,CI,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74153,:,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74154,-0.8,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74155,",",O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74156,-0.1,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74157,;,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74158,P,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74159,=,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74160,0.004,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74161,),O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74162,.,O,2573.0,"A 1 - SD increase in the scores on the high fat / sugar / takeaway pattern was also associated with shorter gestation ( adjusted regression coefficient : -2.7 ; 95 % CI : -4.3 , -1.1 ; P = 0.001 ) and birth length ( adjusted regression coefficient : -0.5 ; 95 % CI : -0.8 , -0.1 ; P = 0.004 ) ."
74279,An,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74280,association,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74281,between,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74282,allergy,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74283,to,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74284,latex,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74285,and,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74286,allergy,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74287,to,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74288,various,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74289,fruits,B-AG.01.h.01,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74290,has,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74291,been,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74292,reported,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74293,.,O,2578.0,An association between allergy to latex and allergy to various fruits has been reported .
74294,This,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74295,study,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74296,investigated,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74297,the,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74298,prevalence,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74299,and,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74300,clinical,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74301,significance,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74302,of,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74303,latex,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74304,sensitization,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74305,in,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74306,children,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74307,seen,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74308,in,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74309,a,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74310,university,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74311,hospital,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74312,allergy,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74313,clinic,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74314,.,O,2579.0,This study investigated the prevalence and clinical significance of latex sensitization in children seen in a university hospital allergy clinic .
74586,Apple,B-AG.01.h.01.c,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74587,",",O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74588,kiwi,B-AG.01.h.01,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74589,",",O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74590,and,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74591,chestnut,B-AG.01.h.01.f,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74592,were,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74593,the,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74594,most,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74595,common,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74596,SPT,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74597,-,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74598,positive,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74599,foods,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74600,.,O,2591.0,"Apple , kiwi , and chestnut were the most common SPT - positive foods ."
74661,Pyrrolizidine,O,2594.0,Pyrrolizidine alkaloids ( PAs ) are secondary metabolites of plants .
74662,alkaloids,O,2594.0,Pyrrolizidine alkaloids ( PAs ) are secondary metabolites of plants .
74663,(,O,2594.0,Pyrrolizidine alkaloids ( PAs ) are secondary metabolites of plants .
74664,PAs,O,2594.0,Pyrrolizidine alkaloids ( PAs ) are secondary metabolites of plants .
74665,),O,2594.0,Pyrrolizidine alkaloids ( PAs ) are secondary metabolites of plants .
74666,are,O,2594.0,Pyrrolizidine alkaloids ( PAs ) are secondary metabolites of plants .
74667,secondary,O,2594.0,Pyrrolizidine alkaloids ( PAs ) are secondary metabolites of plants .
74668,metabolites,O,2594.0,Pyrrolizidine alkaloids ( PAs ) are secondary metabolites of plants .
74669,of,O,2594.0,Pyrrolizidine alkaloids ( PAs ) are secondary metabolites of plants .
74670,plants,O,2594.0,Pyrrolizidine alkaloids ( PAs ) are secondary metabolites of plants .
74671,.,O,2594.0,Pyrrolizidine alkaloids ( PAs ) are secondary metabolites of plants .
74827,This,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74828,paper,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74829,presents,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74830,estimates,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74831,of,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74832,folic,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74833,acid,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74834,intake,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74835,in,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74836,the,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74837,target,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74838,population,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74839,and,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74840,other,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74841,subgroups,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74842,of,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74843,the,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74844,Australian,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74845,population,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74846,following,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74847,implementation,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74848,of,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74849,the,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74850,mandatory,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74851,folic,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74852,acid,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74853,fortification,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74854,standard,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74855,.,O,2600.0,This paper presents estimates of folic acid intake in the target population and other subgroups of the Australian population following implementation of the mandatory folic acid fortification standard .
74933,Food,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74934,Standards,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74935,Australia,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74936,New,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74937,Zealand,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74938,'s,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74939,(,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74940,FSANZ,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74941,),O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74942,custom,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74943,-,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74944,built,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74945,dietary,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74946,modelling,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74947,program,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74948,(,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74949,DIAMOND,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74950,),O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74951,was,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74952,used,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74953,for,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74954,the,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74955,estimates,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74956,.,O,2604.0,Food Standards Australia New Zealand 's ( FSANZ ) custom - built dietary modelling program ( DIAMOND ) was used for the estimates .
74957,The,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74958,mean,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74959,amount,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74960,of,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74961,folic,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74962,acid,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74963,found,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74964,in,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74965,white,B-AG.01.n.11,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74966,bread,I-AG.01.n.11,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74967,was,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74968,200,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74969,,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74970,g/100,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74971,,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74972,g,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74973,which,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74974,demonstrated,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74975,that,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74976,folic,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74977,-,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74978,acid,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74979,-,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74980,fortified,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74981,wheat,B-AG.01.k,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74982,flour,I-AG.01.k,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74983,was,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74984,used,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74985,to,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74986,bake,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74987,the,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74988,bread,B-AG.01.n.11,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
74989,.,O,2605.0,The mean amount of folic acid found in white bread was 200  g/100  g which demonstrated that folic - acid - fortified wheat flour was used to bake the bread .
75222,Also,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75223,",",O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75224,the,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75225,MRP,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75226,showed,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75227,higher,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75228,antioxidant,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75229,activities,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75230,than,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75231,the,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75232,intact,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75233,milk,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75234,protein,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75235,",",O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75236,and,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75237,they,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75238,reduced,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75239,intracellular,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75240,reactive,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75241,oxygen,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75242,species,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75243,production,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75244,and,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75245,inhibited,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75246,the,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75247,depletion,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75248,of,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75249,the,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75250,reduced,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75251,glutathione,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75252,concentrations,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75253,in,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75254,the,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75255,HepG2,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75256,cells,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75257,.,O,2615.0,"Also , the MRP showed higher antioxidant activities than the intact milk protein , and they reduced intracellular reactive oxygen species production and inhibited the depletion of the reduced glutathione concentrations in the HepG2 cells ."
75441,Some,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75442,weeks,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75443,later,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75444,",",O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75445,approximately,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75446,200,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75447,infants,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75448,(,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75449,fed,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75450,exclusively,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75451,with,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75452,formula,B-AG.01,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75453,milks,I-AG.01,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75454,with,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75455,a,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75456,chloride,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75457,content,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75458,of,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75459,only,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75460,2,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75461,-,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75462,4,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75463,mmol,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75464,/,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75465,L,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75466,),O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75467,",",O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75468,were,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75469,admitted,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75470,with,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75471,failure,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75472,to,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75473,thrive,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75474,",",O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75475,constipation,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75476,",",O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75477,food,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75478,refusal,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75479,",",O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75480,muscular,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75481,weakness,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75482,",",O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75483,and,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75484,delayed,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75485,psychomotor,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75486,development,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
75487,.,O,2623.0,"Some weeks later , approximately 200 infants ( fed exclusively with formula milks with a chloride content of only 2 - 4 mmol / L ) , were admitted with failure to thrive , constipation , food refusal , muscular weakness , and delayed psychomotor development ."
76012,The,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76013,pyramid,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76014,describes,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76015,a,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76016,dietary,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76017,pattern,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76018,that,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76019,is,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76020,attractive,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76021,for,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76022,its,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76023,famous,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76024,palatability,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76025,as,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76026,well,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76027,as,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76028,for,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76029,its,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76030,health,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76031,benefits,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76032,.,O,2641.0,The pyramid describes a dietary pattern that is attractive for its famous palatability as well as for its health benefits .
76131,In,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76132,Mediterranean,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76133,diets,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76134,the,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76135,major,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76136,source,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76137,of,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76138,dietary,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76139,fat,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76140,has,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76141,traditionally,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76142,been,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76143,olive,B-AG.01.f,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76144,oil,I-AG.01.f,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76145,",",O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76146,which,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76147,",",O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76148,compared,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76149,with,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76150,saturated,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76151,and,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76152,partially,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76153,hydrogenated,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76154,fats,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76155,",",O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76156,reduces,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76157,low,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76158,-,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76159,density,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76160,-,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76161,lipoprotein,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76162,(,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76163,LDL,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76164,),O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76165,cholesterol,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76166,and,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76167,",",O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76168,compared,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76169,with,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76170,carbohydrates,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76171,",",O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76172,increases,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76173,high,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76174,-,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76175,density,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76176,-,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76177,lipoprotein,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76178,(,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76179,HDL,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76180,),O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76181,cholesterol,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76182,.,O,2645.0,"In Mediterranean diets the major source of dietary fat has traditionally been olive oil , which , compared with saturated and partially hydrogenated fats , reduces low - density - lipoprotein ( LDL ) cholesterol and , compared with carbohydrates , increases high - density - lipoprotein ( HDL ) cholesterol ."
76343,The,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76344,PBPK,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76345,model,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76346,was,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76347,applied,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76348,to,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76349,NLME,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76350,analysis,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76351,of,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76352,a,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76353,data,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76354,set,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76355,consisting,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76356,of,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76357,milk,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76358,drug,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76359,concentrations,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76360,from,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76361,78,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76362,healthy,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76363,cows,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76364,and,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76365,117,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76366,with,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76367,clinical,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76368,mastitis,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76369,.,O,2651.0,The PBPK model was applied to NLME analysis of a data set consisting of milk drug concentrations from 78 healthy cows and 117 with clinical mastitis .
76420,Low,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76421,-,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76422,producing,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76423,cows,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76424,had,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76425,a,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76426,greater,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76427,risk,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76428,of,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76429,prolonged,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76430,milk,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76431,residues,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76432,.,O,2655.0,Low - producing cows had a greater risk of prolonged milk residues .
76514,Using,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76515,NLME,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76516,and,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76517,PBPK,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76518,models,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76519,",",O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76520,we,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76521,identified,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76522,factors,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76523,associated,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76524,with,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76525,changes,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76526,in,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76527,pirlimycin,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76528,milk,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76529,residues,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76530,that,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76531,may,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76532,affect,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76533,food,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76534,safety,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
76535,.,O,2658.0,"Using NLME and PBPK models , we identified factors associated with changes in pirlimycin milk residues that may affect food safety ."
77381,The,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77382,purpose,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77383,of,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77384,this,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77385,review,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77386,article,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77387,is,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77388,to,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77389,provide,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77390,a,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77391,comprehensive,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77392,analysis,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77393,of,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77394,various,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77395,research,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77396,and,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77397,review,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77398,reports,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77399,on,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77400,different,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77401,contraceptive,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77402,and,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77403,fertility,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77404,drugs,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77405,used,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77406,in,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77407,human,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77408,and,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77409,animals,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77410,",",O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77411,their,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77412,occurrence,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77413,in,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77414,the,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77415,environment,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77416,and,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77417,their,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77418,ill,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77419,-,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77420,effects,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77421,on,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77422,living,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77423,systems,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
77424,.,O,2687.0,"The purpose of this review article is to provide a comprehensive analysis of various research and review reports on different contraceptive and fertility drugs used in human and animals , their occurrence in the environment and their ill - effects on living systems ."
78066,We,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78067,identified,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78068,7,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78069,cohort,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78070,studies,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78071,and,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78072,27,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78073,case,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78074,-,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78075,control,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78076,studies,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78077,of,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78078,consumption,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78079,of,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78080,major,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78081,food,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78082,groups,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78083,(,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78084,fruits,B-AG.01.h.01,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78085,and,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78086,vegetables,B-AG.01.h.02,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78087,",",O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78088,meats,B-AG.01.d,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78089,",",O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78090,eggs,B-AG.01.g,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78091,",",O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78092,fish,B-AG.01.d.07,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78093,",",O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78094,dairy,B-AG.01.e,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78095,products,I-AG.01.e,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78096,",",O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78097,grains,B-AG.01.i,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78098,",",O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78099,fats,B-AG.01.f,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78100,and,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78101,oils,B-AG.01.f,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78102,),O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78103,and,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78104,EOC,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78105,risk,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78106,.,O,2708.0,"We identified 7 cohort studies and 27 case - control studies of consumption of major food groups ( fruits and vegetables , meats , eggs , fish , dairy products , grains , fats and oils ) and EOC risk ."
78392,The,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78393,risk,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78394,of,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78395,TNBC,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78396,was,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78397,negatively,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78398,associated,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78399,with,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78400,a,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78401,healthy,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78402,dietary,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78403,pattern,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78404,involving,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78405,consumption,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78406,of,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78407,seafood,B-AG.01.d.07,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78408,and,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78409,vegetables,B-AG.01.h.02,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78410,",",O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78411,and,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78412,positively,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78413,associated,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78414,with,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78415,a,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78416,dietary,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78417,pattern,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78418,of,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78419,consuming,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78420,grains,B-AG.01.i,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78421,",",O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78422,meats,B-AG.01.d,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78423,",",O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78424,and,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78425,eggs,B-AG.01.g,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78426,.,O,2719.0,"The risk of TNBC was negatively associated with a healthy dietary pattern involving consumption of seafood and vegetables , and positively associated with a dietary pattern of consuming grains , meats , and eggs ."
78974,High,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78975,consumption,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78976,of,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78977,margarine,B-AG.01.f,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78978,exerted,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78979,a,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78980,significant,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78981,protection,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78982,against,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78983,cancer,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78984,of,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78985,the,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78986,colon,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78987,whereas,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78988,high,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78989,consumption,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78990,of,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78991,carrot,B-AG.01.h.02.a,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78992,spinach,B-AG.01.h.02.c,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78993,",",O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78994,whole,B-AG.01.n.11,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78995,-,I-AG.01.n.11,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78996,grain,I-AG.01.n.11,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78997,bread,I-AG.01.n.11,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78998,and,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
78999,pasta,B-AG.01.i,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79000,(,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79001,favorably,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79002,),O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79003,and,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79004,red,B-AG.01.d,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79005,meat,I-AG.01.d,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79006,(,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79007,unfavorably,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79008,),O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79009,affected,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79010,rectal,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79011,cancer,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79012,risk,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79013,in,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79014,particular,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79015,.,O,2736.0,"High consumption of margarine exerted a significant protection against cancer of the colon whereas high consumption of carrot spinach , whole - grain bread and pasta ( favorably ) and red meat ( unfavorably ) affected rectal cancer risk in particular ."
79320,Milk,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79321,and,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79322,fermented,B-AG.01.e,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79323,milk,I-AG.01.e,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79324,consumption,B-X,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79325,has,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79326,been,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79327,linked,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79328,to,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79329,health,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79330,and,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79331,mortality,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79332,but,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79333,the,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79334,association,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79335,with,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79336,Parkinson,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79337,'s,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79338,disease,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79339,(,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79340,PD,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79341,),O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79342,is,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79343,uncertain,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79344,.,O,2749.0,Milk and fermented milk consumption has been linked to health and mortality but the association with Parkinson 's disease ( PD ) is uncertain .
79419,Multivariable,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79420,-,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79421,adjusted,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79422,hazard,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79423,ratios,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79424,were,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79425,obtained,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79426,from,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79427,Cox,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79428,proportional,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79429,hazards,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79430,regression,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79431,models,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79432,.,O,2753.0,Multivariable - adjusted hazard ratios were obtained from Cox proportional hazards regression models .
79546,Fermented,B-AG.01.e,2756.0,Fermented milk intake was not associated with PD .
79547,milk,I-AG.01.e,2756.0,Fermented milk intake was not associated with PD .
79548,intake,O,2756.0,Fermented milk intake was not associated with PD .
79549,was,O,2756.0,Fermented milk intake was not associated with PD .
79550,not,O,2756.0,Fermented milk intake was not associated with PD .
79551,associated,O,2756.0,Fermented milk intake was not associated with PD .
79552,with,O,2756.0,Fermented milk intake was not associated with PD .
79553,PD,O,2756.0,Fermented milk intake was not associated with PD .
79554,.,O,2756.0,Fermented milk intake was not associated with PD .
79608,The,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79609,countries,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79610,around,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79611,the,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79612,Mediterranean,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79613,basin,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79614,have,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79615,different,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79616,diets,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79617,",",O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79618,religions,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79619,and,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79620,cultures,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79621,.,O,2760.0,"The countries around the Mediterranean basin have different diets , religions and cultures ."
79868,The,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79869,intake,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79870,of,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79871,400,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79872,-,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79873,600,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79874,g,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79875,/,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79876,d,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79877,of,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79878,fruits,B-AG.01.h.01,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79879,and,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79880,vegetables,B-AG.01.h.02,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79881,is,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79882,associated,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79883,with,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79884,reduced,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79885,incidence,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79886,of,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79887,many,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79888,common,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79889,forms,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79890,of,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79891,cancer,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79892,.,O,2765.0,The intake of 400 - 600 g / d of fruits and vegetables is associated with reduced incidence of many common forms of cancer .
79893,These,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79894,foods,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79895,contain,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79896,phytochemicals,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79897,that,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79898,can,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79899,modulate,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79900,gene,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79901,expression,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79902,to,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79903,inhibit,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79904,carcinogenesis,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79905,via,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79906,multiple,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79907,pathways,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79908,.,O,2766.0,These foods contain phytochemicals that can modulate gene expression to inhibit carcinogenesis via multiple pathways .
79909,Many,O,2767.0,"Many phytochemicals are colorful , providing an easy way to communicate increased diversity of fruits and vegetables to the public ."
79910,phytochemicals,O,2767.0,"Many phytochemicals are colorful , providing an easy way to communicate increased diversity of fruits and vegetables to the public ."
79911,are,O,2767.0,"Many phytochemicals are colorful , providing an easy way to communicate increased diversity of fruits and vegetables to the public ."
79912,colorful,O,2767.0,"Many phytochemicals are colorful , providing an easy way to communicate increased diversity of fruits and vegetables to the public ."
79913,",",O,2767.0,"Many phytochemicals are colorful , providing an easy way to communicate increased diversity of fruits and vegetables to the public ."
79914,providing,O,2767.0,"Many phytochemicals are colorful , providing an easy way to communicate increased diversity of fruits and vegetables to the public ."
79915,an,O,2767.0,"Many phytochemicals are colorful , providing an easy way to communicate increased diversity of fruits and vegetables to the public ."
79916,easy,O,2767.0,"Many phytochemicals are colorful , providing an easy way to communicate increased diversity of fruits and vegetables to the public ."
79917,way,O,2767.0,"Many phytochemicals are colorful , providing an easy way to communicate increased diversity of fruits and vegetables to the public ."
79918,to,O,2767.0,"Many phytochemicals are colorful , providing an easy way to communicate increased diversity of fruits and vegetables to the public ."
79919,communicate,O,2767.0,"Many phytochemicals are colorful , providing an easy way to communicate increased diversity of fruits and vegetables to the public ."
79920,increased,O,2767.0,"Many phytochemicals are colorful , providing an easy way to communicate increased diversity of fruits and vegetables to the public ."
79921,diversity,O,2767.0,"Many phytochemicals are colorful , providing an easy way to communicate increased diversity of fruits and vegetables to the public ."
79922,of,O,2767.0,"Many phytochemicals are colorful , providing an easy way to communicate increased diversity of fruits and vegetables to the public ."
79923,fruits,B-AG.01.h.01,2767.0,"Many phytochemicals are colorful , providing an easy way to communicate increased diversity of fruits and vegetables to the public ."
79924,and,O,2767.0,"Many phytochemicals are colorful , providing an easy way to communicate increased diversity of fruits and vegetables to the public ."
79925,vegetables,B-AG.01.h.02,2767.0,"Many phytochemicals are colorful , providing an easy way to communicate increased diversity of fruits and vegetables to the public ."
79926,to,O,2767.0,"Many phytochemicals are colorful , providing an easy way to communicate increased diversity of fruits and vegetables to the public ."
79927,the,O,2767.0,"Many phytochemicals are colorful , providing an easy way to communicate increased diversity of fruits and vegetables to the public ."
79928,public,O,2767.0,"Many phytochemicals are colorful , providing an easy way to communicate increased diversity of fruits and vegetables to the public ."
79929,.,O,2767.0,"Many phytochemicals are colorful , providing an easy way to communicate increased diversity of fruits and vegetables to the public ."
80827,However,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80828,",",O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80829,comparisons,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80830,across,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80831,nuts,B-AG.01.h.01.f,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80832,(,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80833,walnuts,B-AG.01.h.01.f,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80834,",",O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80835,almonds,B-AG.01.h.01.f,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80836,and,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80837,pistachios,B-AG.01.h.01.f,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80838,),O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80839,with,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80840,varying,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80841,physical,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80842,properties,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80843,do,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80844,not,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80845,support,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80846,this,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80847,view,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
80848,.,O,2798.0,"However , comparisons across nuts ( walnuts , almonds and pistachios ) with varying physical properties do not support this view ."
81116,In,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81117,this,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81118,study,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81119,",",O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81120,a,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81121,new,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81122,approach,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81123,has,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81124,been,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81125,examined,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81126,",",O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81127,based,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81128,on,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81129,previous,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81130,reports,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81131,that,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81132,platelet,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81133,-,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81134,activating,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81135,factor,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81136,(,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81137,PAF,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81138,),O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81139,is,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81140,involved,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81141,in,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81142,atherogenesis,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81143,.,O,2811.0,"In this study , a new approach has been examined , based on previous reports that platelet - activating factor ( PAF ) is involved in atherogenesis ."
81144,An,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81145,attempt,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81146,was,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81147,made,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81148,to,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81149,detect,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81150,key,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81151,components,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81152,in,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81153,wine,B-AG.01.y.01.a,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81154,/,I-AG.01.y.01.a,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81155,must,I-AG.01.y.01.a,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81156,that,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81157,through,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81158,inhibition,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81159,of,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81160,PAF,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81161,action,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81162,may,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81163,contribute,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81164,to,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81165,the,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81166,protective,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81167,role,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81168,of,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81169,white,B-AG.01.y.01.a,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81170,wine,I-AG.01.y.01.a,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81171,/,I-AG.01.y.01.a,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81172,must,I-AG.01.y.01.a,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81173,against,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81174,atherosclerosis,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81175,.,O,2812.0,An attempt was made to detect key components in wine / must that through inhibition of PAF action may contribute to the protective role of white wine / must against atherosclerosis .
81360,Seventy,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81361,-,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81362,four,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81363,children,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81364,(,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81365,30,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81366,(,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81367,se,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81368,05,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81369,),O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81370,months,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81371,old,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81372,),O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81373,participated,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81374,in,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81375,the,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81376,study,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81377,in,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81378,their,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81379,usual,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81380,day,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81381,-,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81382,care,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81383,centres,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81384,.,O,2819.0,Seventy - four children ( 30 ( se 05 ) months old ) participated in the study in their usual day - care centres .
81628,Specific,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81629,serum,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81630,IgE,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81631,was,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81632,measured,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81633,by,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81634,four,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81635,different,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81636,commercially,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81637,available,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81638,tests,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81639,and,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81640,by,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81641,an,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81642,inhouse,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81643,Maxisorp,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81644,RAST,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81645,using,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81646,freshly,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81647,prepared,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81648,food,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81649,extracts,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
81650,.,O,2828.0,Specific serum IgE was measured by four different commercially available tests and by an inhouse Maxisorp RAST using freshly prepared food extracts .
82132,Furthermore,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82133,",",O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82134,vegetarians,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82135,tend,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82136,to,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82137,have,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82138,a,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82139,lower,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82140,body,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82141,mass,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82142,index,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82143,and,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82144,lower,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82145,overall,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82146,cancer,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82147,rates,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82148,.,O,2847.0,"Furthermore , vegetarians tend to have a lower body mass index and lower overall cancer rates ."
82471,It,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82472,was,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82473,concluded,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82474,that,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82475,malic,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82476,acid,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82477,for,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82478,white,B-AG.01.y.01.a,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82479,wine,I-AG.01.y.01.a,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82480,and,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82481,succinic,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82482,acid,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82483,for,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82484,red,B-AG.01.y.01.a,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82485,wine,I-AG.01.y.01.a,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82486,are,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82487,key,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82488,organic,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82489,acids,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82490,that,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82491,contribute,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82492,to,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82493,gastric,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82494,acid,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82495,stimulation,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
82496,.,O,2858.0,It was concluded that malic acid for white wine and succinic acid for red wine are key organic acids that contribute to gastric acid stimulation .
83201,The,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83202,risk,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83203,odds,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83204,ratios,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83205,(,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83206,ORs,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83207,),O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83208,for,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83209,observing,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83210,values,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83211,above,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83212,the,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83213,50th,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83214,percentile,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83215,were,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83216,elevated,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83217,for,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83218,mercury,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83219,and,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83220,fish,B-AG.01.d.07,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83221,consumption,B-X,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83222,",",O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83223,uranium,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83224,and,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83225,milk,B-AG.01.e,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83226,consumption,B-X,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83227,",",O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83228,lead,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83229,and,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83230,female,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83231,sex,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83232,",",O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83233,and,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83234,aluminum,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83235,and,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83236,mineral,B-AG.01.z,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83237,water,I-AG.01.z,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83238,consumption,B-X,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83239,.,O,2883.0,"The risk odds ratios ( ORs ) for observing values above the 50th percentile were elevated for mercury and fish consumption , uranium and milk consumption , lead and female sex , and aluminum and mineral water consumption ."
83484,The,O,2893.0,The potential of these extracts to inhibit key enzymes relevant to type 2 diabetes and inflammation was studied .
83485,potential,O,2893.0,The potential of these extracts to inhibit key enzymes relevant to type 2 diabetes and inflammation was studied .
83486,of,O,2893.0,The potential of these extracts to inhibit key enzymes relevant to type 2 diabetes and inflammation was studied .
83487,these,O,2893.0,The potential of these extracts to inhibit key enzymes relevant to type 2 diabetes and inflammation was studied .
83488,extracts,O,2893.0,The potential of these extracts to inhibit key enzymes relevant to type 2 diabetes and inflammation was studied .
83489,to,O,2893.0,The potential of these extracts to inhibit key enzymes relevant to type 2 diabetes and inflammation was studied .
83490,inhibit,O,2893.0,The potential of these extracts to inhibit key enzymes relevant to type 2 diabetes and inflammation was studied .
83491,key,O,2893.0,The potential of these extracts to inhibit key enzymes relevant to type 2 diabetes and inflammation was studied .
83492,enzymes,O,2893.0,The potential of these extracts to inhibit key enzymes relevant to type 2 diabetes and inflammation was studied .
83493,relevant,O,2893.0,The potential of these extracts to inhibit key enzymes relevant to type 2 diabetes and inflammation was studied .
83494,to,O,2893.0,The potential of these extracts to inhibit key enzymes relevant to type 2 diabetes and inflammation was studied .
83495,type,O,2893.0,The potential of these extracts to inhibit key enzymes relevant to type 2 diabetes and inflammation was studied .
83496,2,O,2893.0,The potential of these extracts to inhibit key enzymes relevant to type 2 diabetes and inflammation was studied .
83497,diabetes,O,2893.0,The potential of these extracts to inhibit key enzymes relevant to type 2 diabetes and inflammation was studied .
83498,and,O,2893.0,The potential of these extracts to inhibit key enzymes relevant to type 2 diabetes and inflammation was studied .
83499,inflammation,O,2893.0,The potential of these extracts to inhibit key enzymes relevant to type 2 diabetes and inflammation was studied .
83500,was,O,2893.0,The potential of these extracts to inhibit key enzymes relevant to type 2 diabetes and inflammation was studied .
83501,studied,O,2893.0,The potential of these extracts to inhibit key enzymes relevant to type 2 diabetes and inflammation was studied .
83502,.,O,2893.0,The potential of these extracts to inhibit key enzymes relevant to type 2 diabetes and inflammation was studied .
83521,Ethyl,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83522,acetate,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83523,extract,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83524,showed,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83525,higher,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83526,activity,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83527,compared,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83528,with,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83529,other,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83530,extracts,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
83531,.,O,2895.0,Ethyl acetate extract showed higher activity compared with other extracts .
84415,Intervention,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84416,periods,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84417,were,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84418,preceded,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84419,by,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84420,2,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84421,-,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84422,week,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84423,depletion,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84424,phases,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84425,.,O,2927.0,Intervention periods were preceded by 2 - week depletion phases .
84523,These,O,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84524,effects,O,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84525,were,O,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84526,not,O,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84527,markedly,O,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84528,changed,O,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84529,by,O,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84530,carrot,B-AG.01.y,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84531,and,I-AG.01.y,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84532,tomato,I-AG.01.y,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84533,juice,I-AG.01.y,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84534,consumption,B-X,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
84535,.,O,2932.0,These effects were not markedly changed by carrot and tomato juice consumption .
85190,These,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85191,results,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85192,support,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85193,the,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85194,hypothesis,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85195,that,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85196,intakes,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85197,of,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85198,meat,B-AG.01.d,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85199,and,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85200,its,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85201,associated,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85202,fat,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85203,are,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85204,risk,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85205,factors,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85206,for,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85207,colon,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85208,",",O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85209,rectal,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85210,",",O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85211,prostate,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85212,",",O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85213,and,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85214,female,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85215,breast,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85216,cancers,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85217,.,O,2952.0,"These results support the hypothesis that intakes of meat and its associated fat are risk factors for colon , rectal , prostate , and female breast cancers ."
85934,The,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85935,earliest,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85936,mushroom,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85937,cultivation,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85938,was,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85939,documented,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85940,in,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85941,China,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85942,",",O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85943,which,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85944,remains,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85945,among,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85946,the,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85947,top,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85948,global,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85949,mushroom,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85950,producers,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85951,",",O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85952,along,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85953,with,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85954,the,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85955,United,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85956,States,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85957,",",O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85958,Italy,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85959,",",O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85960,The,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85961,Netherlands,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85962,",",O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85963,and,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85964,Poland,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
85965,.,O,2977.0,"The earliest mushroom cultivation was documented in China , which remains among the top global mushroom producers , along with the United States , Italy , The Netherlands , and Poland ."
86144,As,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86145,research,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86146,progresses,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86147,on,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86148,the,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86149,specific,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86150,health,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86151,effects,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86152,of,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86153,mushrooms,B-AG.01.h.02.h,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86154,",",O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86155,there,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86156,is,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86157,a,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86158,need,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86159,for,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86160,effective,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86161,communication,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86162,efforts,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86163,to,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86164,leverage,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86165,mushrooms,B-AG.01.h.02.h,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86166,to,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86167,improve,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86168,overall,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86169,dietary,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86170,quality,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86171,.,O,2984.0,"As research progresses on the specific health effects of mushrooms , there is a need for effective communication efforts to leverage mushrooms to improve overall dietary quality ."
86235,Seventeen,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86236,type,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86237,II,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86238,(,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86239,non,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86240,-,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86241,insulin,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86242,-,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86243,dependent,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86244,),O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86245,untreated,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86246,diabetic,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86247,subjects,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86248,were,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86249,given,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86250,single,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86251,breakfast,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86252,meals,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86253,consisting,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86254,of,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86255,50,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86256,g,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86257,glucose,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86258,",",O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86259,or,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86260,50,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86261,g,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86262,glucose,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86263,plus,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86264,25,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86265,g,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86266,protein,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86267,in,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86268,the,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86269,form,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86270,of,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86271,lean,B-AG.01.d.03,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86272,beef,I-AG.01.d.03,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86273,",",O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86274,turkey,B-AG.01.d.06,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86275,",",O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86276,gelatin,B-AG.01.m,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86277,",",O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86278,egg,B-AG.01.g,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86279,white,I-AG.01.g,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86280,",",O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86281,cottage,B-AG.01.e,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86282,cheese,I-AG.01.e,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86283,",",O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86284,fish,B-AG.01.d.07,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86285,",",O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86286,or,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86287,soy,B-AG.01.h.02.g,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86288,.,O,2988.0,"Seventeen type II ( non - insulin - dependent ) untreated diabetic subjects were given single breakfast meals consisting of 50 g glucose , or 50 g glucose plus 25 g protein in the form of lean beef , turkey , gelatin , egg white , cottage cheese , fish , or soy ."
86343,The,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86344,relative,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86345,area,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86346,under,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86347,the,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86348,insulin,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86349,response,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86350,curve,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86351,was,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86352,greatest,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86353,following,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86354,ingestion,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86355,of,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86356,the,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86357,meal,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86358,containing,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86359,cottage,B-AG.01.e,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86360,cheese,I-AG.01.e,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86361,(,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86362,360,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86363,%,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86364,),O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86365,and,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86366,was,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86367,least,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86368,with,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86369,egg,B-AG.01.g,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86370,white,I-AG.01.g,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86371,(,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86372,190,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86373,%,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86374,),O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86375,compared,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86376,with,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86377,that,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86378,following,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86379,glucose,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86380,alone,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86381,(,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86382,100,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86383,%,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86384,),O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86385,.,O,2991.0,The relative area under the insulin response curve was greatest following ingestion of the meal containing cottage cheese ( 360 % ) and was least with egg white ( 190 % ) compared with that following glucose alone ( 100 % ) .
86427,The,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86428,alpha,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86429,amino,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86430,nitrogen,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86431,concentration,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86432,varied,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86433,considerably,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86434,.,O,2994.0,The alpha amino nitrogen concentration varied considerably .
86601,A,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86602,significant,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86603,trend,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86604,of,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86605,increasing,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86606,GC,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86607,risk,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86608,was,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86609,found,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86610,with,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86611,increasing,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86612,consumption,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86613,of,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86614,traditional,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86615,soups,B-AG.01.n.02,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86616,",",O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86617,meat,B-AG.01.d,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86618,",",O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86619,salted,B-AG.01.n.07,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86620,/,I-AG.01.n.07,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86621,dried,I-AG.01.n.07,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86622,fish,I-AG.01.n.07,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86623,and,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86624,a,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86625,combination,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86626,of,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86627,cold,B-AG.01.d,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86628,cuts,I-AG.01.d,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86629,and,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86630,seasoned,B-AG.01.e.02,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86631,cheeses,I-AG.01.e.02,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
86632,.,O,3000.0,"A significant trend of increasing GC risk was found with increasing consumption of traditional soups , meat , salted / dried fish and a combination of cold cuts and seasoned cheeses ."
87205,The,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87206,blood,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87207,glucose,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87208,response,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87209,area,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87210,to,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87211,potatoes,B-AG.01.h.02.a,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87212,with,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87213,100,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87214,g,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87215,butter,B-AG.01.e.01,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87216,(,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87217,448,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87218,+,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87219,/-,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87220,68,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87221,mmol.240,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87222,min,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87223,/,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87224,L,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87225,),O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87226,was,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87227,significantly,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87228,lower,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87229,than,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87230,after,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87231,the,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87232,four,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87233,other,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87234,meals,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87235,:,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87236,596,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87237,+,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87238,/-,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87239,63,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87240,(,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87241,potato,B-AG.01.h.02.a,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87242,alone,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87243,),O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87244,",",O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87245,649,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87246,+,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87247,/-,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87248,82,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87249,(,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87250,potato,B-AG.01.h.02.a,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87251,+,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87252,40,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87253,g,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87254,olive,B-AG.01.f,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87255,oil,I-AG.01.f,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87256,),O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87257,",",O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87258,587,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87259,+,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87260,/-,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87261,80,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87262,(,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87263,potato,B-AG.01.h.02.a,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87264,+,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87265,50,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87266,g,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87267,butter,B-AG.01.e.01,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87268,),O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87269,",",O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87270,and,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87271,604,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87272,+,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87273,/-,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87274,81,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87275,(,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87276,potato,B-AG.01.h.02.a,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87277,+,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87278,80,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87279,g,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87280,olive,B-AG.01.f,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87281,oil,I-AG.01.f,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87282,),O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87283,nmol.240,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87284,min,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87285,/,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87286,L,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87287,",",O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87288,P,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87289,<,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87290,0.05,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87291,",",O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87292,respectively,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87293,.,O,3020.0,"The blood glucose response area to potatoes with 100 g butter ( 448 + /- 68 mmol.240 min / L ) was significantly lower than after the four other meals : 596 + /- 63 ( potato alone ) , 649 + /- 82 ( potato + 40 g olive oil ) , 587 + /- 80 ( potato + 50 g butter ) , and 604 + /- 81 ( potato + 80 g olive oil ) nmol.240 min / L , P < 0.05 , respectively ."
87464,HNC,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87465,patients,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87466,(,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87467,n,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87468,=,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87469,114,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87470,),O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87471,completed,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87472,a,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87473,three,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87474,-,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87475,day,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87476,dietary,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87477,record,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87478,and,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87479,a,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87480,tool,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87481,to,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87482,assess,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87483,Nutrition,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87484,Impact,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87485,Scores,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87486,(,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87487,NIS,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87488,),O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87489,at,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87490,baseline,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87491,",",O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87492,post,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87493,-,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87494,treatment,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87495,",",O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87496,and,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87497,follow,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87498,-,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87499,up,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87500,.,O,3027.0,"HNC patients ( n = 114 ) completed a three - day dietary record and a tool to assess Nutrition Impact Scores ( NIS ) at baseline , post - treatment , and follow - up ."
87908,Mean,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87909,IGF,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87910,-,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87911,I,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87912,levels,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87913,were,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87914,11,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87915,%,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87916,lower,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87917,among,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87918,women,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87919,in,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87920,the,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87921,highest,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87922,tofu,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87923,intake,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87924,category,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87925,compared,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87926,with,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87927,the,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87928,lowest,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87929,",",O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87930,but,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87931,the,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87932,difference,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87933,in,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87934,IGF,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87935,-,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87936,I,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87937,levels,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87938,between,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87939,the,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87940,highest,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87941,and,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87942,lowest,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87943,tofu,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87944,category,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87945,was,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87946,only,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87947,significant,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87948,among,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87949,women,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87950,in,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87951,Japan,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
87952,.,O,3044.0,"Mean IGF - I levels were 11 % lower among women in the highest tofu intake category compared with the lowest , but the difference in IGF - I levels between the highest and lowest tofu category was only significant among women in Japan ."
88393,Milk,B-AG.01.e,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88394,",",O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88395,meat,B-AG.01.d,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88396,",",O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88397,and,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88398,grains,B-AG.01.i,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88399,supplied,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88400,an,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88401,appreciable,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88402,proportion,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88403,of,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88404,each,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88405,vitamin,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88406,except,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88407,vitamin,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88408,A,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88409,",",O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88410,which,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88411,was,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88412,found,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88413,primarily,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88414,in,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88415,the,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88416,two,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88417,vegetable,B-AG.01.h.02,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88418,groups,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88419,.,O,3063.0,"Milk , meat , and grains supplied an appreciable proportion of each vitamin except vitamin A , which was found primarily in the two vegetable groups ."
88472,Amino,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
88473,acids,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
88474,and,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
88475,glucose,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
88476,have,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
88477,been,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
88478,shown,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
88479,to,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
88480,regulate,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
88481,protein,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
88482,synthesis,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
88483,in,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
88484,the,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
88485,mammary,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
88486,gland,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
88487,through,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
88488,their,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
88489,effects,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
88490,on,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
88491,cellular,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
88492,signaling,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
88493,pathways,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
88494,.,O,3067.0,Amino acids and glucose have been shown to regulate protein synthesis in the mammary gland through their effects on cellular signaling pathways .
89921,Gluten,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89922,-,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89923,free,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89924,bread,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89925,quality,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89926,is,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89927,dependent,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89928,on,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89929,ingredients,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89930,and,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89931,additives,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89932,combination,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89933,",",O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89934,but,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89935,also,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89936,processing,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89937,can,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89938,provide,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89939,a,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89940,way,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89941,to,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89942,improve,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89943,bread,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89944,quality,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
89945,.,O,3116.0,"Gluten - free bread quality is dependent on ingredients and additives combination , but also processing can provide a way to improve bread quality ."
90263,This,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90264,work,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90265,demonstrates,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90266,the,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90267,successful,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90268,application,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90269,of,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90270,the,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90271,rejection,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90272,threshold,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90273,method,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90274,to,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90275,a,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90276,complex,B-AG.01.e,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90277,dairy,I-AG.01.e,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90278,food,I-AG.01.e,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90279,.,O,3127.0,This work demonstrates the successful application of the rejection threshold method to a complex dairy food .
90444,Currently,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90445,",",O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90446,there,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90447,is,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90448,a,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90449,need,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90450,to,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90451,study,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90452,specific,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90453,well,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90454,-,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90455,defined,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90456,foods,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90457,",",O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90458,as,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90459,opposed,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90460,to,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90461,calculating,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90462,nutrients,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90463,",",O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90464,in,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90465,order,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90466,to,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90467,better,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90468,understand,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90469,these,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90470,relationships,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
90471,.,O,3134.0,"Currently , there is a need to study specific well - defined foods , as opposed to calculating nutrients , in order to better understand these relationships ."
91138,As,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91139,a,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91140,result,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91141,",",O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91142,the,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91143,polyunsaturated,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91144,fatty,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91145,acid,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91146,content,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91147,was,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91148,27,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91149,to,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91150,28,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91151,per,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91152,cent,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91153,of,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91154,the,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91155,meat,B-AG.01.f,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91156,fat,I-AG.01.f,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91157,and,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91158,butterfat,B-AG.01.f,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91159,;,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91160,saturated,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91161,fatty,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91162,acids,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91163,(,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91164,C12:0,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91165,to,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91166,tc16:0,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91167,),O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91168,were,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91169,18,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91170,to,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91171,19,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91172,per,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91173,cent,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91174,.,O,3160.0,"As a result , the polyunsaturated fatty acid content was 27 to 28 per cent of the meat fat and butterfat ; saturated fatty acids ( C12:0 to tc16:0 ) were 18 to 19 per cent ."
91437,We,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91438,examined,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91439,nutritional,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91440,and,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91441,psychosocial,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91442,factors,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91443,associated,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91444,with,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91445,adherence,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91446,to,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91447,the,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91448,recommended,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91449,diet,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91450,(,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91451,<,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91452,or,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91453,=,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91454,30,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91455,%,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91456,of,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91457,energy,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91458,from,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91459,fat,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91460,and,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91461,<,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91462,10,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91463,%,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91464,from,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91465,saturated,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91466,fat,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91467,),O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91468,in,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91469,children,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91470,with,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91471,familial,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91472,hypercholesterolemia,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91473,.,O,3171.0,We examined nutritional and psychosocial factors associated with adherence to the recommended diet ( < or = 30 % of energy from fat and < 10 % from saturated fat ) in children with familial hypercholesterolemia .
91474,Ninety,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91475,-,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91476,eight,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91477,boys,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91478,and,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91479,74,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91480,girls,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91481,aged,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91482,7,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91483,-,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91484,17,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91485,y,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91486,treated,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91487,for,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91488,>,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91489,or,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91490,=,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91491,18,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91492,mo,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91493,responded,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91494,to,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91495,a,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91496,quantitative,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91497,food,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91498,-,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91499,frequency,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91500,questionnaire,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91501,that,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91502,was,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91503,self-,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91504,(,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91505,ages,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91506,13,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91507,-,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91508,17,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91509,y,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91510,),O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91511,or,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91512,dietitian-(ages,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91513,7,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91514,-,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91515,12,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91516,y,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91517,),O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91518,administered,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
91519,.,O,3172.0,Ninety - eight boys and 74 girls aged 7 - 17 y treated for > or = 18 mo responded to a quantitative food - frequency questionnaire that was self- ( ages 13 - 17 y ) or dietitian-(ages 7 - 12 y ) administered .
92112,Cancer,O,3193.0,Cancer is the second leading cause of death with profound socio - economic consequences worldwide .
92113,is,O,3193.0,Cancer is the second leading cause of death with profound socio - economic consequences worldwide .
92114,the,O,3193.0,Cancer is the second leading cause of death with profound socio - economic consequences worldwide .
92115,second,O,3193.0,Cancer is the second leading cause of death with profound socio - economic consequences worldwide .
92116,leading,O,3193.0,Cancer is the second leading cause of death with profound socio - economic consequences worldwide .
92117,cause,O,3193.0,Cancer is the second leading cause of death with profound socio - economic consequences worldwide .
92118,of,O,3193.0,Cancer is the second leading cause of death with profound socio - economic consequences worldwide .
92119,death,O,3193.0,Cancer is the second leading cause of death with profound socio - economic consequences worldwide .
92120,with,O,3193.0,Cancer is the second leading cause of death with profound socio - economic consequences worldwide .
92121,profound,O,3193.0,Cancer is the second leading cause of death with profound socio - economic consequences worldwide .
92122,socio,O,3193.0,Cancer is the second leading cause of death with profound socio - economic consequences worldwide .
92123,-,O,3193.0,Cancer is the second leading cause of death with profound socio - economic consequences worldwide .
92124,economic,O,3193.0,Cancer is the second leading cause of death with profound socio - economic consequences worldwide .
92125,consequences,O,3193.0,Cancer is the second leading cause of death with profound socio - economic consequences worldwide .
92126,worldwide,O,3193.0,Cancer is the second leading cause of death with profound socio - economic consequences worldwide .
92127,.,O,3193.0,Cancer is the second leading cause of death with profound socio - economic consequences worldwide .
92354,Skin,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92355,reactions,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92356,among,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92357,other,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92358,atopics,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92359,were,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92360,rare,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92361,",",O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92362,and,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92363,non,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92364,-,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92365,atopic,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92366,patients,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92367,showed,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92368,no,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92369,reactions,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92370,to,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92371,fresh,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92372,fruits,B-AG.01.h.01,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92373,and,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92374,vegetables,B-AG.01.h.02,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92375,.,O,3201.0,"Skin reactions among other atopics were rare , and non - atopic patients showed no reactions to fresh fruits and vegetables ."
92421,The,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92422,correlation,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92423,between,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92424,clinical,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92425,symptoms,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92426,and,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92427,skin,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92428,test,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92429,results,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92430,with,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92431,the,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92432,fractionated,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92433,material,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92434,was,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92435,somewhat,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92436,lower,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92437,than,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92438,that,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92439,obtained,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92440,with,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92441,the,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92442,non,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92443,-,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92444,fractionated,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92445,fresh,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92446,material,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92447,.,O,3204.0,The correlation between clinical symptoms and skin test results with the fractionated material was somewhat lower than that obtained with the non - fractionated fresh material .
92588,Yogurt,B-AG.01.e,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92589,consumption,B-X,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92590,may,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92591,improve,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92592,gut,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92593,health,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92594,and,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92595,reduce,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92596,chronic,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92597,inflammation,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92598,by,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92599,enhancing,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92600,innate,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92601,and,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92602,adaptive,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92603,immune,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92604,responses,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92605,",",O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92606,intestinal,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92607,barrier,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92608,function,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92609,",",O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92610,lipid,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92611,profiles,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92612,",",O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92613,and,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92614,by,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92615,regulating,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92616,appetite,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92617,.,O,3212.0,"Yogurt consumption may improve gut health and reduce chronic inflammation by enhancing innate and adaptive immune responses , intestinal barrier function , lipid profiles , and by regulating appetite ."
92901,Indeed,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92902,",",O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92903,the,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92904,immune,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92905,system,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92906,is,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92907,incredible,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92908,arrangement,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92909,of,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92910,specific,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92911,organs,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92912,and,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92913,cells,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92914,that,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92915,enabled,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92916,humans,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92917,to,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92918,carry,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92919,out,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92920,defense,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92921,against,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92922,undesired,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92923,responses,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
92924,.,O,3223.0,"Indeed , the immune system is incredible arrangement of specific organs and cells that enabled humans to carry out defense against undesired responses ."
93304,The,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93305,pattern,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93306,was,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93307,stronger,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93308,among,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93309,the,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93310,high,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93311,-,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93312,fat,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93313,consumers,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93314,after,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93315,controlling,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93316,for,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93317,several,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93318,hormonal,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93319,confounding,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93320,factors,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93321,(,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93322,two,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93323,-,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93324,tailed,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93325,P,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93326,-,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93327,value,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93328,for,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93329,linear,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93330,trend,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93331,=,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93332,0.06,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93333,for,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93334,SC,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93335,and,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93336,P,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93337,=,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93338,0.05,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93339,for,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93340,NC,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93341,),O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93342,.,O,3237.0,The pattern was stronger among the high - fat consumers after controlling for several hormonal confounding factors ( two - tailed P - value for linear trend = 0.06 for SC and P = 0.05 for NC ) .
93674,Skin,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93675,prick,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93676,tests,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93677,with,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93678,carrot,B-AG.01.h.02.a,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93679,",",O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93680,celery,B-AG.01.h.02.a,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93681,",",O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93682,and,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93683,olive,B-AG.01.h.01.e,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93684,",",O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93685,and,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93686,birch,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93687,",",O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93688,grass,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93689,",",O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93690,and,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93691,mugwort,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93692,pollens,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93693,were,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93694,positive,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93695,.,O,3250.0,"Skin prick tests with carrot , celery , and olive , and birch , grass , and mugwort pollens were positive ."
93704,Specific,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93705,IgE,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93706,to,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93707,olive,B-AG.01.h.01.e,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93708,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93709,grass,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93710,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93711,and,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93712,weed,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93713,pollens,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93714,were,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93715,10.92,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93716,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93717,6.17,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93718,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93719,and,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93720,2.4,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93721,AU,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93722,/,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93723,ml,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93724,",",O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93725,respectively,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93726,.,O,3252.0,"Specific IgE to olive , grass , and weed pollens were 10.92 , 6.17 , and 2.4 AU / ml , respectively ."
93751,Immunoblot,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93752,of,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93753,raw,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93754,carrot,B-AG.01.h.02.a,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93755,showed,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93756,a,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93757,single,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93758,IgE,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93759,-,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93760,binding,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93761,18,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93762,-,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93763,kDa,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93764,band,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93765,.,O,3254.0,Immunoblot of raw carrot showed a single IgE - binding 18 - kDa band .
93766,IgE,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93767,reactivity,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93768,for,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93769,raw,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93770,carrot,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93771,immunoblot,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93772,was,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93773,completely,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93774,inhibited,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93775,by,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93776,carrot,B-AG.01.h.02.a,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93777,and,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93778,by,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93779,celery,B-AG.01.h.02.a,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93780,",",O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93781,but,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93782,not,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93783,by,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93784,olive,B-AG.01.h.01.e,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93785,or,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93786,grass,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93787,pollens,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93788,.,O,3255.0,"IgE reactivity for raw carrot immunoblot was completely inhibited by carrot and by celery , but not by olive or grass pollens ."
93992,They,O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
93993,are,O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
93994,Bitter,B-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
93995,Melon,I-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
93996,(,O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
93997,Momordica,B-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
93998,charantia,I-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
93999,),O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94000,",",O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94001,Fenugreek,B-AG.01.l.03,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94002,(,O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94003,trigonella,B-AG.01.l.03,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94004,foenum,I-AG.01.l.03,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94005,graecum,I-AG.01.l.03,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94006,),O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94007,",",O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94008,Gymnema,B-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94009,Sylvestre,I-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94010,",",O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94011,Ivy,B-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94012,Gourd,I-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94013,(,O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94014,Coccinia,B-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94015,indica,I-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94016,),O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94017,",",O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94018,Nopal,B-AG.01,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94019,or,I-AG.01,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94020,Prickly,I-AG.01,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94021,Pear,I-AG.01,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94022,Cactus,I-AG.01,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94023,(,O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94024,Opuntia,B-AG.01,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94025,streptacantha,I-AG.01,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94026,),O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94027,",",O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94028,Ginseng,B-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94029,",",O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94030,Aloe,B-AG.01,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94031,Vera,I-AG.01,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94032,",",O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94033,Russian,B-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94034,Tarragon,I-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94035,(,O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94036,Artemisia,B-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94037,dracunculus,I-AG.01.h.02.i,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94038,),O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94039,",",O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94040,and,O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94041,Garlic,B-AG.01.h.02.e,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94042,(,O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94043,Allium,B-AG.01.h.02.e,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94044,sativum,I-AG.01.h.02.e,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94045,),O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94046,.,O,3264.0,"They are Bitter Melon ( Momordica charantia ) , Fenugreek ( trigonella foenum graecum ) , Gymnema Sylvestre , Ivy Gourd ( Coccinia indica ) , Nopal or Prickly Pear Cactus ( Opuntia streptacantha ) , Ginseng , Aloe Vera , Russian Tarragon ( Artemisia dracunculus ) , and Garlic ( Allium sativum ) ."
94109,The,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94110,Golden,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94111,Syrian,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94112,hamster,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94113,(,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94114,Mesocricetus,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94115,auratus,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94116,),O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94117,has,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94118,been,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94119,shown,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94120,to,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94121,be,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94122,a,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94123,useful,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94124,model,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94125,of,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94126,both,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94127,human,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94128,lipoprotein,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94129,metabolism,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94130,and,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94131,the,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94132,development,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94133,of,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94134,atherosclerosis,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94135,.,O,3268.0,The Golden Syrian hamster ( Mesocricetus auratus ) has been shown to be a useful model of both human lipoprotein metabolism and the development of atherosclerosis .
94244,Removal,O,3271.0,Removal of cholesterol from the diet halted this progression .
94245,of,O,3271.0,Removal of cholesterol from the diet halted this progression .
94246,cholesterol,O,3271.0,Removal of cholesterol from the diet halted this progression .
94247,from,O,3271.0,Removal of cholesterol from the diet halted this progression .
94248,the,O,3271.0,Removal of cholesterol from the diet halted this progression .
94249,diet,O,3271.0,Removal of cholesterol from the diet halted this progression .
94250,halted,O,3271.0,Removal of cholesterol from the diet halted this progression .
94251,this,O,3271.0,Removal of cholesterol from the diet halted this progression .
94252,progression,O,3271.0,Removal of cholesterol from the diet halted this progression .
94253,.,O,3271.0,Removal of cholesterol from the diet halted this progression .
94388,In,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94389,the,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94390,aortic,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94391,arch,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94392,",",O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94393,lesion,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94394,size,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94395,decreased,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94396,linearly,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94397,(,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94398,P,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94399,<,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94400,0.05,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94401,",",O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94402,P,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94403,<,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94404,0.001,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94405,for,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94406,coconut,B-AG.01.f,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94407,oil,I-AG.01.f,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94408,and,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94409,olive,B-AG.01.f,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94410,oil,I-AG.01.f,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94411,respectively,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94412,),O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94413,with,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94414,the,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94415,greatest,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94416,reduction,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94417,being,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94418,seen,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94419,in,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94420,the,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94421,olive,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94422,-,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94423,oil,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94424,-,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94425,fed,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94426,animals,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94427,(,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94428,P,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94429,<,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94430,0.05,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94431,),O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94432,.,O,3275.0,"In the aortic arch , lesion size decreased linearly ( P < 0.05 , P < 0.001 for coconut oil and olive oil respectively ) with the greatest reduction being seen in the olive - oil - fed animals ( P < 0.05 ) ."
94688,A,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94689,subgroup,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94690,of,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94691,patients,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94692,(,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94693,n,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94694,=,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94695,18,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94696,),O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94697,also,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94698,performed,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94699,TG,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94700,determinations,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94701,2,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94702,hours,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94703,after,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94704,the,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94705,test,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94706,meals,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
94707,.,O,3284.0,A subgroup of patients ( n = 18 ) also performed TG determinations 2 hours after the test meals .
95100,Many,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95101,people,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95102,erroneously,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95103,believe,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95104,they,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95105,are,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95106,lactose,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95107,intolerant,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95108,or,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95109,develop,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95110,gastrointestinal,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95111,symptoms,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95112,after,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95113,intake,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95114,of,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95115,lactose,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95116,.,O,3296.0,Many people erroneously believe they are lactose intolerant or develop gastrointestinal symptoms after intake of lactose .
95180,This,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95181,review,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95182,is,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95183,intended,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95184,to,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95185,help,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95186,dietetics,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95187,professionals,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95188,alleviate,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95189,clients,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95190,',O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95191,fears,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95192,about,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95193,lactose,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95194,intolerance,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95195,and,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95196,recommend,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95197,dietary,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95198,strategies,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95199,to,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95200,improve,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95201,tolerance,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95202,to,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95203,lactose,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95204,.,O,3300.0,This review is intended to help dietetics professionals alleviate clients ' fears about lactose intolerance and recommend dietary strategies to improve tolerance to lactose .
95399,Celery,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95400,-,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95401,birch,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95402,positive,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95403,patients,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95404,(,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95405,n,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95406,=,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95407,13,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95408,),O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95409,showed,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95410,negative,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95411,or,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95412,low,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95413,RASTs,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95414,to,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95415,heated,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95416,celery,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95417,extracts,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95418,and,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95419,to,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95420,stick,B-AG.01.h.02.b,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95421,celery,I-AG.01.h.02.b,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
95422,.,O,3307.0,Celery - birch positive patients ( n = 13 ) showed negative or low RASTs to heated celery extracts and to stick celery .
96399,Conversely,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96400,",",O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96401,the,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96402,glucoregulatory,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96403,qualities,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96404,of,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96405,the,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96406,proteins,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96407,in,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96408,animal,B-AG.01,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96409,-,I-AG.01,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96410,based,I-AG.01,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96411,foods,I-AG.01,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96412,are,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96413,extremely,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96414,divergent,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96415,",",O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96416,with,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96417,a,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96418,higher,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96419,intake,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96420,of,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96421,certain,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96422,animal,B-AG.01,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96423,-,I-AG.01,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96424,based,I-AG.01,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96425,protein,I-AG.01,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96426,foods,I-AG.01,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96427,showing,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96428,negative,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96429,effects,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96430,",",O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96431,and,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96432,others,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96433,showing,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96434,neutral,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96435,or,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96436,positive,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96437,effects,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96438,on,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96439,type,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96440,2,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96441,diabetes,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96442,risk,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96443,.,O,3341.0,"Conversely , the glucoregulatory qualities of the proteins in animal - based foods are extremely divergent , with a higher intake of certain animal - based protein foods showing negative effects , and others showing neutral or positive effects on type 2 diabetes risk ."
96939,Additionally,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96940,",",O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96941,the,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96942,effects,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96943,identified,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96944,by,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96945,randomized,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96946,controlled,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96947,trials,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96948,of,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96949,less,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96950,-,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96951,studied,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96952,FD,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96953,products,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96954,",",O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96955,such,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96956,as,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96957,kefir,B-AG.01.e,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96958,and,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96959,kimchi,B-AG.01.n.09,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96960,",",O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96961,on,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96962,cardiometabolic,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96963,risk,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96964,factors,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96965,are,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96966,provided,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96967,.,O,3357.0,"Additionally , the effects identified by randomized controlled trials of less - studied FD products , such as kefir and kimchi , on cardiometabolic risk factors are provided ."
96996,PCSs,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
96997,have,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
96998,revealed,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
96999,that,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97000,the,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97001,total,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97002,consumption,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97003,of,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97004,FD,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97005,appears,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97006,to,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97007,be,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97008,associated,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97009,with,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97010,a,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97011,lower,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97012,risk,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97013,of,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97014,developing,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97015,stroke,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97016,and,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97017,cardiovascular,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97018,disease,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97019,.,O,3359.0,PCSs have revealed that the total consumption of FD appears to be associated with a lower risk of developing stroke and cardiovascular disease .
97074,In,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97075,conclusion,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97076,",",O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97077,the,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97078,intake,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97079,of,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97080,fermented,B-AG.01,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97081,foods,I-AG.01,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97082,containing,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97083,probiotics,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97084,",",O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97085,particularly,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97086,yogurt,B-AG.01.e,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97087,and,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97088,cheese,B-AG.01.e.02,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97089,(,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97090,of,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97091,an,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97092,undetermined,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97093,type,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97094,),O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97095,",",O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97096,opens,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97097,up,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97098,new,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97099,opportunities,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97100,for,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97101,the,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97102,management,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97103,of,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97104,cardiometabolic,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97105,risk,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97106,factors,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
97107,.,O,3363.0,"In conclusion , the intake of fermented foods containing probiotics , particularly yogurt and cheese ( of an undetermined type ) , opens up new opportunities for the management of cardiometabolic risk factors ."
98268,The,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98269,scale,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98270,described,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98271,in,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98272,this,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98273,paper,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98274,provides,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98275,useful,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98276,information,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98277,about,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98278,the,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98279,specific,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98280,food,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98281,components,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98282,recognized,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98283,as,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98284,dietary,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98285,sources,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98286,of,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98287,saturated,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98288,fat,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98289,and,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98290,cholesterol,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98291,and,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98292,helps,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98293,identify,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98294,those,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98295,population,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98296,groups,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98297,that,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98298,would,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98299,benefit,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98300,from,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98301,nutrition,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98302,education,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98303,programs,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98304,.,O,3405.0,The scale described in this paper provides useful information about the specific food components recognized as dietary sources of saturated fat and cholesterol and helps identify those population groups that would benefit from nutrition education programs .
98305,Because,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98306,of,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98307,its,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98308,simplicity,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98309,and,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98310,ease,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98311,of,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98312,administration,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98313,",",O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98314,the,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98315,scale,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98316,may,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98317,be,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98318,a,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98319,useful,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98320,tool,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98321,in,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98322,epidemiological,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98323,research,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98324,.,O,3406.0,"Because of its simplicity and ease of administration , the scale may be a useful tool in epidemiological research ."
98624,To,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98625,fill,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98626,the,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98627,knowledge,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98628,gap,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98629,",",O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98630,dietary,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98631,intake,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98632,was,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98633,assessed,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98634,in,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98635,2057,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98636,children,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98637,using,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98638,a,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98639,24,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98640,-,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98641,hour,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98642,dietary,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98643,recall,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98644,.,O,3420.0,"To fill the knowledge gap , dietary intake was assessed in 2057 children using a 24 - hour dietary recall ."
98645,All,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98646,reported,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98647,foods,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98648,and,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98649,beverages,B-AG.01.y,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98650,were,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98651,assigned,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98652,to,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98653,one,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98654,of,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98655,76,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98656,food,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98657,groups,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
98658,.,O,3421.0,All reported foods and beverages were assigned to one of 76 food groups .
99415,Neutrophil,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99416,function,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99417,and,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99418,the,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99419,severity,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99420,and,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99421,incidence,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99422,of,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99423,mastitis,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99424,in,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99425,dairy,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99426,cows,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99427,is,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99428,related,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99429,to,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99430,the,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99431,intake,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99432,of,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99433,many,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99434,antioxidant,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99435,nutrients,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99436,.,O,3445.0,Neutrophil function and the severity and incidence of mastitis in dairy cows is related to the intake of many antioxidant nutrients .
99514,Treatments,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99515,continued,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99516,until,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99517,7,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99518,d,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99519,after,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99520,cows,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99521,received,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99522,an,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99523,infusion,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99524,of,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99525,10,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99526,microg,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99527,of,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99528,LPS,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99529,into,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99530,one,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99531,quarter,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99532,of,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99533,the,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99534,mammary,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99535,gland,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99536,(,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99537,on,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99538,average,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99539,",",O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99540,this,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99541,occurred,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99542,32,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99543,d,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99544,postcalving,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99545,),O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99546,.,O,3448.0,"Treatments continued until 7 d after cows received an infusion of 10 microg of LPS into one quarter of the mammary gland ( on average , this occurred 32 d postcalving ) ."
99572,Concentrations,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99573,of,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99574,vitamin,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99575,C,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99576,in,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99577,milk,B-AG.01.e,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99578,(,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99579,24,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99580,h,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99581,postinfusion,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99582,),O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99583,and,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99584,in,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99585,neutrophils,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99586,(,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99587,calving,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99588,and,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99589,24,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99590,h,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99591,postinfusion,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99592,),O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99593,were,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99594,not,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99595,affected,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99596,by,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99597,treatment,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99598,",",O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99599,but,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99600,vitamin,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99601,C,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99602,concentrations,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99603,in,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99604,neutrophils,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99605,isolated,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99606,from,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99607,milk,B-AG.01.e,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99608,were,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99609,about,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99610,3,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99611,times,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99612,greater,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99613,than,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99614,concentrations,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99615,in,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99616,blood,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99617,neutrophils,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99618,.,O,3450.0,"Concentrations of vitamin C in milk ( 24 h postinfusion ) and in neutrophils ( calving and 24 h postinfusion ) were not affected by treatment , but vitamin C concentrations in neutrophils isolated from milk were about 3 times greater than concentrations in blood neutrophils ."
99695,Celiac,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99696,disease,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99697,is,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99698,an,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99699,autoimmune,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99700,disease,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99701,that,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99702,affects,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99703,the,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99704,villi,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99705,of,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99706,the,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99707,small,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99708,intestine,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99709,causing,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99710,abdominal,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99711,pain,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99712,",",O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99713,gas,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99714,",",O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99715,diarrhea,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99716,",",O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99717,or,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99718,bad,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99719,absorption,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99720,due,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99721,to,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99722,gluten,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99723,intolerance,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
99724,.,O,3454.0,"Celiac disease is an autoimmune disease that affects the villi of the small intestine causing abdominal pain , gas , diarrhea , or bad absorption due to gluten intolerance ."
100164,Despite,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100165,the,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100166,accumulating,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100167,epidemiological,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100168,research,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100169,",",O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100170,there,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100171,is,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100172,still,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100173,a,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100174,lack,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100175,of,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100176,consistent,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100177,results,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100178,from,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100179,high,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100180,-,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100181,quality,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100182,studies,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100183,for,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100184,many,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100185,health,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100186,outcomes,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100187,(,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100188,i.e.,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100189,certain,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100190,cancers,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100191,and,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100192,metabolism,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100193,-,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100194,related,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100195,disorders,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100196,),O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100197,.,O,3469.0,"Despite the accumulating epidemiological research , there is still a lack of consistent results from high - quality studies for many health outcomes ( i.e. certain cancers and metabolism - related disorders ) ."
100640,Updated,O,3487.0,Updated ED01 estimates ranged between 0.03  mg for walnut protein and 26.2  mg for shrimp protein .
100641,ED01,O,3487.0,Updated ED01 estimates ranged between 0.03  mg for walnut protein and 26.2  mg for shrimp protein .
100642,estimates,O,3487.0,Updated ED01 estimates ranged between 0.03  mg for walnut protein and 26.2  mg for shrimp protein .
100643,ranged,O,3487.0,Updated ED01 estimates ranged between 0.03  mg for walnut protein and 26.2  mg for shrimp protein .
100644,between,O,3487.0,Updated ED01 estimates ranged between 0.03  mg for walnut protein and 26.2  mg for shrimp protein .
100645,0.03,O,3487.0,Updated ED01 estimates ranged between 0.03  mg for walnut protein and 26.2  mg for shrimp protein .
100646,,O,3487.0,Updated ED01 estimates ranged between 0.03  mg for walnut protein and 26.2  mg for shrimp protein .
100647,mg,O,3487.0,Updated ED01 estimates ranged between 0.03  mg for walnut protein and 26.2  mg for shrimp protein .
100648,for,O,3487.0,Updated ED01 estimates ranged between 0.03  mg for walnut protein and 26.2  mg for shrimp protein .
100649,walnut,O,3487.0,Updated ED01 estimates ranged between 0.03  mg for walnut protein and 26.2  mg for shrimp protein .
100650,protein,O,3487.0,Updated ED01 estimates ranged between 0.03  mg for walnut protein and 26.2  mg for shrimp protein .
100651,and,O,3487.0,Updated ED01 estimates ranged between 0.03  mg for walnut protein and 26.2  mg for shrimp protein .
100652,26.2,O,3487.0,Updated ED01 estimates ranged between 0.03  mg for walnut protein and 26.2  mg for shrimp protein .
100653,,O,3487.0,Updated ED01 estimates ranged between 0.03  mg for walnut protein and 26.2  mg for shrimp protein .
100654,mg,O,3487.0,Updated ED01 estimates ranged between 0.03  mg for walnut protein and 26.2  mg for shrimp protein .
100655,for,O,3487.0,Updated ED01 estimates ranged between 0.03  mg for walnut protein and 26.2  mg for shrimp protein .
100656,shrimp,O,3487.0,Updated ED01 estimates ranged between 0.03  mg for walnut protein and 26.2  mg for shrimp protein .
100657,protein,O,3487.0,Updated ED01 estimates ranged between 0.03  mg for walnut protein and 26.2  mg for shrimp protein .
100658,.,O,3487.0,Updated ED01 estimates ranged between 0.03  mg for walnut protein and 26.2  mg for shrimp protein .
100659,ED05,O,3488.0,ED05 estimates ranged between 0.4  mg for mustard protein and 280  mg for shrimp protein .
100660,estimates,O,3488.0,ED05 estimates ranged between 0.4  mg for mustard protein and 280  mg for shrimp protein .
100661,ranged,O,3488.0,ED05 estimates ranged between 0.4  mg for mustard protein and 280  mg for shrimp protein .
100662,between,O,3488.0,ED05 estimates ranged between 0.4  mg for mustard protein and 280  mg for shrimp protein .
100663,0.4,O,3488.0,ED05 estimates ranged between 0.4  mg for mustard protein and 280  mg for shrimp protein .
100664,,O,3488.0,ED05 estimates ranged between 0.4  mg for mustard protein and 280  mg for shrimp protein .
100665,mg,O,3488.0,ED05 estimates ranged between 0.4  mg for mustard protein and 280  mg for shrimp protein .
100666,for,O,3488.0,ED05 estimates ranged between 0.4  mg for mustard protein and 280  mg for shrimp protein .
100667,mustard,O,3488.0,ED05 estimates ranged between 0.4  mg for mustard protein and 280  mg for shrimp protein .
100668,protein,O,3488.0,ED05 estimates ranged between 0.4  mg for mustard protein and 280  mg for shrimp protein .
100669,and,O,3488.0,ED05 estimates ranged between 0.4  mg for mustard protein and 280  mg for shrimp protein .
100670,280,O,3488.0,ED05 estimates ranged between 0.4  mg for mustard protein and 280  mg for shrimp protein .
100671,,O,3488.0,ED05 estimates ranged between 0.4  mg for mustard protein and 280  mg for shrimp protein .
100672,mg,O,3488.0,ED05 estimates ranged between 0.4  mg for mustard protein and 280  mg for shrimp protein .
100673,for,O,3488.0,ED05 estimates ranged between 0.4  mg for mustard protein and 280  mg for shrimp protein .
100674,shrimp,O,3488.0,ED05 estimates ranged between 0.4  mg for mustard protein and 280  mg for shrimp protein .
100675,protein,O,3488.0,ED05 estimates ranged between 0.4  mg for mustard protein and 280  mg for shrimp protein .
100676,.,O,3488.0,ED05 estimates ranged between 0.4  mg for mustard protein and 280  mg for shrimp protein .
100736,Information,O,3493.0,Information about dairy product intake was collected through a FFQ .
100737,about,O,3493.0,Information about dairy product intake was collected through a FFQ .
100738,dairy,B-AG.01.e,3493.0,Information about dairy product intake was collected through a FFQ .
100739,product,I-AG.01.e,3493.0,Information about dairy product intake was collected through a FFQ .
100740,intake,B-X,3493.0,Information about dairy product intake was collected through a FFQ .
100741,was,O,3493.0,Information about dairy product intake was collected through a FFQ .
100742,collected,O,3493.0,Information about dairy product intake was collected through a FFQ .
100743,through,O,3493.0,Information about dairy product intake was collected through a FFQ .
100744,a,O,3493.0,Information about dairy product intake was collected through a FFQ .
100745,FFQ,O,3493.0,Information about dairy product intake was collected through a FFQ .
100746,.,O,3493.0,Information about dairy product intake was collected through a FFQ .
100807,During,O,3497.0,During a median follow - up of 152 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100808,a,O,3497.0,During a median follow - up of 152 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100809,median,O,3497.0,During a median follow - up of 152 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100810,follow,O,3497.0,During a median follow - up of 152 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100811,-,O,3497.0,During a median follow - up of 152 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100812,up,O,3497.0,During a median follow - up of 152 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100813,of,O,3497.0,During a median follow - up of 152 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100814,152,O,3497.0,During a median follow - up of 152 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100815,years,O,3497.0,During a median follow - up of 152 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100816,we,O,3497.0,During a median follow - up of 152 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100817,identified,O,3497.0,During a median follow - up of 152 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100818,884,O,3497.0,During a median follow - up of 152 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100819,stroke,O,3497.0,During a median follow - up of 152 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100820,cases,O,3497.0,During a median follow - up of 152 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100821,(,O,3497.0,During a median follow - up of 152 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100822,503,O,3497.0,During a median follow - up of 152 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100823,ischaemic,O,3497.0,During a median follow - up of 152 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100824,and,O,3497.0,During a median follow - up of 152 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100825,244,O,3497.0,During a median follow - up of 152 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100826,haemorrhagic,O,3497.0,During a median follow - up of 152 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100827,),O,3497.0,During a median follow - up of 152 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100828,.,O,3497.0,During a median follow - up of 152 years we identified 884 stroke cases ( 503 ischaemic and 244 haemorrhagic ) .
100910,We,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100911,did,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100912,not,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100913,observe,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100914,any,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100915,associations,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100916,for,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100917,haemorrhagic,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100918,stroke,O,3500.0,We did not observe any associations for haemorrhagic stroke .
100919,.,O,3500.0,We did not observe any associations for haemorrhagic stroke .
101901,We,O,3536.0,We found a measurable psychoactive doseeffect relationship with each incremental increase in the chocolate 's sugar content .
101902,found,O,3536.0,We found a measurable psychoactive doseeffect relationship with each incremental increase in the chocolate 's sugar content .
101903,a,O,3536.0,We found a measurable psychoactive doseeffect relationship with each incremental increase in the chocolate 's sugar content .
101904,measurable,O,3536.0,We found a measurable psychoactive doseeffect relationship with each incremental increase in the chocolate 's sugar content .
101905,psychoactive,O,3536.0,We found a measurable psychoactive doseeffect relationship with each incremental increase in the chocolate 's sugar content .
101906,doseeffect,O,3536.0,We found a measurable psychoactive doseeffect relationship with each incremental increase in the chocolate 's sugar content .
101907,relationship,O,3536.0,We found a measurable psychoactive doseeffect relationship with each incremental increase in the chocolate 's sugar content .
101908,with,O,3536.0,We found a measurable psychoactive doseeffect relationship with each incremental increase in the chocolate 's sugar content .
101909,each,O,3536.0,We found a measurable psychoactive doseeffect relationship with each incremental increase in the chocolate 's sugar content .
101910,incremental,O,3536.0,We found a measurable psychoactive doseeffect relationship with each incremental increase in the chocolate 's sugar content .
101911,increase,O,3536.0,We found a measurable psychoactive doseeffect relationship with each incremental increase in the chocolate 's sugar content .
101912,in,O,3536.0,We found a measurable psychoactive doseeffect relationship with each incremental increase in the chocolate 's sugar content .
101913,the,O,3536.0,We found a measurable psychoactive doseeffect relationship with each incremental increase in the chocolate 's sugar content .
101914,chocolate,O,3536.0,We found a measurable psychoactive doseeffect relationship with each incremental increase in the chocolate 's sugar content .
101915,'s,O,3536.0,We found a measurable psychoactive doseeffect relationship with each incremental increase in the chocolate 's sugar content .
101916,sugar,O,3536.0,We found a measurable psychoactive doseeffect relationship with each incremental increase in the chocolate 's sugar content .
101917,content,O,3536.0,We found a measurable psychoactive doseeffect relationship with each incremental increase in the chocolate 's sugar content .
101918,.,O,3536.0,We found a measurable psychoactive doseeffect relationship with each incremental increase in the chocolate 's sugar content .
102208,However,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102209,",",O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102210,consumption,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102211,of,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102212,fruit,B-AG.01.h.01,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102213,in,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102214,the,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102215,form,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102216,of,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102217,juice,B-AG.01.ab,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102218,is,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102219,positively,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102220,associated,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102221,with,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102222,type,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102223,2,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102224,diabetes,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102225,risk,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102226,",",O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102227,possibly,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102228,due,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102229,to,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102230,resulting,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102231,hyperglycemia,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102232,.,O,3548.0,"However , consumption of fruit in the form of juice is positively associated with type 2 diabetes risk , possibly due to resulting hyperglycemia ."
102468,Available,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102469,scientific,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102470,evidence,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102471,agrees,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102472,on,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102473,the,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102474,harmful,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102475,effects,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102476,of,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102477,high,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102478,meat,B-AG.01.d,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102479,/,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102480,animal,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102481,protein,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102482,intake,B-X,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102483,and,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102484,low,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102485,calcium,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102486,diets,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102487,",",O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102488,whereas,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102489,high,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102490,content,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102491,of,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102492,fruits,B-AG.01.h.01,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102493,and,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102494,vegetables,B-AG.01.h.02,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102495,associated,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102496,with,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102497,a,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102498,balanced,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102499,intake,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102500,of,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102501,low,B-AG.01.e,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102502,-,I-AG.01.e,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102503,fat,I-AG.01.e,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102504,dairy,I-AG.01.e,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102505,products,I-AG.01.e,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102506,carries,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102507,the,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102508,lowest,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102509,risk,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102510,for,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102511,incident,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102512,kidney,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102513,stones,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102514,.,O,3556.0,"Available scientific evidence agrees on the harmful effects of high meat / animal protein intake and low calcium diets , whereas high content of fruits and vegetables associated with a balanced intake of low - fat dairy products carries the lowest risk for incident kidney stones ."
102854,These,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102855,findings,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102856,support,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102857,the,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102858,need,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102859,for,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102860,education,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102861,campaigns,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102862,to,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102863,reduce,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102864,salt,B-AG.01.l.01,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102865,added,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102866,during,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102867,cooking,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102868,and,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102869,for,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102870,strategies,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102871,to,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102872,reduce,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102873,salt,B-AG.01.l.01,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102874,content,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102875,in,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102876,selected,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102877,manufactured,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102878,foods,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102879,in,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102880,the,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102881,region,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102882,.,O,3570.0,These findings support the need for education campaigns to reduce salt added during cooking and for strategies to reduce salt content in selected manufactured foods in the region .
102943,Impairments,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102944,in,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102945,fat,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102946,perception,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102947,overlapped,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102948,with,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102949,the,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102950,anterior,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102951,insula,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102952,and,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102953,frontal,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102954,operculum,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102955,",",O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102956,together,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102957,assumed,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102958,to,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102959,underpin,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102960,gustatory,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102961,processing,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
102962,.,O,3574.0,"Impairments in fat perception overlapped with the anterior insula and frontal operculum , together assumed to underpin gustatory processing ."
103332,Relative,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103333,risks,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103334,of,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103335,different,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103336,patterns,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103337,of,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103338,milk,B-AG.01.e,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103339,consumption,B-X,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103340,for,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103341,specific,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103342,cancer,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103343,diagnoses,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103344,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103345,adjusted,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103346,for,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103347,sex,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103348,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103349,age,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103350,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103351,smoking,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103352,history,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103353,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103354,education,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103355,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103356,and,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103357,county,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103358,of,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103359,residence,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103360,",",O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103361,were,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103362,calculated,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103363,with,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103364,multiple,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103365,logistic,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103366,regression,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103367,analysis,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103368,.,O,3587.0,"Relative risks of different patterns of milk consumption for specific cancer diagnoses , adjusted for sex , age , smoking history , education , and county of residence , were calculated with multiple logistic regression analysis ."
103655,Laboratory,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103656,and,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103657,human,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103658,studies,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103659,on,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103660,the,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103661,activities,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103662,of,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103663,major,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103664,flavonoids,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103665,(,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103666,flavones,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103667,",",O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103668,isoflavones,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103669,",",O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103670,flavonols,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103671,",",O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103672,etc,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103673,.,O,3598.0,"Laboratory and human studies on the activities of major flavonoids ( flavones , isoflavones , flavonols , etc ."
103857,Changes,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103858,in,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103859,vitamin,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103860,content,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103861,are,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103862,mainly,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103863,observed,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103864,in,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103865,fermented,B-AG.01.e,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103866,milk,I-AG.01.e,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103867,and,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103868,fruits,B-AG.01.h.01,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103869,.,O,3606.0,Changes in vitamin content are mainly observed in fermented milk and fruits .
103870,Fermented,B-AG.01.e,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103871,milk,I-AG.01.e,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103872,and,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103873,fruit,B-AG.01.ab,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103874,juice,I-AG.01.ab,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103875,were,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103876,found,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103877,to,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103878,have,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103879,probiotic,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103880,activity,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103881,.,O,3607.0,Fermented milk and fruit juice were found to have probiotic activity .
103974,The,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103975,predominant,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103976,naturally,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103977,occurring,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103978,isomer,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103979,is,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103980,the,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103981,cis-9,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103982,",",O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103983,trans-11,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103984,modification,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103985,.,O,3612.0,"The predominant naturally occurring isomer is the cis-9 , trans-11 modification ."
103986,Treatment,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103987,of,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103988,linoleic,B-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103989,acid,I-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103990,-,I-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103991,rich,I-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103992,oils,I-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103993,such,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103994,as,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103995,safflower,B-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103996,oil,I-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103997,",",O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103998,soybean,B-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
103999,oil,I-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104000,",",O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104001,or,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104002,maize,B-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104003,oil,I-AG.01.f,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104004,with,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104005,base,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104006,and,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104007,heat,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104008,will,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104009,result,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104010,in,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104011,the,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104012,formation,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104013,of,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104014,CLA,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104015,.,O,3613.0,"Treatment of linoleic acid - rich oils such as safflower oil , soybean oil , or maize oil with base and heat will result in the formation of CLA ."
104016,Two,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104017,isomers,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104018,predominate,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104019,in,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104020,the,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104021,synthetic,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104022,preparation,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104023,",",O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104024,"c9,t11",O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104025,and,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104026,"t10,c12",O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104027,.,O,3614.0,"Two isomers predominate in the synthetic preparation , c9,t11 and t10,c12 ."
104086,When,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104087,young,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104088,animals,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104089,(,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104090,mice,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104091,",",O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104092,pigs,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104093,),O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104094,are,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104095,placed,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104096,on,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104097,CLA,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104098,-,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104099,containing,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104100,diets,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104101,after,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104102,weaning,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104103,they,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104104,accumulate,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104105,more,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104106,body,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104107,protein,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104108,and,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104109,less,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104110,fat,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104111,.,O,3618.0,"When young animals ( mice , pigs ) are placed on CLA - containing diets after weaning they accumulate more body protein and less fat ."
104184,North,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104185,of,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104186,Italy,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104187,was,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104188,severely,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104189,hit,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104190,by,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104191,the,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104192,COVID-19,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104193,(,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104194,Coronavirus,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104195,disease,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104196,19,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104197,),O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104198,pandemic,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104199,.,O,3622.0,North of Italy was severely hit by the COVID-19 ( Coronavirus disease 19 ) pandemic .
104316,Subjects,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104317,significantly,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104318,increased,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104319,daily,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104320,carbohydrates,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104321,consumption,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104322,",",O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104323,all,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104324,fresh,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104325,vegetables,B-AG.01.h.02,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104326,",",O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104327,healthy,B-AG.01.f,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104328,vegetable,I-AG.01.f,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104329,oils,I-AG.01.f,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104330,",",O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104331,milk,B-AG.01.e,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104332,and,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104333,yogurt,B-AG.01.e,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104334,",",O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104335,alcoholic,B-AG.01.y.01,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104336,drinks,I-AG.01.y.01,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104337,",",O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104338,sugars,B-AG.01.l.02,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104339,and,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104340,sweets,B-AG.01.n.17.a,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104341,",",O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104342,and,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104343,coffee,B-AG.01.ad,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104344,.,O,3627.0,"Subjects significantly increased daily carbohydrates consumption , all fresh vegetables , healthy vegetable oils , milk and yogurt , alcoholic drinks , sugars and sweets , and coffee ."
104388,The,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104389,Dietary,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104390,Quality,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104391,Index,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104392,was,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104393,reduced,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104394,from,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104395,42.4,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104396,,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104397,4.1,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104398,to,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104399,37.8,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104400,,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104401,4.7,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104402,(,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104403,Low,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104404,dietary,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104405,fat,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104406,intake,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104407,may,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104408,reduce,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104409,the,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104410,risk,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104411,of,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104412,developing,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104413,atherosclerosis,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104414,.,O,3629.0,The Dietary Quality Index was reduced from 42.4  4.1 to 37.8  4.7 ( Low dietary fat intake may reduce the risk of developing atherosclerosis .
104568,After,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104569,48,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104570,hours,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104571,",",O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104572,moistness,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104573,ratings,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104574,for,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104575,fat,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104576,-,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104577,free,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104578,cookies,B-AG.01.n.14,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104579,were,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104580,acceptable,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104581,and,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104582,higher,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104583,than,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104584,CTL,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104585,(,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104586,P<.01,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104587,),O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104588,.,O,3636.0,"After 48 hours , moistness ratings for fat - free cookies were acceptable and higher than CTL ( P<.01 ) ."
104698,Our,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104699,patient,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104700,-,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104701,associated,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104702,sensitizations,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104703,were,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104704,as,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104705,follows,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104706,:,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104707,10,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104708,to,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104709,latex,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104710,",",O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104711,eight,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104712,to,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104713,chestnut,B-AG.01.h.01.f,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104714,",",O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104715,eight,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104716,to,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104717,banana,B-AG.01.h.01,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104718,",",O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104719,four,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104720,to,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104721,kiwi,B-AG.01.h.01,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104722,",",O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104723,and,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104724,four,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104725,to,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104726,walnut,B-AG.01.h.01.f,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104727,.,O,3642.0,"Our patient - associated sensitizations were as follows : 10 to latex , eight to chestnut , eight to banana , four to kiwi , and four to walnut ."
104875,Nevertheless,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104876,there,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104877,is,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104878,little,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104879,information,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104880,on,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104881,the,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104882,metabolic,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104883,effects,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104884,of,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104885,conventional,B-AG.01.n.17.a,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104886,chocolate,I-AG.01.n.17.a,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104887,or,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104888,specialized,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104889,formulations,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104890,with,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104891,reduced,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104892,sucrose,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104893,content,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
104894,.,O,3649.0,Nevertheless there is little information on the metabolic effects of conventional chocolate or specialized formulations with reduced sucrose content .
105171,A,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105172,lower,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105173,-,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105174,than,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105175,-,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105176,recommended,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105177,potassium,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105178,intake,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105179,is,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105180,a,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105181,well,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105182,-,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105183,established,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105184,risk,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105185,factor,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105186,for,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105187,increased,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105188,blood,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105189,pressure,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105190,.,O,3659.0,A lower - than - recommended potassium intake is a well - established risk factor for increased blood pressure .
105373,Participants,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105374,in,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105375,the,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105376,higher,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105377,UK,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105378,/,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105379,BW,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105380,quartile,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105381,consumed,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105382,significantly,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105383,more,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105384,vegetables,B-AG.01.h,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105385,and,I-AG.01.h,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105386,fruits,I-AG.01.h,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105387,",",O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105388,fish,B-AG.01.d.07,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105389,",",O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105390,and,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105391,milk,B-AG.01.e,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105392,and,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105393,dairy,B-AG.01.e,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105394,products,I-AG.01.e,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105395,",",O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105396,and,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105397,ate,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105398,less,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105399,rice,B-AG.01.i,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105400,and,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105401,noodles,B-AG.01.i,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105402,.,O,3664.0,"Participants in the higher UK / BW quartile consumed significantly more vegetables and fruits , fish , and milk and dairy products , and ate less rice and noodles ."
105584,The,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105585,purpose,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105586,of,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105587,the,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105588,present,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105589,review,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105590,is,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105591,to,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105592,summarize,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105593,the,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105594,current,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105595,literature,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105596,concerning,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105597,the,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105598,beneficial,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105599,effects,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105600,of,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105601,honey,B-AG.01.l.02,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105602,in,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105603,the,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105604,management,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105605,of,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105606,the,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105607,obesity,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105608,-,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105609,related,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105610,dysfunctions,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105611,",",O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105612,including,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105613,neurodegeneration,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105614,.,O,3672.0,"The purpose of the present review is to summarize the current literature concerning the beneficial effects of honey in the management of the obesity - related dysfunctions , including neurodegeneration ."
105615,Based,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105616,on,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105617,the,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105618,key,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105619,constituents,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105620,of,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105621,honey,B-AG.01.l.02,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105622,",",O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105623,the,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105624,paper,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105625,also,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105626,highlights,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105627,polyphenols,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105628,to,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105629,be,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105630,potentially,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105631,responsible,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105632,for,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105633,the,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105634,health,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105635,benefits,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105636,of,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105637,honey,B-AG.01.l.02,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
105638,.,O,3673.0,"Based on the key constituents of honey , the paper also highlights polyphenols to be potentially responsible for the health benefits of honey ."
118917,However,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118918,",",O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118919,thorough,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118920,reviews,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118921,on,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118922,the,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118923,efficacy,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118924,of,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118925,cocoa,B-AG.01,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118926,on,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118927,brain,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118928,processes,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118929,in,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118930,young,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118931,adults,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118932,do,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118933,not,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118934,exist,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118935,precisely,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118936,due,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118937,to,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118938,the,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118939,limited,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118940,number,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118941,of,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118942,studies,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118943,in,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118944,the,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118945,matter,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118946,.,O,4146.0,"However , thorough reviews on the efficacy of cocoa on brain processes in young adults do not exist precisely due to the limited number of studies in the matter ."
118992,Human,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118993,randomized,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118994,controlled,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118995,studies,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118996,were,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118997,selected,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118998,according,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
118999,to,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
119000,PRISMA,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
119001,guidelines,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
119002,.,O,4149.0,Human randomized controlled studies were selected according to PRISMA guidelines .
119307,Determinants,O,4159.0,Determinants of DED did not vary by the calculation method used .
119308,of,O,4159.0,Determinants of DED did not vary by the calculation method used .
119309,DED,O,4159.0,Determinants of DED did not vary by the calculation method used .
119310,did,O,4159.0,Determinants of DED did not vary by the calculation method used .
119311,not,O,4159.0,Determinants of DED did not vary by the calculation method used .
119312,vary,O,4159.0,Determinants of DED did not vary by the calculation method used .
119313,by,O,4159.0,Determinants of DED did not vary by the calculation method used .
119314,the,O,4159.0,Determinants of DED did not vary by the calculation method used .
119315,calculation,O,4159.0,Determinants of DED did not vary by the calculation method used .
119316,method,O,4159.0,Determinants of DED did not vary by the calculation method used .
119317,used,O,4159.0,Determinants of DED did not vary by the calculation method used .
119318,.,O,4159.0,Determinants of DED did not vary by the calculation method used .
119469,Current,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119470,DED,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119471,estimates,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119472,for,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119473,adults,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119474,were,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119475,similar,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119476,to,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119477,those,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119478,calculated,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119479,in,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119480,a,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119481,previous,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119482,survey,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119483,",",O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119484,carried,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119485,out,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119486,10,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119487,years,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119488,earlier,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119489,.,O,4164.0,"Current DED estimates for adults were similar to those calculated in a previous survey , carried out 10 years earlier ."
119765,These,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119766,findings,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119767,do,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119768,not,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119769,support,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119770,the,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119771,view,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119772,that,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119773,replacement,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119774,of,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119775,dietary,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119776,saturated,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119777,fat,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119778,with,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119779,olive,B-AG.01.f,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119780,oil,I-AG.01.f,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119781,has,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119782,a,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119783,major,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119784,impact,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119785,on,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119786,the,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119787,development,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119788,of,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119789,atherosclerosis,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119790,in,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119791,addition,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119792,to,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119793,that,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119794,accounted,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119795,for,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119796,by,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119797,changes,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119798,in,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119799,plasma,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119800,cholesterol,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119801,levels,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
119802,.,O,4173.0,These findings do not support the view that replacement of dietary saturated fat with olive oil has a major impact on the development of atherosclerosis in addition to that accounted for by changes in plasma cholesterol levels .
120759,The,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120760,secular,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120761,trend,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120762,of,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120763,declining,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120764,stroke,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120765,mortality,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120766,was,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120767,parallel,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120768,to,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120769,the,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120770,increase,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120771,in,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120772,the,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120773,consumption,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120774,of,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120775,milk,B-AG.01.e,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120776,",",O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120777,meat,B-AG.01.d,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120778,",",O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120779,fish,B-AG.01.d.07,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120780,",",O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120781,eggs,B-AG.01.g,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120782,",",O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120783,soybeans,B-AG.01.h.02.g,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120784,",",O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120785,oil,B-AG.01.f,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120786,and,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120787,fats,B-AG.01.f,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120788,and,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120789,to,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120790,the,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120791,decrease,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120792,in,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120793,rice,B-AG.01.i,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120794,consumption,B-X,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
120795,.,O,4209.0,"The secular trend of declining stroke mortality was parallel to the increase in the consumption of milk , meat , fish , eggs , soybeans , oil and fats and to the decrease in rice consumption ."
121102,In,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121103,this,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121104,study,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121105,",",O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121106,we,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121107,aimed,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121108,to,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121109,explore,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121110,the,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121111,proteomic,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121112,profile,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121113,of,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121114,milk,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121115,sEV,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121116,from,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121117,BLV,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121118,-,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121119,infected,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121120,cattle,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121121,compared,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121122,with,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121123,those,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121124,from,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121125,uninfected,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121126,cattle,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121127,.,O,4221.0,"In this study , we aimed to explore the proteomic profile of milk sEV from BLV - infected cattle compared with those from uninfected cattle ."
121228,Twenty,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121229,-,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121230,six,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121231,proteins,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121232,in,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121233,milk,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121234,sEV,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121235,were,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121236,differentially,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121237,expressed,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121238,proteins,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121239,more,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121240,than,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121241,two,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121242,-,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121243,fold,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121244,significant,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121245,difference,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121246,(,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121247,p,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121248,,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121249,<,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121250,,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121251,0.05,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121252,),O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121253,in,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121254,BLV,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121255,-,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121256,infected,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121257,cattle,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121258,.,O,4226.0,Twenty - six proteins in milk sEV were differentially expressed proteins more than two - fold significant difference ( p  <  0.05 ) in BLV - infected cattle .
121402,Blood,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121403,glucose,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121404,and,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121405,insulin,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121406,levels,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121407,were,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121408,used,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121409,for,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121410,the,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121411,homoeostasis,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121412,model,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121413,assessment,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121414,of,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121415,insulin,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121416,resistance,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121417,(,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121418,HOMA,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121419,-,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121420,IR,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121421,),O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121422,.,O,4232.0,Blood glucose and insulin levels were used for the homoeostasis model assessment of insulin resistance ( HOMA - IR ) .
121569,This,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121570,study,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121571,reports,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121572,an,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121573,independent,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121574,inverse,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121575,relationship,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121576,between,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121577,daily,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121578,chocolate,B-AG.01.n.17.a,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121579,consumption,B-X,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121580,and,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121581,levels,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121582,of,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121583,insulin,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121584,",",O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121585,HOMA,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121586,-,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121587,IR,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121588,and,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121589,liver,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121590,enzymes,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121591,in,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121592,adults,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121593,",",O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121594,suggesting,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121595,that,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121596,chocolate,B-AG.01.n.17.a,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121597,consumption,B-X,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121598,may,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121599,improve,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121600,liver,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121601,enzymes,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121602,and,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121603,protect,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121604,against,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121605,insulin,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121606,resistance,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121607,",",O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121608,a,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121609,well,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121610,-,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121611,established,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121612,risk,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121613,factor,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121614,for,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121615,cardiometabolic,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121616,disorders,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
121617,.,O,4236.0,"This study reports an independent inverse relationship between daily chocolate consumption and levels of insulin , HOMA - IR and liver enzymes in adults , suggesting that chocolate consumption may improve liver enzymes and protect against insulin resistance , a well - established risk factor for cardiometabolic disorders ."
122050,Plasma,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122051,cholesterol,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122052,and,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122053,triglyceride,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122054,concentrations,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122055,were,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122056,lower,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122057,in,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122058,groups,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122059,that,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122060,consumed,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122061,PE,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122062,.,O,4252.0,Plasma cholesterol and triglyceride concentrations were lower in groups that consumed PE .
122291,With,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122292,moderate,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122293,consumption,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122294,of,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122295,red,B-AG.01.y.01.a,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122296,wine,I-AG.01.y.01.a,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122297,",",O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122298,ethanol,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122299,can,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122300,improve,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122301,the,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122302,effects,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122303,of,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122304,phenolic,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122305,compounds,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122306,.,O,4260.0,"With moderate consumption of red wine , ethanol can improve the effects of phenolic compounds ."
122755,The,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122756,multivariate,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122757,-,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122758,adjusted,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122759,odds,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122760,ratio,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122761,of,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122762,type,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122763,2,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122764,diabetes,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122765,for,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122766,the,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122767,highest,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122768,quintile,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122769,compared,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122770,to,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122771,the,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122772,lowest,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122773,was,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122774,4.43,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122775,(,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122776,95,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122777,%,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122778,confidence,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122779,interval,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122780,:,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122781,1.87,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122782,-,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122783,10.50,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122784,",",O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122785,p,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122786,for,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122787,trend,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122788,<,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122789,0.001,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122790,),O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
122791,.,O,4276.0,"The multivariate - adjusted odds ratio of type 2 diabetes for the highest quintile compared to the lowest was 4.43 ( 95 % confidence interval : 1.87 - 10.50 , p for trend < 0.001 ) ."
123065,The,O,4286.0,"The findings support the diversity of DP among the elderly , highlighting sex - specific differences ."
123066,findings,O,4286.0,"The findings support the diversity of DP among the elderly , highlighting sex - specific differences ."
123067,support,O,4286.0,"The findings support the diversity of DP among the elderly , highlighting sex - specific differences ."
123068,the,O,4286.0,"The findings support the diversity of DP among the elderly , highlighting sex - specific differences ."
123069,diversity,O,4286.0,"The findings support the diversity of DP among the elderly , highlighting sex - specific differences ."
123070,of,O,4286.0,"The findings support the diversity of DP among the elderly , highlighting sex - specific differences ."
123071,DP,O,4286.0,"The findings support the diversity of DP among the elderly , highlighting sex - specific differences ."
123072,among,O,4286.0,"The findings support the diversity of DP among the elderly , highlighting sex - specific differences ."
123073,the,O,4286.0,"The findings support the diversity of DP among the elderly , highlighting sex - specific differences ."
123074,elderly,O,4286.0,"The findings support the diversity of DP among the elderly , highlighting sex - specific differences ."
123075,",",O,4286.0,"The findings support the diversity of DP among the elderly , highlighting sex - specific differences ."
123076,highlighting,O,4286.0,"The findings support the diversity of DP among the elderly , highlighting sex - specific differences ."
123077,sex,O,4286.0,"The findings support the diversity of DP among the elderly , highlighting sex - specific differences ."
123078,-,O,4286.0,"The findings support the diversity of DP among the elderly , highlighting sex - specific differences ."
123079,specific,O,4286.0,"The findings support the diversity of DP among the elderly , highlighting sex - specific differences ."
123080,differences,O,4286.0,"The findings support the diversity of DP among the elderly , highlighting sex - specific differences ."
123081,.,O,4286.0,"The findings support the diversity of DP among the elderly , highlighting sex - specific differences ."
123082,The,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123083,"""",O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123084,healthy,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123085,"""",O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123086,DP,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123087,explained,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123088,the,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123089,largest,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123090,amount,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123091,of,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123092,variance,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123093,in,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123094,intake,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123095,.,O,4287.0,"The "" healthy "" DP explained the largest amount of variance in intake ."
123390,These,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123391,results,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123392,suggest,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123393,diets,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123394,high,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123395,in,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123396,meat,B-AG.01.d,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123397,or,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123398,RS,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123399,could,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123400,influence,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123401,cancer,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123402,initiation,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123403,or,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123404,progression,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123405,by,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123406,changes,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123407,in,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123408,circulating,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123409,levels,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123410,of,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123411,hormones,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123412,and,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123413,other,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123414,factors,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123415,.,O,4301.0,These results suggest diets high in meat or RS could influence cancer initiation or progression by changes in circulating levels of hormones and other factors .
123604,Acidic,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123605,salad,B-AG.01.l.04,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123606,dressing,I-AG.01.l.04,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123607,matrices,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123608,reduced,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123609,the,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123610,detectability,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123611,of,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123612,mustard,B-AG.01.l.03,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123613,by,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123614,the,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123615,mustard,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123616,ELISA,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123617,probably,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123618,because,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123619,of,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123620,acid,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123621,precipitation,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123622,of,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123623,mustard,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123624,proteins,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123625,that,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123626,renders,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123627,them,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123628,insoluble,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123629,and,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123630,nonextractable,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
123631,.,O,4311.0,Acidic salad dressing matrices reduced the detectability of mustard by the mustard ELISA probably because of acid precipitation of mustard proteins that renders them insoluble and nonextractable .
124370,The,O,4336.0,The occurrence and distribution of LTP depend on the wine variety .
124371,occurrence,O,4336.0,The occurrence and distribution of LTP depend on the wine variety .
124372,and,O,4336.0,The occurrence and distribution of LTP depend on the wine variety .
124373,distribution,O,4336.0,The occurrence and distribution of LTP depend on the wine variety .
124374,of,O,4336.0,The occurrence and distribution of LTP depend on the wine variety .
124375,LTP,O,4336.0,The occurrence and distribution of LTP depend on the wine variety .
124376,depend,O,4336.0,The occurrence and distribution of LTP depend on the wine variety .
124377,on,O,4336.0,The occurrence and distribution of LTP depend on the wine variety .
124378,the,O,4336.0,The occurrence and distribution of LTP depend on the wine variety .
124379,wine,O,4336.0,The occurrence and distribution of LTP depend on the wine variety .
124380,variety,O,4336.0,The occurrence and distribution of LTP depend on the wine variety .
124381,.,O,4336.0,The occurrence and distribution of LTP depend on the wine variety .
124975,Additionally,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124976,",",O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124977,during,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124978,the,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124979,development,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124980,of,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124981,liver,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124982,metastasis,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124983,",",O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124984,pro,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124985,-,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124986,inflammatory,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124987,signaling,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124988,is,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124989,crucial,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124990,in,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124991,eliminating,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124992,invading,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124993,cancer,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124994,cells,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124995,but,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124996,ironically,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124997,also,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124998,helps,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
124999,foster,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
125000,a,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
125001,pro,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
125002,-,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
125003,metastatic,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
125004,environment,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
125005,that,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
125006,supports,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
125007,metastatic,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
125008,seeding,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
125009,and,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
125010,colonization,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
125011,.,O,4360.0,"Additionally , during the development of liver metastasis , pro - inflammatory signaling is crucial in eliminating invading cancer cells but ironically also helps foster a pro - metastatic environment that supports metastatic seeding and colonization ."
125012,Here,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125013,we,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125014,review,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125015,how,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125016,Westernized,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125017,high,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125018,-,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125019,fat,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125020,diets,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125021,and,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125022,excessive,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125023,alcohol,B-AG.01.y.01,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125024,intake,B-X,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125025,can,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125026,influence,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125027,inflammation,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125028,within,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125029,the,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125030,liver,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125031,microenvironment,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125032,",",O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125033,stimulating,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125034,both,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125035,primary,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125036,and,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125037,metastatic,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125038,liver,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125039,tumorigenesis,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125040,.,O,4361.0,"Here we review how Westernized high - fat diets and excessive alcohol intake can influence inflammation within the liver microenvironment , stimulating both primary and metastatic liver tumorigenesis ."
125069,The,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125070,aim,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125071,of,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125072,this,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125073,study,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125074,was,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125075,to,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125076,investigate,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125077,substitutions,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125078,of,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125079,red,B-AG.01.d,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125080,meat,I-AG.01.d,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125081,",",O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125082,poultry,B-AG.01.d.06,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125083,and,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125084,fish,B-AG.01.d.07,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125085,with,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125086,vegetables,B-AG.01.h.02,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125087,or,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125088,potatoes,B-AG.01.h.02.a,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125089,for,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125090,MI,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125091,prevention,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125092,.,O,4363.0,"The aim of this study was to investigate substitutions of red meat , poultry and fish with vegetables or potatoes for MI prevention ."
125126,Diet,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125127,was,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125128,assessed,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125129,by,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125130,a,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125131,validated,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125132,192,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125133,-,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125134,item,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125135,FFQ,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125136,at,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125137,baseline,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125138,.,O,4365.0,Diet was assessed by a validated 192 - item FFQ at baseline .
125264,Substituting,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125265,poultry,B-AG.01.d.06,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125266,with,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125267,vegetables,B-AG.01.h.02,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125268,was,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125269,not,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125270,associated,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125271,with,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125272,risk,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125273,of,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125274,MI,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125275,(,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125276,HR,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125277,100,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125278,;,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125279,95,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125280,%,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125281,CI,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125282,090,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125283,",",O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125284,111,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125285,),O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125286,.,O,4370.0,"Substituting poultry with vegetables was not associated with risk of MI ( HR 100 ; 95 % CI 090 , 111 ) ."
125287,Findings,O,4371.0,Findings for substitution with potatoes were similar to findings for vegetables .
125288,for,O,4371.0,Findings for substitution with potatoes were similar to findings for vegetables .
125289,substitution,O,4371.0,Findings for substitution with potatoes were similar to findings for vegetables .
125290,with,O,4371.0,Findings for substitution with potatoes were similar to findings for vegetables .
125291,potatoes,B-AG.01.h.02.a,4371.0,Findings for substitution with potatoes were similar to findings for vegetables .
125292,were,O,4371.0,Findings for substitution with potatoes were similar to findings for vegetables .
125293,similar,O,4371.0,Findings for substitution with potatoes were similar to findings for vegetables .
125294,to,O,4371.0,Findings for substitution with potatoes were similar to findings for vegetables .
125295,findings,O,4371.0,Findings for substitution with potatoes were similar to findings for vegetables .
125296,for,O,4371.0,Findings for substitution with potatoes were similar to findings for vegetables .
125297,vegetables,B-AG.01.h.02,4371.0,Findings for substitution with potatoes were similar to findings for vegetables .
125298,.,O,4371.0,Findings for substitution with potatoes were similar to findings for vegetables .
125615,To,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125616,study,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125617,the,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125618,association,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125619,between,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125620,fruits,B-AG.01.h.01,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125621,and,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125622,vegetables,B-AG.01.h.02,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125623,and,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125624,risk,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125625,of,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125626,RCC,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125627,in,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125628,a,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125629,population,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125630,-,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125631,based,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125632,prospective,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125633,cohort,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125634,study,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125635,of,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125636,Swedish,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125637,women,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125638,",",O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125639,we,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125640,collected,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125641,dietary,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125642,information,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125643,from,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125644,"61,000",O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125645,women,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125646,age,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125647,40,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125648,-,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125649,76,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125650,years,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125651,by,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125652,a,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125653,food,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125654,-,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125655,frequency,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125656,questionnaire,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
125657,.,O,4381.0,"To study the association between fruits and vegetables and risk of RCC in a population - based prospective cohort study of Swedish women , we collected dietary information from 61,000 women age 40 - 76 years by a food - frequency questionnaire ."
126312,Associations,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126313,of,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126314,alcohol,B-AG.01.y.01,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126315,to,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126316,risk,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126317,for,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126318,rectal,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126319,cancer,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126320,may,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126321,be,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126322,related,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126323,to,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126324,cellular,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126325,hyperproliferation,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126326,and,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126327,may,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126328,be,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126329,modified,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126330,by,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126331,NSAID,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126332,use,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126333,.,O,4401.0,Associations of alcohol to risk for rectal cancer may be related to cellular hyperproliferation and may be modified by NSAID use .
126334,To,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126335,evaluate,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126336,the,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126337,associations,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126338,of,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126339,changes,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126340,in,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126341,diet,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126342,during,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126343,adult,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126344,life,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126345,with,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126346,adenoma,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126347,risk,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126348,",",O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126349,data,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126350,from,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126351,a,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126352,case,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126353,-,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126354,control,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126355,study,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126356,of,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126357,146,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126358,colorectal,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126359,adenomas,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126360,and,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126361,226,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126362,controls,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126363,were,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126364,analyzed,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126365,.,O,4402.0,"To evaluate the associations of changes in diet during adult life with adenoma risk , data from a case - control study of 146 colorectal adenomas and 226 controls were analyzed ."
126702,These,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126703,associations,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126704,are,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126705,macronutrient,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126706,specific,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126707,",",O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126708,with,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126709,morning,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126710,carbohydrate,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126711,intake,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126712,associated,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126713,with,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126714,reduced,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126715,daily,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126716,carbohydrate,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126717,intake,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126718,",",O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126719,morning,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126720,fat,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126721,intake,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126722,associated,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126723,with,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126724,reduced,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126725,daily,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126726,fat,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126727,intake,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126728,and,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126729,morning,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126730,protein,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126731,intake,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126732,associated,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126733,with,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126734,reduced,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126735,daily,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126736,protein,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126737,intake,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
126738,.,O,4412.0,"These associations are macronutrient specific , with morning carbohydrate intake associated with reduced daily carbohydrate intake , morning fat intake associated with reduced daily fat intake and morning protein intake associated with reduced daily protein intake ."
127436,Samples,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127437,from,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127438,each,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127439,step,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127440,of,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127441,bread,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127442,preparation,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127443,were,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127444,analyzed,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127445,for,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127446,folic,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127447,acid,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127448,concentration,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
127449,.,O,4434.0,Samples from each step of bread preparation were analyzed for folic acid concentration .
128272,This,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128273,study,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128274,aimed,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128275,",",O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128276,first,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128277,",",O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128278,to,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128279,study,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128280,the,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128281,prevalence,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128282,in,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128283,The,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128284,Netherlands,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128285,of,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128286,atopy,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128287,caused,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128288,by,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128289,apple,B-AG.01.h.01.c,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128290,",",O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128291,peach,B-AG.01.h.01.e,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128292,",",O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128293,and,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128294,hazelnut,B-AG.01.h.01.f,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128295,in,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128296,patients,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128297,with,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128298,tree,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128299,pollinosis,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128300,",",O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128301,and,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128302,",",O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128303,second,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128304,",",O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128305,to,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128306,compare,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128307,three,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128308,extraction,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128309,procedures,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128310,for,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128311,skin,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128312,prick,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128313,testing,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128314,with,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128315,two,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128316,different,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128317,apple,B-AG.01.h.01.c,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128318,strains,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128319,.,O,4461.0,"This study aimed , first , to study the prevalence in The Netherlands of atopy caused by apple , peach , and hazelnut in patients with tree pollinosis , and , second , to compare three extraction procedures for skin prick testing with two different apple strains ."
128779,An,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128780,ex,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128781,vivo,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128782,study,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128783,shows,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128784,that,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128785,epicatechin,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128786,",",O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128787,a,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128788,major,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128789,polyphenol,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128790,in,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128791,chocolate,B-AG.01.n.17.a,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128792,and,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128793,chocolate,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128794,extracts,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128795,",",O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128796,is,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128797,a,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128798,powerful,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128799,inhibitor,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128800,of,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128801,plasma,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128802,lipid,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128803,oxidation,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128804,due,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128805,to,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128806,polyphenols,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128807,',O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128808,ability,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128809,to,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128810,bind,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128811,to,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128812,lower,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128813,density,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128814,lipoproteins,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128815,.,O,4479.0,"An ex vivo study shows that epicatechin , a major polyphenol in chocolate and chocolate extracts , is a powerful inhibitor of plasma lipid oxidation due to polyphenols ' ability to bind to lower density lipoproteins ."
128931,Chocolate,B-AG.01.n.17.a,4484.0,Chocolate has thus been shown to have potential beneficial effects with respect to heart disease .
128932,has,O,4484.0,Chocolate has thus been shown to have potential beneficial effects with respect to heart disease .
128933,thus,O,4484.0,Chocolate has thus been shown to have potential beneficial effects with respect to heart disease .
128934,been,O,4484.0,Chocolate has thus been shown to have potential beneficial effects with respect to heart disease .
128935,shown,O,4484.0,Chocolate has thus been shown to have potential beneficial effects with respect to heart disease .
128936,to,O,4484.0,Chocolate has thus been shown to have potential beneficial effects with respect to heart disease .
128937,have,O,4484.0,Chocolate has thus been shown to have potential beneficial effects with respect to heart disease .
128938,potential,O,4484.0,Chocolate has thus been shown to have potential beneficial effects with respect to heart disease .
128939,beneficial,O,4484.0,Chocolate has thus been shown to have potential beneficial effects with respect to heart disease .
128940,effects,O,4484.0,Chocolate has thus been shown to have potential beneficial effects with respect to heart disease .
128941,with,O,4484.0,Chocolate has thus been shown to have potential beneficial effects with respect to heart disease .
128942,respect,O,4484.0,Chocolate has thus been shown to have potential beneficial effects with respect to heart disease .
128943,to,O,4484.0,Chocolate has thus been shown to have potential beneficial effects with respect to heart disease .
128944,heart,O,4484.0,Chocolate has thus been shown to have potential beneficial effects with respect to heart disease .
128945,disease,O,4484.0,Chocolate has thus been shown to have potential beneficial effects with respect to heart disease .
128946,.,O,4484.0,Chocolate has thus been shown to have potential beneficial effects with respect to heart disease .
128947,In,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128948,the,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128949,United,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128950,States,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128951,",",O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128952,the,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128953,notion,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128954,that,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128955,low,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128956,-,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128957,fat,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128958,",",O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128959,high,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128960,-,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128961,carbohydrate,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128962,diets,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128963,are,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128964,essential,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128965,for,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128966,health,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128967,has,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128968,grown,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128969,into,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128970,an,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128971,obsession,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128972,",",O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128973,driven,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128974,largely,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128975,by,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128976,an,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128977,effort,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128978,to,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128979,reduce,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128980,heart,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128981,disease,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128982,and,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128983,",",O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128984,more,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128985,recently,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128986,",",O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128987,certain,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128988,types,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128989,of,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128990,cancer,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
128991,.,O,4485.0,"In the United States , the notion that low - fat , high - carbohydrate diets are essential for health has grown into an obsession , driven largely by an effort to reduce heart disease and , more recently , certain types of cancer ."
130069,A,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130070,panel,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130071,of,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130072,148,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130073,extracts,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130074,from,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130075,37,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130076,food,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130077,products,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130078,was,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130079,prepared,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130080,using,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130081,organic,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130082,and,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130083,aqueous,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130084,solvents,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130085,and,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130086,both,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130087,neutral,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130088,and,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130089,acidic,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130090,conditions,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130091,.,O,4524.0,A panel of 148 extracts from 37 food products was prepared using organic and aqueous solvents and both neutral and acidic conditions .
130269,Scratch,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130270,tests,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130271,with,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130272,common,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130273,spices,B-AG.01.l.03,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130274,were,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130275,performed,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130276,in,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130277,"1,120",O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130278,atopic,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130279,and,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130280,380,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130281,non,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130282,-,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130283,atopic,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130284,patients,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130285,.,O,4530.0,"Scratch tests with common spices were performed in 1,120 atopic and 380 non - atopic patients ."
130333,A,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130334,high,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130335,correlation,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130336,between,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130337,positive,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130338,skin,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130339,test,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130340,reactions,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130341,to,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130342,spices,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130343,",",O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130344,especially,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130345,to,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130346,curry,B-AG.01.l.03,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130347,and,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130348,its,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130349,components,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130350,",",O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130351,and,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130352,tree,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130353,pollens,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130354,",",O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130355,fruits,B-AG.01.h.01,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130356,and,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130357,vegetables,B-AG.01.h.02,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130358,was,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130359,demonstrated,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130360,",",O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130361,suggesting,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130362,that,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130363,there,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130364,may,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130365,be,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130366,a,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130367,group,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130368,of,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130369,cross,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130370,allergies,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130371,.,O,4533.0,"A high correlation between positive skin test reactions to spices , especially to curry and its components , and tree pollens , fruits and vegetables was demonstrated , suggesting that there may be a group of cross allergies ."
130372,Clinical,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130373,symptoms,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130374,from,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130375,ingested,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130376,spices,B-AG.01.l.03,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130377,were,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130378,noticed,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130379,by,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130380,five,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130381,patients,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130382,.,O,4534.0,Clinical symptoms from ingested spices were noticed by five patients .
130924,Critical,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130925,knowledge,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130926,on,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130927,these,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130928,compounds,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130929,and,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130930,their,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130931,signaling,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130932,pathways,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130933,may,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130934,help,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130935,in,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130936,formulation,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130937,of,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130938,effective,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130939,anticancer,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130940,drugs,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
130941,.,O,4552.0,Critical knowledge on these compounds and their signaling pathways may help in formulation of effective anticancer drugs .
131417,Natural,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131418,compounds,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131419,of,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131420,plant,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131421,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131422,fungus,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131423,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131424,and,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131425,actinomycetes,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131426,origin,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131427,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131428,such,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131429,as,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131430,phenolics,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131431,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131432,polyketides,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131433,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131434,tetrapeptide,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131435,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131436,terpenoids,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131437,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131438,alkaloids,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131439,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131440,and,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131441,hydoxamic,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131442,acid,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131443,",",O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131444,have,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131445,been,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131446,reported,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131447,to,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131448,show,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131449,potential,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131450,HDAC,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131451,-,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131452,inhibitory,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131453,activity,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
131454,.,O,4569.0,"Natural compounds of plant , fungus , and actinomycetes origin , such as phenolics , polyketides , tetrapeptide , terpenoids , alkaloids , and hydoxamic acid , have been reported to show potential HDAC - inhibitory activity ."
132165,The,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132166,low,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132167,de,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132168,novo,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132169,diet,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132170,significantly,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132171,increased,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132172,plasma,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132173,Zn,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132174,and,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132175,milk,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132176,Zn,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132177,content,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132178,",",O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132179,whereas,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132180,dietary,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132181,Zn,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132182,level,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132183,did,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132184,not,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132185,in,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132186,itself,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132187,influence,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132188,these,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132189,parameters,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
132190,.,O,4594.0,"The low de novo diet significantly increased plasma Zn and milk Zn content , whereas dietary Zn level did not in itself influence these parameters ."
